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South Africa has one of the highest HIV prevalence rates globally, with nearly 2.5 
million people accessing antiretroviral treatment (ART) at the end of 2013. Retaining 
patients on ART has become a major problem in this country.  When patients no longer 
show up for ART for unknown reasons, they are considered “lost to follow-up” (LTF). 
LTF is the highest contributor to ART attrition. This study, guided by the health belief 
model, evaluated the effectiveness of a technology-based, mobile health (mHealth) 
appointment reminder intervention on LTF among patients accessing ART services.  The 
study ascertained differences in 6- and 12-month LTF rates between patients enrolled in 
the mHealth intervention (n = 832) and those in the standard of care comparison group (n 
= 918). A quantitative, retrospective cohort approach was used to answer the research 
questions using binary logistic regression analyses. The mHealth intervention was found 
to be significantly linked to lower likelihood of 6- and/or 12-month LTF among patients. 
There were 2 other key findings: a positive correlation between pregnancy and LTF, and 
a positive correlation between viral load increases and LTF. This study added evidence to 
the existing literature on the effectiveness of using mHealth-based interventions to 
improve HIV/AIDS care. Based on these findings, professionals should pay special 
attention to pregnant women and those clients with increasing viral loads to ensure they 
are not LTF. Positive social change that may result from this study is better health 
outcomes for patients on ART due to reduced risk of HIV related complications and other 
illnesses.  This awareness would improve the lives of the patients, and positively impact 
their families, communities, and ultimately the global community, by reducing the overall 
impact of HIV disease.    
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Chapter 1: Introduction to the Study  
Introduction 
This study was a program evaluation of a mobile health (mHealth) - based patient 
appointment reminder intervention to improve retention in antiretroviral treatment (ART). The 
intervention was implemented in September 2012, at a large public sector ART clinic in an inner 
city setting in Johannesburg, South Africa.  
Globally, Sub-Saharan Africa is the worst hit with the HIV/AIDS epidemic, with over 
70% of HIV-positive people living in this part of the world (UNAIDS, 2012). This region has 
been very successful in enrolling individuals on ART (Micek et al., 2009). In South Africa there 
were over 2.5 million individuals on ART in the public sector as of October, 2013 (Ojikutu, 
2008; PEPFAR annual report, 2013).  Most people on ART obtain their care and treatment at 
public sector sites that are managed by the South African government.  
As the ART programs have scaled up, the focus for most countries has moved from 
initiating patients on ART to retaining them, since being on ART is a lifelong commitment 
(Barnighausen et al., 2011). According to one study conducted in Sub-Saharan Africa, only 60% 
of patients were still on ART 2 years after starting treatment (Rosen, Fox, & Gill, 2007). A few 
studies have been published on interventions designed to improve patient retention, especially on 
tracing and following up with patients who drop out the ART program (Rosen & Ketlaphile, 
2010). While these programs have demonstrated improvement in ART retention rates, there is a 
need for more interventions that account for the context of patients dropping out or the reasons 
why patients become lost to follow-up (LTF) (Miller, Ketlaphile, Rybaseck-Smith, & Rosen, 
2010). LTF is defined as the disappearance of individuals from ART for no known reason. The 
US Government’s definition for LTF is patients who have not returned to their ART clinics for 
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follow-up appointments or medicine pick up in more than 3 consecutive months (PEPFAR, 
2007).  It is the largest contributor to ART attrition, followed by death (Rosen & Ketlhapile, 
2010). 
One approach that may be useful withtackling the LTF issue is mHealth.  mHealth is “the 
practice of medical and public health via mobile communication devices” (Catalani, Philbrick, 
Fraser, Mechael, & Israelski, 2013, p. 17), and it has numerous applications in the field of public 
health (Rodrigues et al., 2012; Tomlinson, Rotheram-Borus, Swartz, & Tsai, 2013). mHealth is a 
growing field. It is considered to have great potential for strengthening health service delivery 
which can lead to positive health outcomes, especially in resource-poor countries (Free et al., 
2013), where the mobile phone is the fastest growing communication sector (Bahadur & Murray, 
2010). The existing research and knowledge base around HIV/AIDS and mHealth primarily 
pertains to pilot projects, with a few qualitative studies and a handful of clinical trials (Bahadur 
& Murray, 2010). There is a gap in the literature on (a) outcomes of full-scale mHealth 
interventions to reduce missed ART follow-up appointments and (b) LTF rates among patients 
on ART. This study sought to obtain evidence on the outcomes of an intervention—implemented 
following formative and pilot research phases—in an effort to reduce the gap in the literature.   
Improving retention in HIV care and treatment by reducing LTF are priority areas for the 
South African Department of Health (South African National Strategic Plan on HIV, STIs and 
TB 2012-2016, 2012). The positive social change implication of this intervention and its 
evaluation are significant as improved retention will lead to better patient health outcomes.  
This chapter covers the following topics: a summary of the issue based on data from the 
scientific literature, problem statement, purpose of the study, methodology, research questions 
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and hypotheses, the theoretical framework, variables and their definitions, assumptions, scope, 
limitations, and significance of this study to the field of HIV/AIDS.  
Background  
Globally, there has been a surge in access to ART over the last few years, with a 20-fold 
increase in Sub-Saharan Africa (Micek et al., 2009). Access to ART has dramatically increased 
in the last few years in South Africa since the government rolled out its ART program in 2004. 
The country has the largest ART program in Sub-Saharan Africa with over 2.5 million people on 
ART in the public sector as of October, 2013 (Ojikutu, 2008; PEPFAR annual report, 2013).  
Treatment Retention  
While great strides have been made initiating patients on ART, low patient adherence and 
retention in HIV treatment have raised concerns about long-term outcomes (Maskew, MacPhail, 
Menezes, & Rubel, 2007). Rosen et al., (2007), conducted a systematic file review of ART 
programs in Sub-Saharan Africa and found that, overall, 25% of patients had dropped out by end 
of Year 1 of ART initiation, with this number rising to 40% by Year 2 on ART. Researchers in 
Malawi found that the median time between ART initiation and patients dropping out was 4.3 
months (Yu et al., 2007). Dalal., et al (2007), found the median time between initiation on ART 
and first missed appointment at a public sector, tertiary hospital serving the inner city of 
Johannesburg, South Africa, to be 84 days (IQR 43-168 days, range 13-392 days). 
LTF and death are the most commonly identified reasons for attrition from ART (Rosen 
et al., 2007). Approximately 56% of the treatment attrition is a result of LTF and another 40% is 
due to death (de Pee, 2010). LTF is a major issue for the South African ART program too. LTF 
rates from a multi-site, patient file audit at public sector clinics in two provinces in South Africa 
between 2006 and 2009 were found to be between 14-25%, with the largest proportion of 
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patients becoming LTF within the first 6 months of starting ART (Jaffer et al., 2007). A large 
public sector clinic with over 7,000 patients enrolled on ART in Johannesburg had a LTF rate of 
16.4% among patients initiating ART over a 4-year period. Forty percent of the individuals at 
this clinic became LTF in the first 3 months after starting on ART (Rosen & Ketlhapile, 2010).  
LTF is a major public health issue because patients who discontinue ART are at high risk 
of developing virological failure, acquiring opportunistic infections, and early mortality (Rosen 
et al., 2007; Unge et al., 2010). Harries, Zachariah, Lawn and Rosen (2010), conducted a meta-
analysis of 16 studies in Sub-Saharan Africa and found that 20-60% of patients who were 
identified as LTF had died. Researchers in Malawi found that about 50% of the patients who had 
been identified as LTF had died, most dying soon after they missed their clinic follow-up 
appointment (Yu et al., 2007). Dalal et al., (2007), conducted a study at an ART clinic in a 
tertiary government hospital in Johannesburg, South Africa and found that one in six patients 
initiating ART were LTF. Once again, approximately 50% had died; a majority died within 30 
days of missing their appointments (Dalal et al., 2007).  
Missed appointments and LTF  
 Missed clinical appointments have been found to be a significant risk factor for 
developing virological failure and AIDS-defining illnesses (Lucas, Chaisson & Moore, 1999; 
Rastegar, Fingerhood & Jasinki, 2003), and death (Park et al., 2007). Viral resistance can 
develop quickly in an individual with poor adherence to ART. It can occur after only 11-30% 
missed ARV doses (Maskew et al., 2007). Missed appointments can also negatively impact 
health service quality because they can increase cost and lower efficiency of service delivery 
(Guy et al., 2012). Results from a South African study to ascertain the relationship between 
missed appointments early in the treatment phase of patients initiating ART and the health 
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outcomes of the patients indicated that in a 12-month period after initiating ART, only 65% of 
individuals attended all follow-up visits as scheduled. Of these, 2.6% of the patients had died and 
6.2% were LTF. In addition, a higher number of missed clinical appointments were found to be 
associated with increased risk of mortality and LTF during the study period. The researchers also 
found that patients who missed three or more ART or clinical appointments were at high risk of 
low CD4 improvement. Furthermore, patients with three or more missed ART appointments 
were at increased risk of not achieving viral suppression by 6 months compared to the patients 
who did not miss any appointments (Brennan, Maskew, Sanne, & Fox 2010). 
Regular clinic visits reflect good retention in care among patients on ART (Geng et al., 
2010). Poor retention in care is reflective of low treatment adherence and of treatment cessation. 
Once treatment is interrupted, the effects of ART can quickly reverse and cause harm to the 
patients (Geng et al., 2010). Patient tracking has been recommended by some researchers while 
others have suggested some form of reminder system, which could reduce the rate of missed 
appointments (Dalal et al., 2007; Kliner, Knight, Mamvura & Wright, 2013). Other researchers 
have recommended implementing a patient tracer program, whereby patients missing their clinic 
appointments are contacted and asked to return to the clinic in a timely manner (Yu et al., 2007). 
Researchers studying the effectiveness of tracer projects have found improvements in patients 
returning to the facility after being contacted by a patient tracer. In a Kenya-based study, the rate 
of return of patients was found to be 65% and 49% in urban and rural areas respectively (Rosen 
& Ketlhapile, 2010). However, this type of intervention can be resource intensive, based on 
patient load per tracer, follow-up workers’ salaries, transportation, and communication costs 
(Rosen & Ketlhapile, 2010). Therefore, there is ongoing search for alternate, efficient, and cost-
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effective ways of tracing or communicating with patients to help them maintain good 
appointment adherence and retention in care. 
Some of the reasons documented for missed appointments include forgetfulness, 
confusion regarding follow-up appointment dates, relocation, illness, hospitalization, 
transportation cost, side effects, death, and insufficient medication supply (Dalal et al., 2007; 
Maskew et al., 2007). Forgetting appointments is a common reason given by patients in a variety 
of health care settings (Guy et al., 2012; Kliner et al., 2013; Leong et al., 2006). The intervention 
evaluated by this study aimed to reduce appointment forgetfulness among patients on ART by 
sending them multiple reminders.  
Mobile Health technology to improve health services  
mHealth is defined as “the practice of medical and public health via mobile 
communication devices” (Catalani et al., 2013, p.13). Mobile technology includes cell phones, 
patient monitoring devices, personal digital assistants, and other equipment. (Bahadur & Murray, 
2010). mHealth is a rapidly growing field. It is considered to have a great potential for 
strengthening health service delivery and leading to positive health outcomes especially in 
resource poor countries (Free et al., 2013). The acceptance of cell phones and their low cost has 
led to the quick uptake of mHealth technology in health services (Rodrigues et al., 2012).  
mHealth has great potential for success in South Africa since the country has one of the 
highest proportions of mobile phones per capita, with over 90% of people having a mobile phone 
subscription (Leon, Schneider & Daviaud, 2012). Researchers exploring the feasibility and 
acceptability of mHealth related interventions in the South African population found a high level 
of interest and acceptability (Crankshaw et al., 2010). The South African government has also 
shown a keen interest in the use of mHealth technology in the public health care sector. In 2012, 
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the National Department of Health (NDoH) circulated a comprehensive eHealth strategy, which 
included the need for development, implementation, and evaluation of mHealth interventions to 
strengthen the public health sector (NDoH, 2012). In addition, there is growing support by the 
United States government, the World Health Organization, multinational companies, and other 
private entities (such as the cell phone network providers) to develop, implement, and evaluate 
innovative mHealth interventions to help strengthen the South African government’s response to 
the HIV epidemic.  
SMS-related interventions in HIV care and treatment 
SMS or text messaging is a well-established technology that is used around the world. It 
is a cheap and efficient method of two-way communication, which costs much less than a cell 
phone call. Over the last few years, SMS has become the most prevalent mHealth technology 
application (Bahadur & Murray, 2010; Leong et al., 2006). Bahadur and Murray (2010), 
conducted a literature review between February and December 2008, to examine the use of SMS 
in health care settings. They found SMS to be an efficient, cost-effective, and appropriate 
technology for strengthening various health services sectors. However, Bahadur and Murray 
noted that some researchers were skeptical about the evidence for the effectiveness of SMS, 
since many of the reports or articles generated were from pilot projects or feasibility studies. 
They concluded that while SMS has been found to be effective in the public health sector, there 
is a need for further rigorous review of the benefits of this technology to improve health services 
in South Africa (Bahadur & Murray, 2010). In addition, none of the studies reported by Bahadur 
and Murray pertained to use of SMS to improve ART clinic attendance.  
	  	  	  
 
8 
SMS to improve adherence on ART  
Patient adherence to ART is crucial for continued benefits of ART in avoiding the 
development of viral resistance, reducing opportunistic infections, and early mortality (Rosen et 
al., 2007). In addition, adherence to ART has been linked to improved health outcomes; 
adherence is important to contain undue program costs (Lester et al., 2010). Since adherence is 
crucial for ART success, a number of interventions have been developed and implemented over 
the last few years. These have ranged from direct administration of ART, provision of financial 
incentives, education, additional counseling regarding adherence, facilitation of social support, 
and electronic and phone reminders (Rodrigues et al., 2012). In the last 3–5 years, a handful of 
studies have been conducted in resource-constrained countries that explored the use of SMS in 
improving ART adherence. These studies, which have included RCTs, have found an overall 
positive correlation between SMS or other mHealth intervention and increase in adherence to 
ART (Lester et al., 2010; Pop-Eleches et al., 2011; Rodrigues et al., 2012). 
SMS for Clinic Appointment Reminders 
Use of SMS to improve clinic appointment adherence in primary health care and other 
settings has been recorded by some studies; however, studies looking at SMS for improving 
ART appointment reminders have been minimal in the peer-reviewed or published literature. 
SMS reminders have been found to be effective in improving follow-up appointment adherence 
in numerous health care settings, including primary health care (Leong et al., 2006), medical 
male circumcision (Odeny et al., 2012), pediatrics, ophthalmology, orthodontics, and preventive 
health (Guy et al., 2012). 
The importance of adherence to and retention in care of patients on ART is well 
documented in the scientific literature, along with the need for interventions to tackle these 
	  	  	  
 
9 
issues. mHealth is a rapidly growing field and researchers have found strong evidence of 
associations between mHealth and HIV treatment adherence in a handful of clinical trials. 
However, there is a need for more information from program outcomes and clinical trials 
(Bahadur & Murray, 2010). In addition, there is a gap in the peer- reviewed and grey literature 
on studies that examine the effectiveness of SMS on improving ART clinic appointment 
adherence among patients receiving ART services in South Africa.  
This study was a program evaluation of an appointment reminder intervention, which was 
rolled out at a large government funded ART clinic in Johannesburg, South Africa, with over 
16,000 patients enrolled on ART since 2004. This study was important because it attempted to 
fill the gap in the literature about the use and effectiveness of mHealth to strengthen the public 
sector HIV/AIDS treatment programs in South Africa. The appointment reminder intervention 
was developed after a comprehensive project development cycle, which included formative 
studies (feasibility and acceptability studies), and a pilot phase.  
Problem Statement 
ART has been successfully scaled up globally and specifically in resource-limited 
settings such as Sub-Saharan Africa, leading to improvements in health outcomes of HIV- 
positive individuals (Brennan et al., 2010). However as programs have scaled up, treatment 
attrition has become an issue. LTF is the largest contributor to attrition, followed by death 
(Rosen & Ketlhapile, 2010). People who are HIV positive are expected to take the antiretrovirals 
(ARVs) for the rest of their lives to suppress viral replication (Ketlhapile, Rybasack-Smith & 
Rosen, 2010). Thus, adherence to ART is also expected to be life-long (De Pee, Grede, Forsythe 
& Bloem, 2012). As mentioned earlier, nonadherence to the ART regimen can lead to 
development of viral resistance, opportunistic infections, treatment failure, and early mortality 
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(Unge et al., 2010). Despite the known risks associated with nonadherence to ART, LTF and low 
treatment adherence remain a major challenge (Brennan et al., 2010).  
Following the emergence of evidence of high LTF rates in the HIV/AIDS programs; 
studies have been undertaken over the last 5–7 years to (a) identify the LTF rates globally (Dalal 
et al., 2007; Rosen et al., 2007; Yu et al., 2007), (b) understand the reasons for LTF (Miller et al, 
2010), (c) ascertain the impact of LTF on patient health outcomes, and (d) determine outcomes 
of interventions such as patient tracer programs using clinic and/or community-based individuals 
to bring the patients back to the clinic (Rose & Ketlhapile, 2010). Studies have also been 
conducted on use of innovative methodologies and technologies to improve adherence to ART 
(Lester et al., 2010). Some of the conclusions and recommendations from these studies were as 
follows:  
! Interventions are needed to respond to the reasons for LTF (Unge et al., 2010).  
! More evidence is needed on the effectiveness of interventions designed to 
improve short- and long-term retention in ART (Barnighausen et al., 2011).  
! The work must move beyond pilots to ascertain the outcomes of implemented 
interventions (Bahadur & Murray, 2010),  
! More evidence is needed from studies conducted in resource-limited settings, 
since most evidence is from resource-rich settings (Barnighausen et al., 2011). 
! Ascertain the results from innovation- and context-based interventions, which are 
developed based on the reasons for LTF (Unge et al., 2010).  
Most of these conclusions reflect gaps in the current literature. The scope of this 
evaluation study was limited to ascertaining the role of mHealth to reduce missed appointments 
and lower resulting LTF. Nonetheless, both the appointment reminder intervention and its 
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evaluation were based on some of the above mentioned recommendations and conclusions found 
in the literature. The appointment reminder intervention was developed in response to the issue 
of appointment forgetfulness among patients on ART. It was rolled out following a formative 
and pilot research phase, and conducted in a resource limited setting. The intervention was 
designed to prevent the occurrence of LTF among patients on ART; it was also a way for the 
clinic to keep in touch with its clients.  
Purpose of the Study 
This quantitative, retrospective, cohort study analyzed existing secondary data. The study 
purpose was to evaluate the effectiveness of a mHealth appointment reminder intervention to 
improve retention in care of patients by reducing LTF rates among patients on ART. The intent 
was to compare LTF outcomes between the intervention and comparison groups at two points in 
time. The intervention group included individuals on ART who enrolled in the intervention 
between September 1, 2012 and February 28, 2013. The comparison group consisted of 
randomly selected individuals on ART at the clinic who were not enrolled in the intervention. 
Individuals in both the intervention and comparison groups were assigned to one of six cohorts 
based on their time on ART as at September 1, 2012. The six cohorts (listed below) were formed 
based on historical LTF information found from a patient file review conducted at this clinic in 
2009.  
Cohort 1: Individuals initiated on ART between September 1, 2012 and February 28, 
2013. 
Cohort 2: Individuals initiated on ART from 1-6 months prior to September 1, 2012. 
Cohort 3: Individuals initiated on ART from 7-12 months prior to September 1, 2012. 
Cohort 4: Individuals initiated on ART from 13-24 months prior to September 1, 2012. 
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Cohort 5: Individuals initiated on ART from 25-36 months prior to September1, 2012. 
Cohort 6: Initiated on ART more than 36 months prior to September 1, 2012. 
The independent variable was the presence or absence of the ART appointment reminder 
intervention. The dependent variables were LTF at 6 and 12 months from September 1, 2012. 
The two time periods were selected based on evidence from mHealth-based ART adherence 
studies found in the literature. These studies found significant differences in adherence to ART 
in the 6- and 12-month timeframes (Lester et al., 2010; Rodrigues et al., 2012). LTF for the 
comparison group was determined to be June 1, 2013, and December 1, 2013 respectively (90 
days after 6 and 12 months from September 1, 2012 – the start date of the intervention, based on 
the PEPFAR definition of LTF). Age, gender, baseline CD4 count, concurrent illnesses, ART 
regimen, and ART side effects were considered covariate variables for this study.  
Research Questions and Hypotheses 
This study was guided by the following research questions and hypotheses: 
Research Question 1. Is there a difference in 6-month LTF rates between clients in the 
ART appointment reminder intervention and clients in the standard of care comparison group 
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa, after 
controlling for the identified covariates? 
 Ho1. There are no statistically significant decreases in the likelihood of 6-month LTF for 
clients on ART who received the appointment reminder intervention when compared to 
clients in the standard of care comparison group.  
Ha1. There are statistically significant decreases in the likelihood of 6-month LTF for 
clients on ART who received the appointment reminder intervention when compared to 
clients in the standard of care comparison group. 
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Research Question 2. Is there a difference in 12-month LTF rates between clients in the 
ART appointment reminder intervention and clients in the standard of care comparison group 
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after 
controlling for the identified covariates? 
 Ho2. There are no statistically significant decreases in the likelihood of 12-month LTF for 
clients on ART who received the appointment reminder intervention when compared to 
clients in the standard of care comparison group.  
Ha2. There are statistically significant decreases in the likelihood of 12-month LTF for 
clients on ART who received the appointment reminder intervention when compared to 
clients in the standard of care comparison group. 
Basic demographic information, along with the ART initiation date, baseline CD4 count, 
ART side effects, and concurrent illnesses were collected at the beginning of the study. 
Theoretical Framework for the Study  
The theoretical foundation for this study was the health belief model (HBM), which was 
developed to explain the relationship between health practices, behaviors, and health service 
utilization. Later, the model was revised to study people’s behavioral responses to health-related 
conditions (Rosentock, Stretcher, & Becker, 1994; Janz & Becker, 1984). HBM is one of the 
most widely used theories in the field of public health. It has been the basis of numerous 
population studies to explain health-related behavior among different types of populations 
(Rosenstock et al., 1994), as well as health promotion and disease prevention interventions 
(Burke, 2014). 
Initially, four perceptions formed the main constructs of HBM: perceived seriousness, 
perceived susceptibility, perceived benefits, and perceived barriers. Later, three other constructs 
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were added: cues to action, motivating factors, and self-efficacy. The latter three constructs 
affect the initial four perception-related constructs (Hayden, 2009).  
The construct of interest for this study was “cues to action.” A theoretical framework was 
not incorporated in the intervention design. However, some assumptions were made based on the 
literature review, that is, individuals who had agreed to partake in the appointment reminder 
intervention had experienced the various HBM perceptions when they initiated on ART and 
received adherence counseling from the clinic staff, which included information on following the 
ART regimen, looking out for side effects, and the importance of treatment adherence. Another 
assumption was that an individual’s decision to initiate ART indicated that its perceived benefit 
had been recognized. Similarly, the individuals may have also perceived a benefit to the 
intervention offered, and believed that they had the ability to adhere to their follow-up clinic 
appointments.  
The rationale for choosing the “cues to action” was that the appointment reminder was an 
external trigger to help participants maintain or improve their clinic appointment adherence 
behavior. As explained later in the chapter, the participants received three reminder “cues” 
between appointments (usually 30 days); one message was sent 2 weeks before the appointment, 
another a day before, and one the day after the appointment. In terms of the theoretical model, 
the key question of this study was: how effective were the cues to action in leading to the desired 
behavior or intervention?   
Cues to action can be internal or external events, an exchange of information or 
communication that can influence human behavior change. The cues can be developed to raise 
awareness or provide specific advice to the target audience.  Cues can also result from 
experiences of or events occurring in the individuals’ circle of influence, for example, a similar 
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illness in a family member (Hayden, 2009).  According to the HBM, one or more cues are 
generally required to serve as a “trigger” for initiation of healthy behavior (Olsen, Smith, Oei, & 
Douglas, 2010). 
According to Olsen et al. (2010), HBM has been heavily investigated to predict 
adherence in several disease models, including for prostate cancer screening, mammography, and 
general health promoting behaviors.  However, very few studies have measured the cues to 
action. Olsen et al. also mentioned that it is difficult to assess the effect of the cues prospectively, 
that is, before the behavior change happens. Thus cues to action studies are often designed as 
retrospective cross-sectional studies in order to understand the effects of the prompts on the 
desired behavior modification (Olsen et al., 2010). This was a key point in this study’s 
development phase, which was designed as a retrospective assessment of the appointment 
reminder cue to improve clinic appointment adherence among individuals on ART. Some of the 
HIV/AIDS-related studies based on HBM constructs and conducted in the international health 
arena used different cues to action methodologies, such as drama or song, to increase HIV/AIDS 
knowledge and to remind participants to adopt safer sexual behaviors (Bosompra, 2007). 
Rochon et al., (2011) conducted a qualitative study to ascertain feasible communication 
strategies that could influence ART adherence. The authors found that cues to action was one of 
the acceptable and feasible constructs for communicating adherence messages to patients on 
ART (Rochon et al., 2011). The results from the study indicated the acceptability and feasibility 
of using cues to improve adherence on ART, thus strengthening the rationale for this study to test 
whether appointment reminders would be effective in bringing about adherence (attending all 
appointments) and thus lower LTF rates in the population.  
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Nature of the Study 
The rationale for designing this study as a retrospective cohort study was that it was an 
outcome evaluation of an appointment reminder intervention, which was implemented in 
September 2012. The goal was to ascertain the effectiveness of the intervention in reducing LTF 
among patients on ART at the clinic. Retrospective project and clinic data was used in this study 
to answer the research questions. A quantitative method of inquiry was chosen for this evaluation 
as it would yield the information required to answer the research questions.   
The key independent variable for this study was the presence or absence of the 
intervention. Individuals enrolled in the intervention group should have received three reminders 
for each appointment. Follow-up appointments were usually 1 month apart, although the clinic 
could have scheduled appointments every 2 months for some stable patients. The study 
covariates were age, gender, CD4 counts (first, baseline and current), ART regimen, concurrent 
illnesses, ART side effects, and viral load.  There were two dependent variables in this study. 
These were LTF at 6 and 12 months after the intervention was implemented at the site. LTF 
outcome was determined when a patient had not returned to the ART clinic or picked up their 
ARVs for at least 3 consecutive months (PEPFAR SASI Manual, 2007). Individuals who died 
during the study period were noted but not included in the analysis.  
Fieldworkers were hired by the mHealth team to recruit participants in the intervention 
and for data collection for the project. After a comprehensive training and mentoring phase, the 
fieldworkers were placed at Ward 21 and asked to be present at the clinic every day. They 
approached patients in the waiting room, ascertained if the patient was eligible to participate by 
asking if they were on ART, explained the intervention to qualifying patients, and asked them if 
they wanted to enroll. If the patients agreed to participate in the intervention, the fieldworkers 
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walked them through an informed consent process. The consent form was approved by the Wits 
University IRB, which is the regulatory body for the host institution that implemented the 
intervention. The mHealth team developed data capturing tools and an electronic database for the 
intervention. The field workers collected the information in the intake forms and transferred it to 
the database at the end of each day. The clinic uses an electronic patient management and a 
pharmacy dispensing system, which the project team accessed to obtain patients’ demographic, 
clinical and follow-up appointment information. The team used patients’ clinic ID numbers as 
identifiers in the intake forms and for the project database. They also assigned unique 
intervention IDs for the individuals enrolled in the intervention. 
Permission was obtained from WRHI to request for the retrospective program data from 
September 2012 to June 2014. This would cover the twelve month plus 90 days follow-up period 
for all the individuals who enrolled in the intervention between September 2012 and February 
2013. Determination of LTF at 90 days after the end of six months of enrollment was based on 
the PEPFAR definition of assigning the LTF status (PEPFAR SASI Manual, 2007). In addition, 
permission was obtained to request for retrospective data from the clinic database for 
demographic, clinical, and appointment information for the intervention and comparison groups.  
The project data was in Microsoft Excel file format. Additional demographic and study 
related data were included in this database as relevant. All study data was cleaned (i.e., reviewed 
for errors) then exported to SPSS 21.0 for data analyses. All the study variables were assigned a 
variable name, with the variable values coded (e.g. male = 1 and female = 0). Descriptive 
statistics were computed for the study variables, inclusive of study covariates. The mean, 
standard deviation, and minimum and maximum values were computed for ratio variables and 
frequencies, and percentages were calculated for dichotomous and categorical variables.  
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Spearman’s rho correlations and model chi-square analyses were conducted between each 
of the study covariates and the two dependent variables. Covariates found to be associated with 
the dependent variables with p-values of < 0.25 were included as predictor variables in the 
logistic regression analyses, performed to address the study research questions. The p-value 
criteria of < 0.25 for covariate association were used for analysis based on the assumption that a 
covariate may not be significantly associated independently but may contribute to the model in 
conjunction with other variables. Two binary logistic regression analyses were conducted for the 
two dependent variables, LTF at 6 months and 12 months. Binary logistic regression was 
selected for this study as the dependent variables were dichotomously coded and the relationship 
between the intervention and the outcomes of LTF could be determined when covariate variance 
was accounted for (Agresti, 2013). The model chi-square (χ²) determined the significance of the 
overall regression model, while the classification table generated by the statistical tool 
determined correct classification of the dependent variable categories based on the predictors in 
the model (Agresti, 2013). The Hosmer-Lemeshow (H-L) statistic for logistic regression, which 
answers the question, “how best does my model fit the data?” was used as the model goodness-
of-fit statistic (Allison 2013). In the regression model, any probability value of significance (p-
value) less than or equal to 0.05 were considered statistically significant. 
Definitions  
  The independent variable for this study was presence or absence of the appointment 
reminder intervention. Presence of intervention was defined as individuals at the clinic who 
enrolled in the appointment reminder intervention between September 1, 2012 and February 28, 
2013. Absence of intervention was defined as all individuals who attended the clinic during the 
study period but did not enroll in the intervention. This group of individuals received the 
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standard of care provided by the clinic. Age and gender was collected as part of basic 
demographic information. Below are definition of key study variables and covariates: 
Age. Client age at initiation of ART was used as a measure of age. Age is a ratio variable 
and was calculated in years. 
Gender. Gender was a dichotomous variable where 1 = male and 0 = female. 
ART Initiation Date. ART initiation date was the date the person started on ART at the 
clinic and considered as time zero for ART follow up. 
Baseline CD4 count. Baseline CD4 was defined as the most recent CD4 count available 
within 3-6 months prior to ART initiation. CD4 count is the number of CD4 cells, a type of white 
cell that fights infection, in the body. A low baseline CD4 count can put a person at a high risk of 
getting sick. It can have an effect on adherence to ART appointment and loss to follow up. For 
the purpose of this study, Baseline CD4 was the most recent CD4 count available within 3-6 
months prior to ART initiation (The ART Cohort Collaboration, 2011) 
ART regimen. This covariate was a categorical variable based on two types of ART 
regimens commonly prescribed in the public sector sites in South Africa. Some patients in South 
Africa receive a combination prescription if ARV side effects and other physiological or 
psychological issues arise. The commonly prescribed regimens as per the National ART 
Treatment Guidelines, 2004 are:  
First line: Regimen1a - d4T / 3TC / efavirenz; Regimen1b - d4T / 3TC / NVP 
Second line: Regimen 2 - AZT / ddI / lopinavir / ritonavir 
Concurrent illnesses. This covariate was based on the presence of concurrent illnesses as 
noted in the patient’s records. These were any other illnesses or diseases that manifested in the 
patient and could have affected the patient’s clinic attendance and LTF outcome. For example, 
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tuberculosis, mental health issues, cancer, herpes zoster and other illnesses. The concurrent 
illnesses was coded by the type of illness and number of occurrences. 
ART side effects. This covariate was based on evidence of ART side effects as noted in 
the patient’s records. These can cause unplanned delays in patient returning to the clinic for their 
appointments, therefore it is important to note these. These were coded by type of side effect and 
number of occurrences. 
Loss to Follow up. Programmatically, Lost to Follow up is defined as the disappearance 
of the individuals from ART for no known reason (Rosen et al., 2007). For the purpose of this 
study a patient was considered lost to follow up if they had not been to the clinic or had not 
picked up their ARVs for at least 3 consecutive months. (PEPFAR Strategic Information Manual 
South Africa, 2007).  
Virological failure. Plasma viral load above 1000 copies/ml based on two consecutive 
viral load measurements after 3 months, with adherence support. (WHO, 2013); Virologic failure 
happens when anti-HIV medications cannot reduce the amount of virus in the blood. While 
taking medications, viral load drop or it repeatedly rises again after having dropped (NIH, 2014). 
Assumptions 
This study was based on the following assumptions:  
! The study population was representative of the population on ART in any urban-
based public health facility in South Africa. The population accessing services at 
the clinic was considered to be heterogeneous which was reflective of the 
catchment population of the clinic.  
! The participants felt comfortable about their confidentiality when enrolling in the 
intervention and felt that they had an option to opt out. The fieldworkers were 
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trained to review the patient confidentiality information with the participants, and 
the participants were informed that they could opt out at any time. A separate 
SMS number was specially created which participants could use if they wanted to 
opt out of the intervention.  
! Individuals who had agreed to partake in the appointment reminder intervention 
may have experienced the various HBM perceptions when they initiated on ART, 
and they had received adherence counseling from the clinic staff which included 
information on following the ART regimen, looking out for side effects, and the 
importance of treatment adherence. An individual’s decision to initiate on ART 
may indicate that the individuals saw the perceived benefit of ART. The 
individual may have also seen a perceived benefit of the intervention offered and 
believed that they had the ability to be adherent to their follow-up clinic 
appointments.  
The assumption regarding heterogeneity of the population was necessary to allow for 
generalizability to other urban populations in South Africa. The clinic population includes 
individuals from various social, economic and cultural backgrounds. Thus any strong tendencies 
or circumstances pertaining to social, economic, environmental, mental and other factors among 
individual participants that could grossly affect or skew the outcomes were not expected. The 
assumption regarding freedom to opt out was necessary since individuals self-selected to receive 
the appointment reminder intervention. The individuals should not have felt at any time that they 
were coerced into enrolling in the intervention. The assumption about the perceived benefit of 
being on ART was important as individuals needed to be at a particular level of readiness to 
consider and take advantage of the intervention as a useful tool to improve their health outcomes. 
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Scope and Delimitations 
This study sought to ascertain the effectiveness of an appointment reminder intervention 
in reducing LTF rates among patients on ART in a resource-constrained setting. The intervention 
was developed based on the information found in the literature, which indicated a correlation 
between missed appointments with LTF (Brennan et al., 2010; Geng et al., 2010). As mentioned 
earlier, South Africa has made great strides in enrolling a large number of people on ART since 
the national ART roll out started in 2004. However, patient attrition from ART negatively affects 
the achievements, and the long-term effects of LTF have a worse impact on the individual’s 
health as it puts them at undue risk of adverse events such as viral resistance and treatment 
failure (Rosen et al., 2007).  
The intervention population included all adults on ART including pregnant women at the 
ART clinic, Ward 21, located at the HCHC in the inner city of Johannesburg, South Africa. 
Ward 21 had over 16,000 individuals on ART when the appointment reminder intervention was 
implemented. The study sample comprised all individuals who chose to enroll in the intervention 
(intervention group) during the defined study period, and a randomly selected sample of 
individuals on ART at the clinic but not enrolled in the intervention (comparison group). 
Children under 18 years old were excluded from the intervention and the study because there are 
different treatment guidelines and regimens for the pediatric population. The cues to action 
construct of the HBM was deemed to be the most relevant for the study’s theoretical framework.  
The study outcomes were generalizable to other urban settings in South Africa since the 
appointment reminder intervention was rolled out as a health services improvement intervention, 
and the fact that there was a treatment and a comparison group, along with the assumption that 
the individuals assessing the services at the clinic were representative of typical urban based 
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populations accessing public sector ART sites in South Africa. Some of the dynamics may be 
different in a rural setting and may need a separate inquiry. 
Limitations 
This study was subject to the following limitations:  
!  The lack of random selection of individuals to enroll in the intervention. The 
intervention was rolled out as a health services improvement project and not as a 
research study. It had been piloted and found to be effective in improving adherence 
to clinic appointments at a primary health facility in the inner city of Johannesburg. 
When the intervention was implemented, patients on ART attending the clinic were 
approached and the intervention was offered to them. The intervention enrollment 
period was from September 2012 to December 2013. Based on the recruitment 
design, the participants self-selected to receive the intervention, and thus there was a 
risk of selection bias. All individuals enrolled in the intervention between September 
2012 and February, 2013 (the study period), who received the intervention as planned 
without major information missing were assigned to the intervention group. A partly 
purposeful, partly random stratified approach was used to select individuals on ART 
at the clinic but not exposed to the intervention, for assignment to the control group.   
! Following lessons learned from the pilot phase, the mHealth team made a major 
modification to the original project design. Instead of offering only the appointment 
reminder intervention to individuals newly (< 30 days) initiated on ART, all 
individuals on ART (regardless of time on ART) were offered the appointment 
reminder intervention along with weekly treatment adherence reminder messages for 
one year. While this modification was based on the lessons learned, it could have 
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affected the evaluation outcomes. It is impossible to confidently state if differences 
noted between the intervention and control groups were due to the appointment 
reminder or the adherence reminder intervention. An evaluation of the adherence 
reminder program may assist to distinguish the differences between the two 
interventions.  
! Only a quantitative methodology was used. A mixed method would have been a more 
appropriate methodology as a qualitative component could have explained some of 
the participant behavior, decisions or nuances leading to the outcomes noted. These 
items were not easy to ascertain from a quantitative methodology alone. To this 
effect, the researcher has discussed with the mHealth team about them conducting a 
complimentary qualitative study using a sample of the study cohort to make the 
evaluation results more comprehensive. This study may be conducted at a later date. 
! Since the study design required use of retrospective data, it was not possible to 
control the quality of the collected data. The mHealth team had incorporated some 
quality assurance mechanisms such as quality checks by the project coordinator, but it 
was not possible to ascertain how successful the team was at implementing these as 
planned or as stated in the recruitment Standard Operating Procedures.  
! Given the sheer size of the HIV epidemic in South Africa, HIV is the focus of the 
government, donors and other international agencies agendas. For example, the 
minister of health started country wide HIV counseling and testing campaigns in 
2010. These campaigns were in their second year in 2012 and were being scaled up 
by the NDoH as only 31% of HIV positive individuals were enrolled in ART (HSRC 
report, 2012). The South African public is constantly exposed to messages regarding 
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HIV prevention, testing and treatment from the government, donors, non-government 
organizations, community-based organizations and others. In addition, it is likely that 
given the high prevalence of HIV a large proportion of the population in South Africa 
has been affected by HIV directly or indirectly. Therefore, it is possible that the other 
experiences and exposures may have acted as cues to action for the study participants, 
and could have possibly driven the outcomes towards the null hypothesis.  
! At the intervention design phase it was found that the South African public has a 
tendency to change their phone sim cards or their cell phone numbers frequently so 
the project would potentially not be able to send messages as planned. Two events 
that may have assisted in controlling this issue were that the government instituted a 
requirement for cell phone users to register their sim cards using their government 
issued identity card or passport numbers. This may have reduced the behavior of 
frequent changing of sim cards. Another intervention the team put in place in 
response to this issue was that they asked the clinic and pharmacy staff to ask the 
patients for updates to their contact information at each visit. 
Significance 
LTF is a major problem that affects the HIV/AIDS treatment programs globally, 
However, its impact are strongest in Sub-Saharan Africa and some developing countries because 
of the high HIV prevalence rate and poor access to and availability of health services. This 
evaluation and the related intervention have the potential to provide positive social change at a 
local, national policy and possibly global level. I expected the evaluation outcomes to provide 
evidence to fill some of the gaps in the literature around LTF, and use of mHealth as a viable tool 
in the field of HIV/AIDS.  
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  As described in Chapter 2, there is a high acceptability of mHealth interventions by 
various stakeholders and the technology has the ability to reach a large number of populations in 
a short amount of time. In addition, mHealth-related interventions can offer individualized 
messages to the target population based on their needs. mHealth is an innovative way to promote 
health messages and improve health services in the developing and developed country contexts, 
simply because of the high cell phone penetration and its use globally.  
Individuals who start on ART have to be followed regularly to make sure that they are 
adhering to the treatment regimen, and to identify any side effects or other issues arising at an 
early stage. mHealth is a tool that can assist with this need. The literature review conducted as 
part of this dissertation highlighted that while mHealth is a fast growing field, there are still gaps 
in the literature pertaining to the effectiveness of this technology in the field of HIV/AIDS. There 
is also an identified need for evidence-based information from mHealth based HIV/AIDS 
interventions, which have been fully implemented versus pilot projects (Bahadur & Murray, 
2010). This is where the outcomes of this study could potentially contribute to the field. The 
appointment reminder intervention that this study evaluated was one of three interventions 
implemented and managed by the mHealth team at WRHI. The other two projects will be 
evaluated by the WRHI staff at a later date. Once the evaluations have been completed, the plan 
is to present the collective results to the South African NDoH and relevant funders. The 
information is meant to be used by the NDoH to inform policy and as relevant for possible roll 
out of the interventions at a national level. For the funders and other international agencies, the 
outcomes also provide viable options that could be replicated in other countries or serve as 
platforms for further funding and query.  




In this chapter, a summary of the information found in the scientific and some grey 
literature around the issue of LTF and the current gaps was presented. This was followed by an 
overview of the methodology, the indirect and direct variables, the research questions and the 
relevant hypotheses, and the theoretical framework that the study was based on. An objective 
view of the study scope, limitations, and threats were provided. Cross cutting the various 
sections was the point about how the study could potentially impact positive social change and 
contribute to the field of HIV/AIDS using innovative solutions.  
Chapter 1 provided a general overview of the study, including the topic of concern and 
the research methods. Chapter 2 includes findings from the literature review, gaps in the 
literature, the theoretical framework, and the need for this study.  
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Chapter 2: Literature Review 
Introduction 
 The purpose of this study was to evaluate the effectiveness of a mHealth patient 
appointment reminder intervention to improve retention in care of ART patients by reducing 
LTF rates.  
ART has been successfully scaled up globally—especially in resource-limited settings 
such as Sub-Saharan Africa—leading to improvements in health outcomes of HIV-positive 
individuals (Brennan et al., 2010). However as programs have scaled up, treatment attrition has 
become a major issue. LTF, defined as the disappearance of the individuals from ART for no 
known reason is the largest contributor to attrition, followed by death (Rosen & Ketlhapile, 
2010). HIV positive individuals who are started on ART are expected to take the antiretrovirals 
(ARVs) for the rest of their lives to suppress viral replication (Ketlhapile et al., 2010).  Non-
adherence to the ART regimen can lead to development of: viral resistance, opportunistic 
infections, treatment failure and early mortality (Unge et al., 2010). Despite the known risks 
associated with non-adherence to ART, LTF and low treatment adherence remain a major 
challenge (Brennan et al., 2010). More evidence is needed on the effectiveness of interventions 
designed to improve short- and long-term retention in ART (Barnighausen et al., 2011).  
This chapter includes: a summary of the information found during the literature review, 
the theoretical framework suggested for the study, a review of the problem under query, and 
evidence to support the need for this study to address the gap in the literature.  
General information on the HIV epidemic both globally and in sub-Saharan Africa is 
provided at the beginning of this chapter followed by roll out and scale up of ART in Sub-
Saharan Africa and specifically in South Africa. The issues of long-term sustainability of patients 
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on ART and LTF are discussed next followed by linkages between missed appointments and 
reduced adherence to ART, and retention in care. The role of mobile health (mHealth) 
technology in improving health services and particularly retention in care forms the second part 
of this chapter. The discussion starts with an overview of mHealth technology, followed by a 
review of mHealth studies to improve clinic appointment adherence. Use of SMS for 
appointment reminders to improve clinic attendance is the central component of this dissertation 
therefore it forms a large portion of the second half of this chapter. The chapter ends with a 
summary of the key information and gaps found in the literature; the need for the study, and 
provides a segue to Chapter 3.  
The primary source of information for the literature review was peer-reviewed journals; 
however, some reports were also accessed, such as the WHO Bulletin, and United States and 
South African government documents. In addition, grey literature in the form of white papers, 
program reports, and conference presentations was accessed. The use of grey literature was kept 
to a minimum.  
 The literature search was carried out in two phases. Phase 1 involved searching PubMed, 
Medline, and EBSCO HOST databases using the following keywords: HIV/AIDS in South 
Africa, Scale up of ART, HIV treatment retention in care, Loss to Follow up of patients on ART, 
interventions for Loss to follow up, mHealth technology, mHealth and HIV, mHealth and 
appointment reminders, and SMS for appointment reminders. Phase 2 of the literature search 
involved review of the references found in the Phase 1 papers and conducting a search by 
specific titles. Phase 2 was found to be most effective in identifying specific articles on clinic 
appointment reminders. Note that the terms SMS and text messaging have been used 
interchangeably throughout this document.  
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mHealth is the overarching topic of interest however, the dissertation research question 
drills down to the use of SMS technology in improving patient retention on ART at public sector 
clinics in South Africa. Some general observations from the literature review are that since 
mHealth is a relatively new field, the articles found were mostly published in the last ten years. 
Numerous published studies pertained to the use and outcomes of mobile technology in the 
health arena, however, most of the studies were conducted in resource rich countries and in areas 
other than HIV care and treatment. Many of the mHealth articles were reviews and meta-
analyses of previously published papers and grey literature versus new research. The new 
research found included a substantial amount of pilots and feasibility studies. That said, some of 
the new research were trials from Sub-Saharan Africa, and pertained to use of SMS in improving 
adherence to ART.  
Theoretical Foundation 
The theoretical foundation for this study was the Health Belief Model. This model was 
developed in the 1950s by three social psychologists: Godfrey Hochbaum, Irwin Rosenstock and 
Stephen Kegels, who were working for the United States Public Health service at the time. The 
model was originally developed to provide a systematic way to explain the reasons for failure of 
individuals to engage in preventive health measures. HBM was developed to explain the 
relationship between health practices, behaviors and health service utilization. Later, the model 
was revised to study people’s behavioral responses to health-related conditions (Rosentock, 
Stretcher & Becker, 1988; Janz & Becker, 1984).  
HBM is one of the most widely used theories in the field of public health. It has been the 
basis of numerous population studies to explain health related behavior among different types of 
populations (Rosenstock et al., 1994), and health promotion and disease prevention interventions 
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(Burke, 2014). HBM is referred to as an “interpersonal” theory. That is, it uses the individual’s 
personal/internal knowledge and beliefs regarding the issue under study. It ascertains health 
behavior of individuals by examining the perceptions and attitudes individuals have towards 
illness and negative outcomes of certain actions (Burke, 2014). According to Hayden 2009, the 
essence of HBM is that health behavior is influenced by personal beliefs. This is reflected in the 
constructs that form the foundation of this model. 
Initially, four perceptions formed the main constructs of HBM. These were: perceived 
seriousness, perceived susceptibility, perceived benefits, and perceived barriers. Later, three 
other constructs were added which were: cues to action, motivating factors, and self-efficacy. 
The latter three constructs affect the initial four perception related constructs (Hayden, 2009). 
The constructs lead to what has been coined as “Likelihood of Action” or behavior change (Janz 
& Becker, 1984).  
Perceived Seriousness relates to a person’s perception about the intensity or severity of a 
disease. While this perception often stems from information from medical resources, it may also 
result from an individual’s perception of how the disease would negatively affect their wellbeing 
and their life in general (Hayden, 2009). 
Perceived Susceptibility is based on an individual’s perceived risk or susceptibility to 
acquire the disease. The behavior change can be directly proportional to the intensity of the 
perceived risk. That is, the stronger the perceived risk, the higher the probability of risk reducing 
behavior. On the flip side, the opposite can also be true. That is, when people believe that they 
are not at risk or have low susceptibility, then they may have more or continue with unhealthy 
behaviors. Public health practitioners have found that behavior change often occurs when there is 
a combined high perception of threat and severity of disease (Hayden, 2009). 
	  	  	  
 
32 
Perceived Benefits is when a person sees the value or usefulness of the new behavior in 
reducing the risk of developing the disease outcome. This has been found to be particularly 
important for uptake of health screening related interventions such as colorectal cancer screening 
and others (Hayden, 2009). 
Perceived barriers is related to the individual’s perception of the barriers in bringing 
about the particular behavior change. The barriers could be personal, environmental, 
psychological, social, economic, cultural and others (Hayden, 2009).  
Cues to action are internal or external events, information exchange, communication and 
other items, which can influence behavior change among individuals. The cues may be 
developed to raise awareness or provide advice or include personal symptoms or similar illness 
in a family member or a friend. The cues can be anything that can trigger a person to change 
behavior. The items or events listed above can act as cues for individuals to undertake a behavior 
change (Hayden, 2009). According to the HBM, one or more cues are generally required to serve 
as a “trigger” for initiation of healthy behavior (Olsen et al., 2010). 
Motivating factors also known as modifying variables relate to the fact that the four 
original constructs of individual’s perceptions and thus behavior change can be modified by 
external or internal variables such as education, personal experience with the disease, culture, 
motivation and others (Hayden, 2009). 
Self-efficacy is the “belief in one’s own ability to do something” (Hayden, 2009). It is 
based on the fact that individuals generally do something new if they believe that they can or 
have the capability to do it. For example, based on a perceived benefit, a person may believe that 
a new behavior may be beneficial, however, if the person does not believe that they are able to 
carry out the behavior change, then the chances of behavior change would be low.  
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As mentioned earlier, HBM has been applied in numerous public health settings and 
populations to study the correlation between the HBM constructs and desired behavior change. 
According to Conner and Norman, (1996) and Janz and Becker, (1984), the applications can be 
divided into three broad areas: 1) Preventive health behaviors including health promotion and 
health risk behaviors to avoid illness or injury. 2) Sick role behaviors, which refers to actions 
taken after a medical diagnosis of disease has been made and complying with a recommended 
medical regimen to restore health (Janz & Becker, 1984). 3) Clinic visit which includes clinical 
or health service utilization for any health reason. Janz and Becker (1984) conducted a review of 
46 HBM related studies which they divided into one of the above listed three areas. Studies 
under the preventive health behaviors area included influenza and swine flu surveys, seatbelt use, 
exercise, nutrition, dental and medical checkups, drinking and driving, and others. Screening 
behavior related studies on Tay-Sachs disease screenings, practice of breast self-examination, 
and others. Sick behavior role studies included regimen compliance studies such as for 
hypertension, insulin and non-insulin dependent diabetic regimens, end stage renal disease, and 
others. Clinic visit studies were focused on use of clinical services for illness or disease 
symptoms, pediatric visits, preventive, acute and emergency clinical visits, and others. Overall, 
Janz and Becker found substantial evidence in the studies, which supported HBM constructs as 
key contributors to the prediction or explanation of the participants’ behaviors being investigated 
in each of the studies (Janz & Becker, 1984). 
The construct of interest for this study was “cues to action”. A theoretical framework was 
not incorporated in the intervention design however, during the study design phase some 
assumptions were made based on the information found via the literature review. These were: the 
individuals who had agreed to partake in the appointment reminder intervention had experienced 
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the various HBM perceptions when they initiated on ART and received adherence counseling 
from the clinic staff which included information on following the ART regimen, looking out for 
side effects, and the importance of treatment adherence. An individual’s decision to initiate on 
ART indicated that the individual saw the perceived benefit of ART. The individual may have 
also seen a perceived benefit of the intervention offered and believed that they had the ability to 
be adherent to their follow-up clinic appointments.  
The rationale for choosing the “cues to action” was that the appointment reminder was an 
external trigger to assist the individuals to achieve the clinic appointment adherence behavior. As 
explained later in the chapter, the participants received three reminder “cues” in the time 
between appointments (usually 30 days); one message was sent a week before the appointment, 
another a day before and one the day after the appointment. The key question for the study in 
terms of the theoretical model was: how effective were the cues to action in leading to the 
desired behavior or intervention outcome?   Figure 1 shows the basic elements of the proposed 
appointment reminder intervention HBM and the cue to action construct possibly leading to the 
desired behavior of clinic appointment adherence.  
The cues to action construct of the HBM has been studied in various areas either as a 
component of the overall HBM constructs or as an independent entity. One study found in the 
literature was on the effect of the HBM constructs on weight loss related behavior among middle 
school girls. The researchers found cues to action to be the most important variable for predicting 
behavior intentions of weight loss among the study population (Park, 2011). Another study 
assessed predictors of intent to receive the H1N1 influenza vaccine among a convenience sample 
of college students and grocery store patrons. The investigators found that participants were 
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more likely to receive the vaccine if a physician provided the cue or recommended the vaccine 
(Coe, Gatewood, Moczygemba, Goode, & Beckner, 2012).  
 
 
Figure 1. Elements of the HBM for the mHealth appointment reminder intervention. 
(Adapted from Burke E, n.d) 
Another study focused on the cues to action construct for starting CPAP in obstructive 
sleep apnea and adherence over time (Olsen et al., 2010). According to Olsen et al., HBM has 
been heavily investigated to predict adherence in several disease models including for prostate 
cancer screening, mammography, and general health promoting behaviors, however, very few 
studies have measured the cues to action. Olsen et al. also mentioned that it is difficult to assess 
the effect of the cues prospectively, that is before the behavior change happens. Thus cues to 
action studies are often designed as retrospective cross sectional studies to understand the effects 
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of the prompts on the desired behavior modification (Olsen et al., 2010). This was a key point 
during the study development phase, and it was designed as a retrospective assessment of the 
appointment reminder cue to improve clinic appointment adherence among individuals on ART. 
Some of the HIV/AIDS related studies based on HBM constructs conducted in the international 
health arena used different methods of communication cues to action methodologies, such as 
drama or song to increase HIV/AIDS knowledge and to remind the participants to adopt safer 
sexual behaviors (Bosompra, 2007). A qualitative study was conducted to ascertain feasible 
communication strategies which may influence ART adherence. The authors found that cues to 
action was one of the constructs that was acceptable and feasible to use to communicate 
adherence messages with patients on ART (Rochon et al., 2011). Mattson (1999) conducted a 
study to review the role of persuasive communication cues by HIV test counselors in changes in 
safe sex behavior of individuals getting tested for HIV. The pre- HIV test results did not show 
any correlation between the HBM constructs and safe sex attitude among participants. However, 
post-HIV test results which took place after an HIV test and a persuasive communication session 
was conducted with the counselor, indicated higher perceptions of susceptibility, severity and 
improved health behavior attitude. This highlighted the importance of communication cues in 
affecting knowledge and attitudes among individuals  
Starks et al. (2008) conducted a qualitative study at a hospital in Beijing, China to better 
understand what patients on ART need, to obtain optimal treatment adherence. They 
hypothesized that four crucial components, which work interactively but result from various 
factors from individuals’ lives, have an effect on ART adherence. These were: (a) Access to 
ART (a structural factor around availability of ART, (b) Knowledge about ART (cognitive factor 
around regimen, side effects viral resistance, etc.), (c) Motivation to take the medication (a 
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psychological factor), and (d) Prompts or cues to remember to take the medication on time 
(internal or external cues). The study participants raised stigma and discrimination, side effects 
of ART, cost of lab tests, transportation to the clinic and time away from work as major barriers 
to treatment adherence. Most of the participants were comfortable with their ART knowledge 
and knew how the ARTs worked, how to manage side effects, consequences of missed doses, 
etc. The motivation to take the meds was also high as they were aware of the health benefits of 
ARVs and they had a strong desire to live longer. The participants used a mix of internal 
(personal schedules) and external (alarm and electronic tools, or other people) cues to remind 
them to take the medication. The results from the Starks et al study indicated the acceptability 
and feasibility of using cues to improve adherence on ART, thus strengthening the hypothesis for 
this study that the appointment reminders would be effective in bringing about the behavior of 
appointment adherence in the study population.  
Literature Related to Key Variables and Concepts 
HIV Epidemic 
Sub-Saharan Africa region is the worst hit by the HIV epidemic compared to the rest of 
the world. Approximately 25 million out of 35 million people globally living with HIV are in 
this part of the world (UNAIDS, 2012). South Africa ranks as one of the most affected countries, 
with a national antenatal HIV prevalence of 30%, in a population of approximately 47 million 
(South African National Strategic Plan on HIV, STIs and TB 2012-2016, 2012). In 2008, 5.5 
million people were living with HIV in South Africa and over a million people needed be on 
ART (Ojikutu et al., 2008). At the end of 2013, 6.1 million people were living with HIV in South 
Africa (PEPFAR annual report, 2013) 
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Globally, there has been a surge in access to ART over the last few years with a 20-fold 
increase in Sub-Saharan Africa (Micek et al., 2009). The South African government rolled out its 
ART program in 2004. The government with support from international donors, and local and 
international development agencies has made great strides in enrolling a large number of people 
on ART in a short period of time. South Africa currently has the largest ART program in Sub-
Saharan Africa with over 2.5 million individuals on ART in the public sector as of October 2013 
(Ojikutu et al., 2008; PEPFAR annual report, 2013).  
Loss to Follow-up 
As the ART programs have scaled up, the focus for most countries has moved from 
initiating patients to retaining them on ART since being on ART is a life time commitment. Once 
on ART, patients have to strictly adhere to their daily medication regimen, which can be multiple 
pills at various times during the day, and the patient is required to return to the clinic for follow-
up appointments for clinical management and medicine refills (Miller et al., 2010; Ketlhapile et 
al., 2010). While great achievements have been made in initiating patients on ART, there are 
concerns about the long-term outcomes in terms of patient adherence and retention in HIV 
treatment (Barnighausen et al., 2011; Maskew et al., 2007). A systematic review of ART 
programs in Sub-Saharan Africa showed only 60% of patients still on ART two years after 
starting treatment (Rosen, et al., 2007). This was similar to the rates found in treatment of other 
chronic diseases globally. Rosen et al., 2007, found that 25% of patients had dropped out by year 
one of ART initiation, with this number rising to 40% by year two on ART. Researchers in 
Malawi found that the median time between initiation of ART and patients stopping follow-up 
clinic attendance was 4.3 months (Yu et al, 2007). The median time between initiation on ART 
and first missed appointment at a public sector tertiary hospital serving the inner city of 
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Johannesburg, South Africa was found to be 84 days (IQR 43-168 days, range 13-392 days) 
(Dalal et al., 2007).  
Rosen et al. (2007) placed the reasons for attrition from ART into four main categories. 
Death and LTF were the most common followed by patients intentionally stopping their 
treatment, and patients transferring to other ART facilities without informing their former ART 
clinic (Rosen et al., 2007). LTF is defined as the disappearance of the patient from the ART 
program for no reported reason (Rosen & Ketlhapile, 2010). Researchers and countries use 
different time frames to identify patients as LTF. These can range from 30-90 days past the 
missed follow-up clinic appointment date (Yu et al., 2007). LTF rates from a multi-site patient 
file audit at public sector clinics in two provinces in South Africa between 2006 and 2009, were 
found to be between 14-25%, with the largest proportion of patients becoming lost to the system 
in the first 6 months of starting ART (Jaffer et al, 2007). A large public sector clinic with over 
7000 patients enrolled on ART in Johannesburg had a LTF rate of 16.4% among patients 
initiating ART between April 1, 2004 and March 31, 2008. Forty percent of the individuals 
became LTF in the first three months after starting on ART (Rosen & Ketlhapile, 2010).  
LTF is the major cause of treatment attrition. Patients who discontinue ART are at high 
risk of: developing virological failure, acquiring opportunistic infections and early mortality (et 
al., 2007). Harries et al., 2010, conducted a meta-analysis of sixteen studies in Sub-Saharan 
Africa and found that between 20-60% of patients who were identified as LTF had died. 
Researchers in Malawi found that about 50% of the patients who had been identified as LTF had 
died, most dying soon after they missed their clinic follow-up appointment (Yu et al., 2007). 
Dalal et al., 2007, conducted a study at an ART clinic in a tertiary government hospital and 
found that one in six patients initiating ART were LTF. Once again, approximately 50% had died 
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with a majority of patients dying within 30 days of missing their appointments (Dalal et al., 
2007). Some of the reasons found for LTF included ART costs, unavailable transport or transport 
costs, long waiting times at the clinic, stigma, family pressures, illness, transferring to other ART 
facilities, and others (Dalal et al., 2007). Health services factors identified for missed clinic 
appointments included poor communication, poor waiting areas, and duration between 
appointments. Patient related factors included transportation difficulties, health beliefs and 
forgetfulness (Kliner et al., 2013). The mHealth intervention that was evaluated during this study 
was developed to improve communication with patients, reduce waiting times (resulting from 
patients arriving on the day and time of their scheduled appointment), and reduce appointment 
forgetfulness among the patients.  
According to the South African HIV/AIDS care and treatment guidelines outpatient HIV 
care program starts at the PHC level. That is, individuals have to get their pre-test counseling, 
HIV testing and post-test counseling at a PHC. If the individuals test positive, then their blood is 
drawn to ascertain their CD4 count. It can take between 5-7 working days to receive the CD4 
count result. The current standard of care requires the individuals to return to the clinic to receive 
their CD4 results. ART commencement eligibility is ascertained via a WHO guideline staging 
and the individual’s CD4 count. The current eligibility for immediate ART initiation are as 
follows:  
! Any HIV positive child 0-5 years  
! Any HIV positive pregnant woman 
! Any HIV positive individual with active TB disease 
! Any individual with a baseline CD4 <350 cells/ml3 
	  	  	  
 
41 
If individuals are found to be eligible to start on ART, they are enrolled in pre-ART care, 
provided adherence and ART initiation counseling, and initiated on ART. The patients are 
required to return to the clinic once a month for follow-up appointments for clinical monitoring 
and ARV refills (South African National Strategic plan on HIV, STIs, and TB 2012-2016; South 
African HIV/AIDS treatment and PMTCT guidelines, 2011 and 2013).  
Results from patient file reviews in South Africa have indicated that at each key phase of 
the clinical cascade, there is a risk of patient attrition (Jaffer et al., 2009). The attrition can 
happen at two key phases in the clinical cascade. One is the pre-ART and the other is the post-
ART phase. Results from retrospective file reviews conducted at public sector ART sites in 
South Africa indicated between 50- 60% attrition or loss to initiation during the pre-ART phase, 
and between 14-20% loss to follow up in the post-ART phase (Jaffer et al, 2007). Figure 2, 
derived from the UNAIDS 2014 report shows that in Sub-Saharan Africa, 45% of individuals 
who have HIV get tested to find out their HIV status. Of the individuals who are eligible for 
ART, only 39% get initiated on ART, and retention after ART initiation is under 30%.  




Figure 2. Proportion of HIV positive individuals who get tested to find out  
their HIV status, initiate on ART and are retained on ART in Sub-Saharan Africa. 
Source: UNAIDS Report, 2014; extracted from Abdool Karim, 2014. 
 
Missed appointments and LTF  
Regular follow-up clinic attendance is crucial for positive clinical outcomes of patients as 
the patients receive their ARV refills at the end of the visit. Missed clinical appointments have 
been found to be a significant risk factor for development of virological failure and AIDS 
defining illnesses (Lucas et al., 1999; Nyandiko et al., 2013; Rastegar et al., 2003), and death 
(Park et al., 2007). Viral resistance can develop quickly in an individual with poor adherence to 
ART. It can occur after 11-30% missed ARV doses (Maskew et al., 2007).  
There is evidence in the literature on linkages between repeated missed appointments and 
low treatment adherence in patients with chronic illnesses (Levine et al., 1987), and between 
missed appointments and LTF of patients on ART (Jaffer, 2009). Missed appointments also have 
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negative impacts on health services, as they can increase cost and lower efficiency of service 
delivery (Guy et al., 2012). Moreover, missed appointments can lead to delays in diagnosis of 
treatment related side effects or other illnesses, thus delaying timely management of diseases, 
leading to unanticipated burden on the health system where resources are already limited (Car, 
Guro-Urganci, de Jongh, Vodopivec-Jamsek & Atun, 2012; Rosen et al., 2007).  
Brennan et al. (2010) conducted a retrospective cohort study at one of the largest ART 
clinics in South Africa with more than 17,000 patients enrolled on ART in 2010. They looked at 
the relationship between missed follow-up ART clinical appointments in the first six months of 
ART initiation and the outcome of mortality, LTF, immunologic response to ART, and 
virological suppression due to ART. The researchers found that of the 4476 individuals who had 
initiated on ART during the study twelve month observation period, only 65% attended all 
follow up visits as scheduled. Approximately, 2.6% of the patients had died and 6.2% were LTF. 
In addition, higher missed clinical appointments were found to be associated with increased risk 
of mortality and LTF during the study period. Immunologic response was ascertained by 
improvement in CD4 count compared to the CD4 count immediately before initiation on ART. 
The researchers found that patients who missed three or more ART or clinical appointments were 
at high risk of low CD4 improvement. Furthermore, patients with three or more missed ART 
appointments were at increased risk of not achieving viral suppression by six months compared 
to the patients who did not miss any appointments. This study was one of the first to look at the 
relationship between missed appointments early in the treatment phase of patients initiating ART 
and the health outcomes of the patients, in a resource limited setting (Brennan et al., 2010).  
Some of the reasons for missing appointments include forgetfulness, confusion regarding 
follow-up appointment, relocation, illness, hospitalization, transportation cost, side effects, death 
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and insufficient medication supply (Dalal et al., 2007; Maskew et al., 2007). Forgetting 
appointments is a common reason given by patients for missing outpatient clinic appointments in 
a variety of health care settings (Leong et al., 2006; Guy et al., 2012; Kliner et al., 2013) 
Regular clinic visits reflect good retention in care among patients on ART. Retention in 
care is needed for continued access to ART and appropriate monitoring of side effects, toxicities, 
and treatment failure (Geng et al., 2010). Good retention also translates into continued social and 
clinical support. Poor retention in care is reflective of low treatment adherence and treatment 
cessation. Once treatment is interrupted, the effects of ART can quickly reverse and cause harm 
to the patients (Geng et al., 2010). Streamlined and active patient tracking has been 
recommended by some researchers while others have suggested some form of reminder systems 
which may reduce the rate of missed appointments (Dalal et al., 2007; Kliner et al., 2013). Other 
researchers have recommended implementing a patient tracer program whereby patients missing 
their clinic appointments are contacted and asked to return to the clinic in a timely manner (Yu et 
al., 2007).  
Since LTF was highlighted as a critical issue by some key studies especially by Rosen et 
al., 2007 and Dalal et al., 2007, some countries in Sub-Saharan Africa developed and 
implemented patient follow-up or tracker programs. Some of the projects involved hiring a social 
worker or counselor who contacted patients missing clinic appointments by phone or home 
visits. Other projects used a community based approach, whereby community workers 
approached the patients identified as LTF (Rosen & Ketlhapile, 2010). Researchers studying the 
effectiveness of tracer projects have found success in improving patients returning to the facility 
after being contacted by a tracer. In a Kenya based study, the rate of return of patients was found 
to be 65% and 49% in urban and rural areas respectively (Rosen & Ketlhapile, 2010). The 
	  	  	  
 
45 
researchers of this study also examined the cost effectiveness of a patient tracer project. They 
found that the average cost of returning a patient to the clinic was $432/year. This was equivalent 
to the cost of almost one year of the first line ART regimen for one person. The researchers 
questioned that in an environment of reduced donor funding and resource poor settings, is it 
appropriate to spend this much money to return a patient to care when there are patients 
waitlisted to initiate on ART?  The researchers later suggested using a junior tracer person and 
also indicated that the cost would reduce to $18 if the cost of the patient tracer project was 
distributed among all patients accessing ART services (Rosen & Ketlhapile, 2010).  
While a patient tracer program has been found to be an effective and useful intervention, 
it can be resource intensive based on patient load per tracer, and follow-up workers’ salaries, 
transportation and communication costs. Therefore, there is ongoing search for alternative ways 
of tracing or communicating with patients to assist them with maintaining good appointment 
adherence and retention in care. The intervention evaluated in this study used a low cost way of 
communicating with patients on ART to promote clinic appointment adherence. No studies were 
found in the peer reviewed or grey literature that examined the association or effectiveness of 
SMS on improving ART clinic appointment adherence among patients receiving ART services in 
South Africa. Additionally, improving retention in HIV care and treatment by reducing LTF are 
priority areas for the South African Department of Health (South African National Strategic Plan 
on HIV, STIs and TB 2012-2016, 2012). The department is looking for solutions to improve 
long-term retention in care of patients on ART, following the huge success of initiating over 2.5 
million people on ART in the last ten years. 
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Mobile Health technology to improve health services 
Mobile technology includes cell phones, patient monitoring devices, personal digital 
assistants, and other equipment. (Bahadur & Murray, 2010). mHealth applications range from 
communication between health care provider and patient, delivery of services, patient education, 
data collection at point of care, disease outbreak monitoring and reporting, training of health 
workers in remote settings, HIV medication and treatment adherence support, and appointment 
reminders. (Rodrigues et al., 2012; Tomlinson et al., 2013). The methods of communication with 
cell phones include: text messaging or SMS, voice messaging, phone calls, World Wide Web 
based social media platforms, Unstructured Supplementary Service Data (USSD), and smart 
phone applications.  
mHealth is a rapidly growing field. It is increasingly being used to improve delivery of 
health services in both resource limited and rich settings (Leong et al., 2006; Peron et al., 2010). 
mHealth is considered to have a great potential for strengthening health service delivery and 
leading to positive health outcomes especially in resource poor countries (Free et al., 2013). The 
acceptance of cell phones and their low cost has led to the quick uptake of mHealth technology 
in health services (Rodrigues et al., 2012). One of the main reasons for mHealth popularity and 
growth is a result of the extensive cell phone penetration globally. In 2009, more than four 
billion or two-thirds of the world’s population owned cell phones. Over 60% of these phones 
were in developing countries or emerging economies (Free et al., 2013; Bahadur & Murray, 
2010). In most developed countries, there are more cell phones than the population. In 
developing countries, mobile phone is the fastest growing communication sector. This is due to 
poor infrastructures for landline phones, greater mobility with cell phones, easier access, low 
startup cost, flexible payments, relatively low cost of communication especially as it pertains to 
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text messaging, access to the Internet, Unstructured Supplementary Service Data  (USSD)- a 
widely used mobile communication technology between the phone user and mobile network, and 
other modes of mobile communications (Bahadur & Murray, 2010). Eighty percent of the 
world’s population lives in areas with an active mobile phone network thus making mobile 
phone technology a viable option for reaching a large number of people (Bahadur & Murray, 
2010).  
mHealth has great potential for success in South Africa as the country has one of the 
highest proportions of mobile phones per capita, with over 90% of people having a mobile phone 
subscription (Leon et al, 2012). The rural and remotest parts of the country also have high 
cellular network coverage (Crankshaw et al., 2010). The South African Government has shown a 
keen interest in the use of mHealth technology in the public health care sector. In 2012, the 
National Department of Health (NDoH) circulated a comprehensive eHealth strategy which 
included the need for development, implementation and evaluation of mHealth interventions to 
strengthen the public health sector (NDoH eHealth strategy, 2012). In addition, there is growing 
interest and support by the United States government, the World Health Organisation, 
multinational companies and other private entities such as the cell phone network providers to 
develop, implement and evaluate innovative mHealth interventions to help strengthen the South 
African government’s response to the HIV epidemic. This is evident from the increase in funding 
these agencies have been making available in South Africa over the last 2-3 years. Studies 
exploring the feasibility and acceptance of using mHealth in the South African population have 
indicated a high level of interest and acceptability (Crankshaw et al., 2010).  
The project evaluated by this study used mHealth technology via SMS to strengthen ART 
follow-up appointments and thus reduce LTF in public sector facilities. The project was piloted 
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between November 2011 and October 2012 at a primary health care facility based ART clinic in 
the inner city of Johannesburg with approximately 2000 patients enrolled on ART. Following the 
positive outcomes of the pilot, there was a request by the funding agencies and the DoH to scale 
up the SMS for ART appointment reminder at a larger secondary level community health center 
in the inner city. This facility, Hillbrow Community Health Center (HCHC), had over 16,000 
patients enrolled in ART at the time of program implementation. This is one of the largest ART 
sites in Sub-Saharan Africa serving South Africans and a large number of immigrant and hard to 
reach populations such as sex workers, pregnant women, and others. The ART clinic (WARD 
21), at HCHC was started in April 2004, when the NDoH rolled out the national ART program. 
A patient file audit was conducted in 2008 to ascertain the patient outcomes at the facility, four 
years post ART roll out. This site had similar issues of patient LTF, as noted earlier in this 
chapter. Historical clinical and loss to follow up data from Ward 21was used in the study. This 
information, along with the project and retrospective patient clinical data provided an appropriate 
evidence base to draw conclusions from.  
SMS Related Interventions in HIV Care and Treatment 
SMS or text messaging is a well-established technology, which is recognized and utilized 
around the world. It allows a person with a cell phone to send a short message, about 160 
characters, to another person on their cell phone. The message delivery is immediate if the 
recipient’s phone is switched on and in a network area. The recipient has the option to respond 
immediately or wait. SMS is a cheap and efficient method of two way communication which 
costs much less per text message versus per minutes expenses for a cell phone call (Leong et al., 
2006; Bahadur & Murray, 2010).  
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Over the last few years, SMS has been identified and used as the most prevalent mHealth 
technology application. Bahadur and Murray (2010) conducted a literature review between 
February and December 2008, to examine the use of SMS in health care settings. Out of 212 
articles and reports reviewed, 28 were found to meet the study criteria. The authors found studies 
which indicated that SMS had: improved service delivery through appointment reminders, 
improved communications between health care workers, increased: diagnosis, prevention, 
adherence to treatment, treatment monitoring, contact tracing, and others. The authors concluded 
that most of the studies were conducted in developed countries. SMS was found to be an 
efficient, cost effective and appropriate technology for strengthening various health services 
sectors. However, Bahadur and Murray noted that some researchers were skeptical about the 
evidence around the effectiveness of SMS since many of the reports or articles generated were 
from pilot projects or feasibility studies versus rigorous enquiry. The authors concluded that 
while SMS has been found to be effective in the public health sector, there is a need for further 
rigorous review of the benefits of this technology to improve health services in South Africa 
(Bahadur & Murray, 2010). In addition, none of the studies reported by Bahadur and Murray 
pertained to use of SMS to improve ART clinic attendance. This is where this study was 
important. Retrospective clinical and program data from the appointment reminder intervention 
was used to examine the effectiveness of SMS technology in reducing LTF in the public sector in 
South Africa.  
Acceptability and Feasibility of Cell Phone Use in HIV Care and Treatment                                                   
In the last five years there has been a growing interest in the use of SMS technology to 
strengthen the HIV/AIDS health services sector. Chib, Willkin, Ling, Hoefman & Biejma, 2012 
conducted a study in Uganda in 2009 to look at the effectiveness of an incentive based 
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HIV/AIDS health education intervention using SMS to: increase knowledge around HIV/AIDS, 
improve awareness among the participants about their local HIV testing facilities, advocate HIV 
Counseling and Testing (HCT), and increase uptake of HCT among the participants. The 
messages in the form of thirteen multiple choice and true/false questions were sent to 10,000 
mobile phone subscribers with the help of the local telecommunication company, over a one 
month campaign period and in one district. The information was provided by “Text to Change”, 
a Dutch not for profit organization which provides health education services via mobile phones, 
in Africa. The questions pertained to: HIV/AIDS knowledge, testing, and HCT services in the 
area. The subscribers were given an option to opt out, however, none did. Subscribers, who 
answered the questions correctly, received a free HCT service and were enrolled into weekly 
drawings for free mobile phones or airtime. The authors reported that 233 out of 10,000 (2.3%) 
subscribers accessed HCT services at the local clinic during the campaign period. This paper 
only examined HIV knowledge among the subscribers as the researchers did not collect data to 
look at association between the campaign and testing behavior. Approximately a quarter, 2,363 
of the 10,000 people who were sent messages responded. Of these, 1,954 answered the quiz 
questions with most people only answering one or two of the questions. Thirty individuals 
answered all thirteen questions. On an average, the respondents got 68% of the questions correct. 
The researchers only looked at existing HIV knowledge versus changes in HIV knowledge. Only 
the subscribers who answered the questions were provided with the correct answers. While the 
researchers set out to look at correlations between SMS and service uptake, they did not collect 
the relevant data to answer the question. This type of a study design also indicates the limitations 
of blast messaging to the subscribers. The researchers indicated limited success and 
recommended making SMS a constituent of an integrated mass media campaign versus a 
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standalone intervention, one should question if the study design had an impact on the results. 
(Chib et al., 2012).  
Apunyu and Hoefman (2010), who were co-authors on the Chib et al., (2012), study 
conducted another study in a different district in Uganda in 2010. The aim of the study was 
similar to the previous one; however, the study methodology was different. The researchers used 
a survey methodology using “Text to Change” services. Information regarding the survey was 
broadcasted via radio talk shows on two radio stations serving the district followed by short radio 
messages broadcasted seven times a day (five times in the local language and twice in English), 
to encourage people to participate. People were informed that they could opt in to participate in 
the survey by sending a SMS to a toll free number. Additionally, flyers were distributed in the 
main town and community health workers collected phone numbers face to face. As with the 
previous study, participation in this study was incentivized. 8272 individuals subscribed to 
participate in the study. Of these, 1,222 did not respond to any SMS messages. Therefore, 
analysis was done on the remaining 7,050 participants. Fifty three-percent of participants 
answered the HIV knowledge and family planning questions. Over 50% of respondents answered 
an average of 74% of question correctly. More women answered correctly versus men (p < .001). 
The AIDS information Centre located in town also offered free HCT during the survey period. 
The center noticed a momentary increase in HCT uptake after announcement of free testing. 
Eighty percent of the initial respondents had heard about the survey by radio. Ninety six percent 
of the participants stated that they had improved their HIV knowledge from participating in the 
survey. The researchers did not conduct a pre and post study so one does not know if there was 
an actual change in HIV knowledge. The authors mentioned that the participants had a relatively 
higher HIV knowledge compared to the national average (ascertained by national surveys). They 
	  	  	  
 
52 
also stated that the SMS survey was highly valued by the participants and the acceptability was 
high. The AIDS information center had an increase in HCT uptake however; the authors did not 
provide information differentiating the survey participants from the general population. There 
was a high acceptability of the SMS survey and a large number of the participants indicated that 
their HIV knowledge increased however, the authors do not provide any evidence showing a 
correlation between the intervention and increase in HIV knowledge and HCT uptake among the 
participants. One should also consider the possibility of participant bias on the outcomes noted.  
A group of researchers conducted a cross sectional study to examine the use of and 
feasibility of cell phones for ART clinic appointment reminders and adherence messages in 
Durban, South Africa (Crankshaw et al., 2010). Primary analysis was on the existing patterns of 
cell phones and willingness to be contacted by the clinic, by gender. Three hundred individuals 
over eighteen years of age were enrolled in the study between October and December 2007, from 
an ART clinic located in an urban/peri-urban state subsidized district hospital. Approximately 
81% of the participants owned a cell phone. The female (67%) to male (33%) proportions among 
the participants was similar to the gender proportions of individuals accessing services at the 
clinic. Over 60% of the participants were unemployed and more than 52% had a secondary level 
education. Approximately 41% of the participants had been on ART for less than six months, 
followed by 26% and 33% for 7-12months and more than 12 months respectively. The 
researchers found that regardless of gender, 99% of the participants were willing to receive 
phone calls from the clinic, and 96% were willing to receive text messages. However, while the 
participants considered the reminders as useful, they did not consider it critical to the success of 
their treatment. Significant gender differences were found for questions pertaining to patterns of 
cell phone use. More women: switched off their phones during the day (p = 0.002), sometimes 
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did not take phone calls in certain places (p < 0.0001), shared a phone with someone (p = 0.002), 
and left the phone sometimes where someone could pick it up and read the messages (p = 0.005). 
Most of the participants stated using the cell phone alarm to remind them to take their 
medications. The researchers also found other factors, which they mentioned, should be 
considered when designing mHealth interventions. These included items such as theft or damage 
to cell phones, which could affect long-term sustainability of the project and may affect 
participant confidentiality. A solution to the sustainability issue was to update the contact details 
at each clinic visit. Another issue highlighted was the unavailability of the participant to receive 
the call. Text messaging was found to be more viable as the messages could be accessed by the 
participants any time. Another point raised was the need to involve the patients when developing 
the messages. This study had several advantages in that it involved a representative sample of 
patients accessing ART in a high HIV prevalence area in South Africa. The researchers found 
that the participants were similar as far as time on ART and gender breakdowns were concerned. 
Disaggregation of the data by gender highlighted hidden nuances that can impact the outcome of 
an appointment reminder intervention. Some of the limitations of this study were that the 
information was based on responses from the participants. Actual behaviors associated with the 
use of cell phone were not ascertained. As the researchers mentioned in the article, there could be 
some degree of courtesy bias for willingness towards reminders. This could have overestimated 
the positive response noted. There is also a possibility of recall bias for responses to cell phone 
use questions. In addition, the authors caution the readers against generalizing the results to other 
populations. The clinic where the study took place has a small fee for ART services. This is 
different from other public sector clinics where services are provided free of charge. The clinic 
may be supporting populations with some socio-demographic differences compared to the 
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population receiving services at public sector clinics. In conclusion, the authors found a high 
acceptability of appointment reminders in South Africa, and highlighted the importance of 
conducting acceptability and feasibility studies prior to development and implementation of 
interventions. 
The three studies reported above show varying levels of acceptability for cell phone calls 
or SMS in HIV care and treatment. The Apunyu and Hoefman (2010) study highlighted the 
advantage of individuals opting in to participate in an activity versus the Chib et al. (2012), study 
which used blast messaging to enroll individuals. Crankshaw et al., (2010), showed the need for 
formative studies prior to development and implementation of interventions. The appointment 
reminder intervention that was evaluated during this study was developed using a project 
development cycle. The intervention was developed following a focus group based acceptability 
and feasibility study in the target population. The participants were asked about acceptable SMS 
content too. The intervention was piloted for a year at a primary health care based ART clinic 
and then rolled out to the current ART clinic, which provides free services. People accessing 
services at the clinic were approached by program staff and enrolled after a consent process. 
Informal process evaluations were undertaken over the last two years to ascertain appropriate 
implementation of the planned intervention. An outcome evaluation was the next relevant step in 
the project’s development cycle. It ascertained if the intervention was effective in improving 
adherence to clinic appointments and reducing LTF among patients on ART who received the 
appointment reminder intervention versus a comparison group, which did not receive the 
intervention.  
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SMS to Improve Adherence on ART 
As mentioned earlier, patient adherence to ART is crucial for continued benefits of ART 
in avoiding development of viral resistance, reducing opportunistic infections, and early 
mortality (Rosen et al 2007). In addition, adherence to ART has been linked to improved health 
outcomes and is important to contain undue program costs (Lester et al., 2010). According to 
Pop-Eleches et al., (2011), it is important to prevent adherence related treatment failure, 
especially in resource constrained settings as the cost of second line regimen can be up to 17 
folds higher than the first line regimen, that is, if the second line regimen is even available in the 
country. Since adherence is crucial for ART success, a number of interventions have been 
developed and implemented over the last few years. These have ranged from direct 
administration of ART, provision of financial incentives, education, additional counseling 
regarding adherence, facilitation of social support, and electronic and phone reminders 
(Rodrigues et al., 2012). In the last 3-5 years, a handful of studies exploring the use of SMS in 
improving ART adherence have been published. 
Lester et al., 2010 conducted a Randomized Control Trial (RCT) in Kenya between May 
2007 and October 2008 to study the effectiveness of SMS on ART adherence. According to the 
researcher, this was the first clinical trial to report use of mHealth in improvement of clinical 
level outcomes in patients on ART. This trial is seen as a landmark study in the field of 
HIV/AIDs and mHealth. The trial was conducted at three ART clinics, involving 538 patients 
who were equally randomized to the intervention or the control group. The intervention group 
received weekly SMS messages from the clinic nurse with a simple question asking how they 
were. The participants were supposed to respond within 48 hours if everything was OK or if 
there were problems. If the response mentioned “problems”, then the nurse called the 
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participants to inquire. The control group received the standard of care. The primary outcomes of 
interest were self-reported ART adherence at the 6 and 12 months follow-up visits, and viral load 
suppression at twelve months. Secondary outcomes included attrition at twelve months due to 
death, transfer to other non-study clinic, withdrawal from the study or loss to follow up. The 
researchers also examined differences on outcomes noted by gender, type of residence (urban or 
rural), disease staging, phone ownership and others. One of the major strengths of this study was 
the review of the viral load at twelve months. While self-reported adherence is the most 
commonly used method of ascertaining treatment adherence, there is a high risk of reporting 
bias. In this study, the participants were considered adherent if they mentioned taking more than 
95% of their prescribed pills in the thirty days prior to their six and twelve month visits. Viral 
load ascertainment requires a blood draw and it indicates the actual viral count in the blood. 
According to Lester et al., (2010), “viral load is an important composite endpoint for monitoring 
adherence and takes into account pharmacological, biological and socio-behavioral factors.” In 
this study, viral suppression was 400 copies per mL or less at the twelve month follow up. 
Participants with more than 400 copies per mL were classified as having virological failure. The 
study was powered to note a 10% improvement from baseline, between the two groups. The 
researchers found that significantly more patients in the intervention group reported adherence of 
> 95% (p = 0.006) versus the control group. The difference was significant even after adjusting 
for baseline covariates (p = 0.0028). In addition, more patients in the SMS group had suppressed 
viral loads of < 400 copies per mL at twelve months (p = 0.04) versus the control group. After 
adjustment, there was weak evidence of improved viral load suppression in the intervention 
versus the control group (p = 0.058). There were no significant associations with the secondary 
outcomes. At the end of the study, 98.5% of the participants in the intervention arm wanted the 
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intervention to continue, and 98% mentioned that they would recommend the SMS intervention 
to a friend. Many patients mentioned that they felt “like someone cares”. Results of this study 
showed that mHealth interventions can improve clinical health outcomes of patients on ART and 
participants found the intervention valuable. The researchers also mentioned that the SMS 
intervention was inexpensive as each SMS message was USD 0.05 which totaled $20 per month 
for 100 people. The calls per care providers averaged $3.75 per month indicating that the 
interventions can include a human touch at a low cost. The researchers further indicated that 
based on these statistics, this intervention may have been cheaper than the cost of a community 
adherence intervention, which involves individuals to make home visits and requires travel and 
personnel time. The authors also presented a hypothetical example for scale up of the 
intervention in Kenya using the example of close to 300,000 individuals who received ART in 
2009, supported by U.S. government funding. They estimated that if the SMS intervention was 
scaled up in 2009, approximately 26,000 additional people could have had fully suppressed viral 
loads (Lester et al., 2010). 
Another study conducted in a rural setting in Kenya examined the correlation between 
SMS and ART adherence (Pop-Eleches et al., 2011). The RCT was conducted at a single public 
sector rural health clinic between June 2007 and August 2008 with 720 participants. All the 
participants were provided with a mobile phone with basic features, and they were told to use the 
phone as they wanted. However, the participants were asked to bring the phones to the monthly 
follow-up visits. A replacement phone was not provided if the participants lost or damaged the 
phone. The participants were also asked to take one of their three ART regimen medications to 
the pharmacy, where the medication was transferred to a container with a medication event 
monitoring system (MEMS) cap, which captured information on the number of times the 
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container is opened. A third of the participants were randomly assigned to the control group, 
which did not receive any SMS messages. The remaining participants were randomly but evenly 
allocated to one of the four intervention groups. The four interventions were based on four 
different types of short and long one–way SMS reminder messages based on adherence barriers 
identified by other studies. The barriers included forgetfulness and social support issues. The 
short messages just reminded the participants to take their medications while the long messages 
provided some supportive language. The participants had to return to the clinic on a monthly 
basis to get their MEMS cap recording. The researchers gave money to the participants to pay for 
charging of the cell phones at public charging stations as there was poor access to electricity and 
most participants could not afford it. In addition, small amount of money was added on each 
phone every two months. The study was powered to detect a 15% difference between the 
intervention and control group. Adherence was measured based on a proportion of number of 
actual container opening over prescribed opening over a 12-week period. The primary study 
outcome queried was adherence of > 90%. Secondary outcome included treatment interruption of 
greater than 48 hours (ascertained by MEMS opening), during each analysis period of twelve 
weeks. Baseline demographic information was similar among all participants. Approximately 
16% of the participants were lost to follow up at the end of the study with no significant 
difference in the loss to follow up rates between the four intervention and control groups (p = 
0.48). The study results showed that the patients receiving weekly reminders had a higher 
likelihood of achieving 90% adherence to ART – almost 13-16% higher compared to the control 
group that did not receive any reminders. The control group had a drop in adherence from 60-
46% over the 48 weeks of observation. Instances of treatment interruptions of more than 48 
hours were also lower in the group that received the weekly reminders. The investigators did not 
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find a difference in the effectiveness of the longer or shorter text messages in improving the ART 
adherence. The investigators also found that while the group receiving the weekly reminders had 
improved adherence, this was not the case with the group receiving the daily reminders. One of 
the reasons provided for the reduction in effect was “Habituation” i.e. the possibility of over 
stimulus. The researchers concluded that they had provided robust evidence that SMS reminders 
may improve ART adherence in resource constrained settings, and the low cost of setting up the 
system and sending SMS may be beneficial in these types of settings. Pop-Eleches et al., further 
stated that their study was one of the first with evidence of the beneficial effects of mHealth in 
the field of HIV care and treatment and suggested the need to test it in other areas in the field 
such as appointment reminders, treatment side effects and other communications between the 
patients and their care providers (Pop-Eleches, 2011).  
Rodrigues et al. (2012), conducted a quasi-experimental cohort study in India between 
2010 and 2011 to examine the effects of weekly mobile phone reminders on adherence to ART 
in the short term (6 months) and long term (12 months). Interactive Voice Response (IVR) and 
SMS technologies were used in this study. The cohort included individuals who were (a) HIV 
infected adult patients followed up as outpatients at the clinic, (b) had access to a cell phone, (c) 
had been initiated on ART for at least a month at the time of enrollment in the study, and (d) on 
the first line ART regimen. The intervention had two components and it was provided to all the 
participants, once a week for six months. The first component was an interactive IVR call with 
one question that the participants had to respond to. The question was “have you taken all your 
medicines yesterday?”  The second component was a non-interactive SMS, which included a 
simple picture of a lamp and did not have any text. The participants were trained to respond to 
the IVR and access the SMS message. One hundred and fifty individuals enrolled in the study. 
	  	  	  
 
60 
The researchers collected general demographic and some clinical marker information such as 
baseline CD4 count, regimen type, duration on ART and other. Retention in the study at month 
12 was found to be high at 94%. The results indicated a positive effect of the intervention on 
adherence. The participants gave forgetfulness as the most common reason for non-adherence 
however, this reduced significantly between baseline (17%), one month (10%), three months 
(6%) and six months (3%) (p< .001). The participants preferred IVR (34%) to SMS (11%), 
however, a larger portion preferred both methods (44%) (p < .001). There was significant 
improvement in adherence over time, 85% at baseline to 94% at twelve months (p = 0.016) for 
individuals falling in the “adequately adherent” category at each time point. While this study 
indicated an improvement in adherence, it was reported by the participants, which can be biased 
(Rodrigues et al., 2012). 
The last three studies indicate a positive correlation between SMS messages or reminders 
and treatment adherence using various ways of measuring adherence. As mentioned earlier in the 
chapter, loss to follow up rates among patients initiating ART in South Africa are high (Jaffer et 
al., 2007; Rosen & Ketlhapile, 2010). In addition, missed clinic appointments are linked to 
reduction in treatment adherence among patients on ART (Levine et al, 1987; Rosen et al., 2007; 
Car et al., 2012). Therefore, it is imperative to improve ART patients’ attendance to ART clinics 
(Pop-Eleches, 2011). However, no studies were found during the literature search which were 
based in Sub-Saharan Africa, and which had examined the effects of SMS reminders on ART 
clinic appointment adherence and LTF. This study provided the evidence needed. In the study, 
LTF outcomes at six and twelve months were compared between the intervention and the 
comparison groups. The intervention group comprised of all individuals on ART who had 
enrolled in the appointment reminder intervention between September 1, 2012 and February 28, 
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2013. The comparison group was selected from the clinic population that had not enrolled in the 
appointment reminder intervention. A partly purposeful, partly random stratified approach was 
used to align the comparison and the intervention group. The standard of care provided to all the 
individuals remained the same, and the health providers were not aware of who was and was not 
enrolled in the intervention. The intervention was planned such that the group received 
appointment reminders three times between their clinic appointments (usually 30 days); one 
message two weeks before and one a  day before the scheduled appointment, followed by  one 
message the day after the appointment. The first two messages were simple reminders that the 
person has an appointment on a particular date. The third message varied based on if the patient 
showed up for their appointment. If they showed up then they received a message thanking them 
and information for the next appointment was included.  If they did not attend the clinic then the 
message urged them to return to the clinic as soon as possible. The evaluation of this intervention 
was sufficiently powered to provide evidence if the SMS reminder was effective in improving 
the desired behavior of clinic attendance and ideally lower LTF rates.  
SMS for Clinic Appointment Reminders 
Due to the lack of studies in the literature which examined use of SMS technology to 
improve ART clinic attendance, especially in resource limited countries, the literature search 
included review of studies which pertained to use of SMS for appointment reminders in a 
number of health care settings in resource rich and limited countries. The search was focused on 
use of SMS in outpatient clinic settings because ART services in South Africa are often offered 
in outpatient settings.  
One of the earlier studies on use of text messaging to improve primary clinic attendance 
was conducted in Malaysia by Leong et al., 2006. The study was a three-arm multicenter 
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randomized control trial with a total of 993 participants. The primary hypothesis was that text 
message reminders were more effective than no intervention in improving primary clinic 
attendance. Secondary hypothesis of the study was that text message reminders would be more 
cost effective than the cell phone calls. The trial took place at seven primary health care facilities 
(five private and two public). The three arms were text message reminders, mobile phone call 
reminder, and no reminders. In both the intervention arms, a reminder was sent around 24-48 
hours before the clinic appointment and the messages were kept similar. The researchers had a 
strict definition for non-attendees. Any participant who did not come to the clinic on the day of 
the appointment was marked as a non-attendee. If the participants came earlier or on another day, 
changed the appointment date, cancelled or did not come at all for their appointment they were 
marked as non-attendees. The attendance rate of the individuals in the text message reminder 
group was significantly higher (59%) versus the control group (48.1%, p = .005). Similar rate 
was found for individuals who received a cell phone reminder (59.6%) versus the control group 
(48.1%, p = .003). However, there was no significant difference between the groups receiving 
the text message versus the group receiving phone reminders (p = .874). The researchers also 
found that while there were significant differences between the intervention and control groups, 
approximately 40% of the participants were classified as non-attendees. A reason for this high 
non-attendee rate could be due to the strict definition for non-attendees. Close examination of the 
data reveled that about 48% of the attendees did not come to the clinic on their appointment 
days, but they did return on another day. The authors also found that text messaging was much 
cheaper than the cell phone call. In conclusion, both the text message and phone reminders were 
found to be more effective versus no messages and the text messages were more cost effective 
than the cell phone reminders.  
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Another study was conducted in Kenya by Odeny et al., (2012), to measure the 
effectiveness of text messages on improving the seven day follow-up appointment rate for 
patient undergoing a male circumcision procedure. According to the researchers, this was the 
first randomized control trial which looked at the outcomes of SMS to improve clinic attendance 
in a resource limited country. Male circumcision has been found to be effective in lowering the 
risk of men acquiring HIV (Gray et al., 2012; Weiss, Quigley & Hayes, 2000). It is a 
recommended procedure by the World Health Organization (WHO) and Joint United Nation 
Programme on HIV/AIDS (UNAIDS), which is being adopted by various countries 
(WHO/UNAIDS 2011). Circumcision is a simple procedure, however there is a risk of 
development of postoperative adverse events (Muula, Prozesky, Mataya & Ikechebelu, 2007). A 
seven-day post procedure appointment is standard of care and it is important as the health care 
providers can monitor the healing process, development of any adverse events, and reinforce 
postoperative care. However, the seven-day clinic attendance rates are low in many countries 
(Odeny et al., 2012). The trial was conducted in a large district in Kenya that had an average 
baseline seven-day follow up rate of 43%. For this trial, men were approached during their post-
operative recovery period. A total of 1200 men were enrolled between September 2010 and April 
2011 and equally randomized to either the intervention (SMS) or the control group (no message). 
The text messaging was one-way (researchers to the participants), except for the initial SMS, 
which the participants were asked to send to the research team at the time of enrollment in the 
study. The participants were reimbursed for this SMS. Individuals in the intervention group 
received a SMS each day for seven days at the participant selected time and language. The 
participants were counted as attended the seven-day postoperative appointment as long as they 
attended within three days before or after the scheduled appointment date. The study was 
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powered for a 9.5% change in the attendance rate (43% to 52.5%). Outcome data was available 
for approximately 99% of individuals in both the intervention and the cohort group. Overall, 
62.5% of the participants returned for their follow-up appointment. Further analysis indicated 
that the rate of return although modest, was significantly higher in the intervention (65.4%) 
versus the control group (59.7%) (RR1.09, 95% CI 1.00-1.20; p = 0.04). Secondary association 
such as distance to clinic and follow up attendance rate was found to be significant. Association 
between education level and follow up rate was also noted however it was not significant. The 
authors discussed limitations in terms of lack of generalizability as they had to exclude almost 
49% of the individuals initially screened as they were younger than 18 years. Individuals who 
did not have cell phones with them at the time of enrollment or who did not own a cell phone 
were also excluded from the study so it is not possible to compare between the group of people 
who did or did not have a phone as data was not collected on the latter group. The authors 
pointed out that the intervention arm still had over 30% of the patients who missed their 
appointment, even after receiving a SMS. This phenomenon has been noted in other studies, 
including the Leong, 2006 study described above. The authors noted the need for studies, which 
would query into the reason for participants missing appointment in the intervention arm. The 
text messaging was found to be cost effective and not human resource intensive once the 
individuals were enrolled in the study as thousands of pre-programmed messages were sent out 
electronically. This would support scale up of this intervention to a larger population.  
Guy et al., 2012, conducted a meta-analysis of published and unpublished studies, which 
presented outcomes comparing appointment attendance among patients who had received SMS 
reminders and those who had not. The researchers looked at overall clinic attendance outcomes 
stratified by study design and level of health care facility (primary, secondary, tertiary). Eighteen 
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studies met the review criteria, of these eight were RCTs and ten were controlled observational 
studies. All of the studies were conducted prior to 2010. The primary outcome of the studies was 
the attendance rate, which was the proportion of patients in the intervention and control arms, 
coming to the clinic on their appointment date. The studies pertained to clinical program areas 
such as outpatient clinics at hospitals and primary health care facilities. Services included 
pediatric, ophthalmology, orthodontics, and preventive health. The final group of studies for the 
meta analysis did not include ART or HIV/AIDS services. Most of the studies (13 of 18) sent 
generic SMS reminders. Three of the studies used personalized messages and two did not 
specify. The SMS reminders were mostly sent less than 24 hours (n = 10) prior to the 
appointment, a few of the studies sent the reminders 24-48 (n = 3) and more than 72 hours (n = 
4), prior to the appointments. Analysis showed a high (> 94%) heterogenicity among the 
observational trials (p < .01), versus RCTs, which had 0% (p = .84) heterogenicity. Therefore the 
meta-analysis was restricted to only the RCTs. The researchers found that the SMS intervention 
in RCTs increased the likelihood of patients attending their appointment by 50% versus the 
control groups which did not receive any reminders. This was found for all the services areas. 
The authors concluded that there substantial evidence that SMS reminders may improve 
attendance rates in a variety of health care settings and thus may be a viable technology to 
improve health services.  
A randomized control trial was conducted at a clinic in Geneva between April and June 
2008, to ascertain the effectiveness of patient reminders on missed appointment rates and to get a 
demographic profile of the individuals missing appointments. 2130 patients were part of the trial. 
The researchers used a "sequential reminder intervention" for the treatment group, using three 
modes of reminders starting at 48 hours prior to the clinic appointment. The first mode of 
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appointment reminder was phone call either to a land line or a mobile phone, followed by SMS 
or text message if there was no answer to the phone calls after three tries, and finally sending a 
postal reminder if the participant did not respond to the previous two mechanisms or did not have 
a land line or a mobile phone. The control group did not receive any reminders. The researchers 
reported that the intervention led to an overall significant reduction in the rate of missed 
appointment from 11.4% to 7.8%. Subgroup analyses indicated that the reductions noted were 
only significant in the general outpatient and smoking cessation appointments. They were not 
significant in the HIV and dietician clinics (Perron et al., 2010).  
Kunutsor et al. (2010), conducted a cross-sectional and prospective study at two rural 
sites in Uganda to ascertain access to and use of cell phones and assess the feasibility of SMS or 
cell phone calls to improve clinic attendance among patients on ART and ultimately adherence to 
ART. The researchers identified and approached individuals attending the ART clinic. They 
conducted a survey on a random sample of 276 people. Of these 176 individuals had access to a 
cell phone (either they owned one or were using their friend or relative’s), and agreed to be 
contacted for the study purposes. These individuals also met the study eligibility criteria which 
included 18 years and older and had been on ART for at least three months. Structured 
questionnaire was used to collect the baseline information on participants, which included, 
social, demographic and basic ART treatment data, access to cell phone and extensive questions 
on the patterns of phone use. Study participants were prospectively followed up for 28 weeks to 
ascertain if they attended their ART refill appointment every four weeks. Participants missing 
their appointments were contacted immediately by SMS or cell phone call – based on the 
method, the participant had chosen, and reminded to attend their appointment. Participant 
adherence to ART was also calculated every four weeks via a pill count and rated as “optimal” if 
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found to be 95% and up, and “sub-optimal” if less than 95%. A total of 560 appointments were 
scheduled during the study period. The clinic visits were classified as “on schedule”, “early” or 
“missed”. The rate of attendance was 85%, 4% and 11% respectively. Fifty participants had 
missed their scheduled appointments during the study. Forgetfulness was the highest reason for 
missing appointment followed by illness, having enough medication, financial and travel issues, 
and confusion over the appointment dates. The participants predominantly chose to receive a 
phone call versus SMS due to inability to read the messaged resulting from illiteracy or language 
issues. Forty (80%) of participants who missed their appointment returned to the clinic after the 
phone call. The average return time was 2.2 days. Four (8%) of the participants had transferred 
out, died or classified as loss to follow up. Six (12%) of participants did not return to the clinic. 
Reasons cited by these individuals included financial constraints or being too sick to attend. 
Mean treatment adherence level differences pre and post phone call were found to be statistically 
significant. The researchers concluded that the use of mHealth technology, in this case, cell 
phone calls were found to be effective in improving clinic attendance and there was high 
acceptability for this type of an intervention in a resource limited setting. They acknowledged 
that other studies in developed countries found SMS to be effective however, in the rural Uganda 
setting, cell phones were preferred. While this study provides evidence of feasibility and 
acceptance of mHealth intervention to improve clinic attendance and adherence to treatment, it 
lacked a control group. Also, the researchers did not collect information on whether the patients 
would have returned to the clinic without the call. Generalizability to the rest of the Ugandan 
population is questionable too. The researchers  suggested a need for a RCT to determine if the 
outcomes noted in this study could be replicated in other resource limited countries. 
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Based on the outcomes of the studies included above, there is reasonable evidence that 
SMS are well accepted and effective in improving clinic appointment outcomes in various health 
care services settings. The evaluation of the appointment reminder intervention provided 
evidence on the effectiveness of using text messages in improving clinic attendance and thus 
lowering the LTF rates among patients on ART at a busy public sector ART clinic. Retrospective 
clinical and intervention data was used in this study. 
Summary and Conclusion 
Results from various studies conducted globally have highlighted LTF and retention in 
care as major threats to the effectiveness of ARVs in controlling the replication of the virus in 
HIV positive individuals, and the success of the ART programs. Need for innovative solutions 
and interventions to control these issues have also been identified by various stakeholders. There 
are numerous published articles on the use and effectiveness of mHealth technology in 
improving health services in developed countries; however, there are not a lot of studies in the 
developing country context. Furthermore, there is a gap in the literature on program effectiveness 
studies pertaining to use of SMS, particularly looking at health related outcomes (Chib et al., 
2012), especially in the field of HIV/AIDS. Authors have stated in numerous articles that many 
of the mHealth studies were based on pilots and lacked rigorous enquiry. Apunyu and Hoefman 
(2010) go as far as to say that many studies present anecdotal evidence, and they lack sufficient 
grounded evidence when discussing effectiveness of the interventions.  
This study evaluated a mHealth appointment reminder project underway since September 
2012 at a large public sector ART site in Johannesburg, South Africa with over 16,000 patients 
enrolled on ART. The evaluation queried if appointment reminders sent via SMS were effective 
in reducing missed appointments among individuals enrolled in the intervention versus 
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individuals not enrolled in the intervention. The 6 and 12 months LTF rates between the two 
study groups were the key outcomes of interest in this study. The appointment reminders also 
acted as cues to action for the participants. The effectiveness of the cues in leading to the 
expected behavior was reviewed during the evaluation.  
As mentioned earlier, improving patient retention in care is a priority for the South 
African NDoH. The appointment reminder project was one of three mHealth interventions 
implemented in Johannesburg. The NDoH has been informed about these projects and the 
evaluation outcomes will be shared with the government for possible integration in the national 
strategy to improve retention in ART. 
The next chapter includes information on the rationale for the study design, which was 
developed in line with the gaps identified during the literature search and the recommendations 
for future query by the various researchers. The research methodology is tailored to maximize 
the data available, given the retrospective nature of the evaluation, the intervention design and 
historical LTF data information available from the clinic.  
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Chapter 3: Research Method 
Introduction 
The purpose of this study was to evaluate the effectiveness of a mHealth ART 
appointment reminder intervention to improve retention in care of patients on ART at a large 
public-sector ART clinic in Johannesburg, South Africa. This chapter provides a review of the 
study research methodology. It starts with the research design and rationale section, which 
includes a description of the mHealth intervention. This is followed by information on the study 
research design, variables that were analyzed to respond to the research questions, the research 
methodology and data analysis plan. The chapter ends with information on threats to validity and 
ethical procedures.  
Research Design and Rationale 
Intervention 
This study evaluated a mHealth ART appointment reminder intervention that was 
implemented at a public sector ARV clinic (Ward 21) located in the Hillbrow Community Health 
Center (HCHC) in Johannesburg, South Africa.  HCHC offers secondary level health services in 
the inner city of Johannesburg, including maternal child health, TB, HIV, family planning, 
sexually transmitted illnesses management, plus minor surgeries and labor and delivery services. 
HCHC is also a referral center for public sector primary health care centers in the area and serves 
as a step-down facility for a tertiary level teaching hospital in Johannesburg. Ward 21 is an 
outpatient clinic and it is one of the largest clinics in Sub-Saharan Africa that provides free ART 
services.  
The ART appointment reminder intervention was one of three mHealth intervention 
projects developed in response to pre- and post- ART patient attrition issues discussed in Chapter 
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2. All three interventions were pilot tested and revised based on the findings before being scaled 
up to the HCHC and two other primary health care (PHC) facilities in the HCHC’s network.  
One of the interventions was focused on provision of CD4 count by cell phone to ART 
naïve patients. This intervention was rolled out at the two PHCs only, since in South Africa, the 
outpatient HIV diagnosis and initial CD4 assessment primarily takes place at the PHC level. The 
other mHealth intervention pertained to ART adherence reminders. This intervention was 
originally planned to be offered to patients who had been on ART for more than 6 months. The 
mHealth team altered the project design at the time of roll out, and offered the adherence 
reminders to all patients on ART at the implementation sites. As part of this intervention, the 
participants received weekly adherence messages for 1 year. These messages had been field 
tested by one of the partnering mHealth organizations and included social, cultural, behavioral, 
nutritional and other messages to improve ART adherence. The CD4 by cell phone and ART 
adherence interventions mentioned above will be evaluated by other individuals and thus are not 
the focus of this study. The outcomes of the various evaluations, including this study, will be 
used to provide a comprehensive evidence base on the effectiveness of mHealth interventions in 
responding to the three key areas of concern affecting the HIV/AIDS care and treatment program 
in Sub-Saharan Africa and other countries.  
The ART appointment reminder intervention was implemented at Ward 21 in September 
2012, following positive outcomes from a pilot study conducted at one of the primary health 
clinics in this clinic’s network. The intervention was originally planned for individuals newly 
initiating ART (less than 30 days). However, based on the pilot results, the project design was 
altered to offer and enroll everyone regardless of how long they had been on ART, to both the 
appointment and adherence reminder interventions. The content of the SMS messages for the 
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two interventions were distinct. Once enrolled in the ART appointment reminder intervention, 
the participants received an introductory e-mail, which was followed by three e-mail messages 
reminding the individuals of their scheduled appointments. These emails were sent 2 weeks prior 
to the appointment, 1 day prior to the appointment, and 1 day after the appointment. The pre-
appointment messages were simple reminders that the client had an appointment on the 
particular date. The message after the appointment date varied based on whether the individual 
kept the clinic appointment or not. If the individual attended the clinic appointment, they 
received a message that thanked them for adhering to their appointment and reminded them of 
the next appointment date. If the individual missed their appointment then they received a 
message that informed them of the missed appointment and urged them to schedule another 
appointment. Figure 3 shows the messages sent to the participants.  
 
 
Figure 3. Appointment reminder intervention messages sent to the participants. 
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Research Design and Rationale 
A large proportion of the existing primary research and knowledge base in the HIV/AIDS 
and mHealth field are pilot projects; there are few qualitative studies and even fewer clinical 
trials. There is an identified gap in the literature on studies conducted to evaluate the 
effectiveness of mHealth interventions in an HIV treatment setting, and specifically related to 
LTF. This study assisted in reducing the gap in the literature. The evaluation was based on a 
retrospective cohort study design to answer the question:  
Is there a difference in 6 and 12 month LTF rates between clients in the ART 
appointment reminder intervention and clients in the standard of care comparison group 
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa 
after controlling for the identified covariates?   
The retrospective cohort nature of this evaluation, which used a baseline plus specific 
follow up period was consistent with the research design required to advance knowledge in the 
field of HIV/AIDS treatment. Six and twelve month LTF outcomes were ascertained among 
patients on ART at the clinic who had self-selected to enroll in the appointment reminder 
intervention between September 2012 and February 2013, and for a representative comparison 
group, which did not receive the intervention. This group only received the standard of care.  
HIV treatment programs in South Africa and other countries are at highest risk of losing 
patients to LTF in the first 6 months of ART initiation (Dalal et al., 2007; Jaffer et al., 2007; 
Rosen & Ketlhapile, 2010; Yu et al., 2007,). The historical LTF statistics from this clinic 
indicated that this is not the case at Ward 21. Unpublished results from a 2008 patient file audit 
of over 6000 client files of clients who had initiated ART between April 2004 and March 2008 
indicated a different LTF pattern at this clinic, as shown in Figure 4. The reasons for the 
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difference in LTF rates compared to other sites are unknown. The mHealth team took this 
information into consideration when implementing the appointment reminder intervention, and 
therefore decided to keep the recruitment criteria open to include patients who were either newly 
initiating ART (< 30 days) or who had been on ART for several months or years.  
 
 
Figure 4. Distribution of patients lost to follow up at Ward 21, HCHC for  
period April 2004 to March 2008.  
 
Major time and resource constraints were not expected since the study design required a 
retrospective review. Data collected by the program staff for project monitoring purposes, 
existing patient level data available at the clinic and if needed, the pharmacy databases were used 
as sources of information, therefore resource constraints were minimal. However, one of the 
disadvantages of using existing program data was that there was no guarantee that appropriate 
quality assurance measures were implemented during data collection and reporting. The actual 
time required to clean the data set in preparation for analyses was determined after the data was 
made available to the researcher.  
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Presence or absence of the appointment reminder intervention was the  independent 
variable of this study. The dependent variables were LTF at six and twelve months after 
enrollment in the appointment reminder intervention during the specified study period of 




The population for this study were the over 16,000 patients, 18 years and above, who had 
initiated on ART at either Ward 21 or at another facility and transferred to Ward 21, and were 
accessing follow up ART services at the clinic at the time of the implementation of the 
appointment reminder intervention. ART has been available to persons in the clinic’s catchment 
area since 2004, and the population accessing services at this clinic is quite heterogeneous in that 
individuals from various ethnic, socioeconomic and cultural backgrounds reside in the clinic 
catchment area.  
Sampling and Sampling Procedures 
 The intervention sample for this study comprised of all individuals eighteen years and 
older on ART at Ward 21 who enrolled in the intervention between September 1, 2012 and 
February 28, 2013 (N = 806). Information from figure 2, was used to categorize the study 
participants into six cohorts based on their duration on ART. The six cohorts and the estimated 
number of people in each of the intervention cohort according to the mHealth team were as 
follows:  
Cohort 1 (n = 91). Initiated on ART between September 1, 2012 and February 28, 2013. 
Cohort 2: (n = 123). Initiated on ART between 1-6 months prior to Sept 1, 2012. 
Cohort 3: (n = 86). Initiated on ART between 7-12 months prior to Sept 1, 2012 
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Cohort 4: (n = 193). Initiated on ART between 13-24 months prior to Sept 1, 2012 
Cohort 5: (n = 150). Initiated on ART between 25-36 months prior to Sept 1, 2012 
Cohort 6: (n = 163). Initiated on ART >36 months prior to Sept 1, 2012 
The comparison sample for this study was identified using partly purposeful, partly 
random stratified approach where by the demographic profile of the intervention group (age and 
gender), and time on ART was used to create matching criteria to align the comparison and the 
intervention groups. Comparison group comprised of individuals who were on ART and received 
the standard of care at the clinic but who did not receive the intervention. The researcher 
expected a higher chance of missing or incorrect information in the comparison group as the 
clinic’s data quality practices were not clear. Therefore, the sample size of the comparison 
groups was estimated approximately 20% higher than the sample size of the intervention group. 
Consequently, the number of individuals in each of the comparison group cohorts were 
oversampled to accommodate for missing or incorrect information.  
SPSS version 21was used to randomly select the individuals for the six comparison 
cohorts. Drawing the study samples from the same clinic population assisted in reducing 
variations and confounding, although there was a possibility of selection bias as the individuals 
had self-selected to enroll in the intervention. The inclusion criteria for the study was all adult 
(18 years and above) male and female (including pregnant) patients. The only exclusion criteria 
was patients under 18 years of age.  
A power analysis via G*Power (Faul, Erdfelder, Lang, & Buchner, 2007) was conducted 
to determine the necessary sample size required per cohort group for a logistic regression 
analysis, which was used to address the study research questions. For the power analysis, 
specific input parameters were entered which were: effect size, set at medium, ʄ² = .30, power set 
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at .80, and the significance (p) set at < 0.05. Based on these parameters, the total sample size per 
group required to achieve adequate statistical power was N = 176. The actual sample sizes for the 
intervention and comparison groups exceeded this value. 
Procedures for Recruitment, Participation, and Data Collection  
The mHealth team at the host institution, Wits Reproductive Health and HIV Institute 
(WRHI), in Johannesburg obtained IRB approval from the Witwatersrand (Wits) University to 
implement the mHealth interventions and conduct formative, evaluative and other research 
activities in relation to these projects. As part of the Wits University IRB requirement, the team 
was required to acquire approval from the Provincial Department of Health to conduct the 
mHealth projects at the DoH ART clinics and to access the clinic and pharmacy patient records 
for the intervention and subsequent evaluations. Copies of the Wits IRB and DoH approval 
letters were included as supporting documents in the Walden IRB package.  Individuals enrolled 
in the post-ART interventions had the option to opt out at any time. Patients opting out received 
a follow up call from the project staff to confirm the decision, and to ascertain the reason for 
opting out.  
The mHealth team recruited fieldworkers and placed them at Ward 21 after a rigorous 
training and mentoring phase, which emphasized on patient recruitment methods, patient 
confidentiality, data quality, quality assurance, and other items. The field workers were present 
at the clinic every day. They approached patients in the waiting room, ascertained if the patient 
were on ART, explained the intervention, and asked the patients if they wanted to enroll. If the 
patients agreed to participate in the intervention, the fieldworkers walked them through an 
informed consent process. The consent form was approved by the Wits University IRB. It 
included items such as participants giving permission to receive SMS appointment reminders, be 
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contacted by phone (if needed for follow-up), and for use of their clinical information for 
program improvement, research and evaluation activities.  
The mHealth team had developed data capturing tools that included patient intake and 
follow up forms and an electronic database. The field workers collected the information in the 
intake forms and transferred it to the database each day. An electronic patient management and a 
pharmacy dispensing system is used at the clinic, and the program team accessed this system to 
obtain patients’ demographic, clinical, and follow-up appointment information. The mHealth 
team used patients’ clinic ID numbers as identifiers in the project database. As per Wits IRB 
requirements, the patient level information was accessed only by key project personnel and was 
stored appropriately to maintain patient confidentiality.  
Approval was obtained from WRHI to request retrospective program data from 
September 2012 to June 2014. This covered the twelve month plus 90 days follow-up period for 
all the individuals who enrolled in the intervention between September 2012 and February 2013. 
Figure 5 provides information on the timelines to ascertain LTF status at six and twelve months 
after enrollment in the intervention. Determination of LTF at 90 days after the end of six and 
twelve months of enrollment was based on the PEPFAR definition of assigning the LTF status 
(PEPFAR SASI Manual, 2007). In addition, permission was obtained to receive data from the 
clinical and the pharmacy databases for demographic, clinical, and appointment information for 
the intervention and comparison groups. For the comparison group, the six and twelve months 
LTF status were determined from September 1, 2012.  




Figure 5. Data analysis timeline to ascertain loss to follow up in the study cohorts, six and 
twelve months after enrolling in the intervention. 
 
Instrumentation and Operationalization of Constructs 
Operationalization of Variables 
Independent Variable. The key independent variable for this study was the presence or 
absence of the ART appointment reminder intervention. This independent variable was 
dichotomously coded where 0 = standard of care and 1 = ART appointment reminder 
intervention. Clients should have received all three of the reminders per appointment period to be 
included in the intervention group.  
Covariates. Covariates are variables, which may not be part of the main study inquiry 
however, they can influence the dependent variable (Field, 2012). The covariates for this study 
were identified based on information found in the literature from studies on mHealth and 
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adherence to ART (Lester et al, 2010; Pop-Eleches, 2011; Rodrigues et al, 2012). The  study 
covariates and their operational definitions are presented below:  
  Age. Client age at initiation of ART was used as a measure of age. Age is a ratio 
variable and will be calculated in years. 
Gender. Gender is a dichotomous variable where 1 = male and 0 = female. 
Baseline CD4 count. CD4 count is the number of CD 4 cells, a type of white cell that 
fights infection. A low baseline CD4 count can put a person at a high risk of getting sick. It can 
have an effect on adherence to ART appointment and loss to follow up. A CD4 count is a ratio 
variable, as it can range from 0 cells/mm3 to 1,500 cell/mm3. A normal CD4 count ranges 
between 500 to 1,500 cells/mm.3 In South Africa, ART is recommended when the CD4 count is 
below 350 cells cell/mm3 (Carter and Hughson, 2014; South African ART Guidelines, 2013). 
The baseline CD4 count is the count taken three months before ART initiation. 
ART regimen. This covariate is a categorical variable based on four different types of 
ART regimens, and it is coded where 1 = Regimen 1A, 2 = Regimen 1B, 3 = Regimen 2, and 4 = 
Other Regimen. 
Concurrent illnesses. This covariate was based on the presence of concurrent illnesses as 
noted in the patient’s records. This variable was dichotomously coded where 0 = no concurrent 
illnesses and 1 = yes, concurrent illnesses. 
ART side effects. This covariate is based on evidence of ART side effects as noted in the 
patient’s records. This variable was dichotomously coded where 0 = no ART side effects and 1 = 
yes, presence of ART side effects. 
Dependent Variables: LTF. There were two dependent variables in this study, both of 
which pertained to LTF. Programmatically, LTF is defined as the disappearance of the 
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individuals from ART for no known reason (Rosen et al., 2007). For the purpose of this study a 
patient was considered LTF if they have not been to the clinic or picked up their ARVs for at 
least 3 consecutive months. (PEPFAR Strategic Information Manual South Africa, 2007). Data 
on individuals who had died during the study period were noted but not included in the analysis. 
There were two LTF dependent dichotomously coded variables: (a) 0 = no, no loss of client at 
follow up at 6 months and 1 = yes, loss of client at follow up at 6 months and (b) 0 = no, no loss 
of client at follow up at 12 months and 1 = yes, loss of client at follow up at 12 months. The two 
time periods were selected based on evidence from mHealth based ART adherence studies found 
in the literature. These studies found significant differences in adherence to ART at the six and 
twelve month timeframes (Lester et al, 2010; Rodrigues et al, 2012).  
The study data was planned to be derived from four sources:  (a) ART appointment 
reminder intervention data from the project database; (b) patient demographic and clinical data 
from the Electronic Medical Records (EMR), of patients who initiated on ART between 
September 2012 and February 2013 and for the relevant comparison groups by cohort; (c) patient 
appointment dates from the EMR or electronic pharmacy dispensing system for patients who 
initiated on ART between September 2012 and February 2013 and for the relevant comparison 
groups by cohort; and (d) the 2009 HCHC File Audit Report (unpublished). 
Data Analysis Plan  
The purpose of this study was to evaluate the effectiveness of a mHealth patient 
appointment reminder intervention to improve retention in care of patients initiating ART at a 
large public sector ART clinic in Johannesburg, South Africa.  
Research question 1. Is there a difference in six month LTF rates between clients in the 
ART appointment reminder intervention and clients in the standard of care comparison group 
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who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after 
controlling for the identified covariates? 
 Ho1. There are no statistically significant decreases in the likelihood of 6 month LTF for 
clients on ART who received the appointment reminder intervention when compared to clients in 
the standard of care comparison group.  
Ha1. There are statistically significant decreases in the likelihood of 6 month LTF for 
clients on ART who received the appointment reminder intervention when compared to clients in 
the standard of care comparison group.  
Research question 2. Is there a difference in 12-month LTF rates between clients in the 
ART appointment reminder intervention and clients in the standard of care comparison group 
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after 
controlling for the identified covariates? 
 Ho2. There are no statistically significant decreases in the likelihood of 12 month LTF for 
clients on ART who received the appointment reminder intervention when compared to clients in 
the standard of care comparison group.  
Ha2. There are statistically significant decreases in the likelihood of 12 month LTF for 
clients on ART who received the appointment reminder intervention when compared to clients in 
the standard of care comparison group. 
The project data was obtained in Microsoft Excel file formats from the mHealth project 
staff. Additional demographic and study related data was be included in this database as relevant. 
All study data was cleaned (i.e., reviewed for errors) then exported to a SPSS 21.0 data file for 
data analysis. All of the study variables were assigned a variable name, with the variable values 
coded (e.g., male = 1 and female = 0). Cases were reviewed for missing at random (MAR) and 
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not missing at random (NMAR) data, and multiple analyses were conducted on the NMAR data 
(Agresti, 2013). Descriptive statistics were computed for the study variables, inclusive of the 
study covariates. The mean, standard deviation, and minimum and maximum values were 
computed for ratio variables and frequencies and percentages calculated for dichotomous and 
categorical variables. Outliers were addressed by replacing the outlier with the next highest or 
lowest value (Agresti, 2013). Spearman’s rho correlations and chi-square analyses were 
conducted between each of the identified study covariates and the dependent LTF variables. 
Covariates found to be associated with the dependent variables with p-values of < 0.25 were 
included as predictors in the logistic regression analyses performed to address the study research 
question. The p-value criteria of < 0.25 for covariate association was used for analysis as it is 
possible that a covariate may not be significantly associated independently but may contribute to 
the model in conjunction with other variables.  
A benefit of using logistic regression is that the assumptions of normality, linearity, and 
homogeneity of variance are not relevant to this type of statistic as thus data need not be 
examined for violations of these assumptions (Agresti, 2013). Two binary logistic regression 
analyses were conducted for the two dependent variables (LTF at 6 months and LTF at 12 
months). Binary logistic regression was selected for this study as the dependent variables were 
dichotomously coded and the relationship between the intervention and the outcomes of LTF 
could be determined when covariate variance were accounted for (Agresti, 2013). The model 
chi-square (χ²) determined the significance of the overall regression model, while the 
classification table generated by the statistical tool determined correct classification of the 
dependent variable categories based on the predictors in the model (Agresti, 2013). The Hosmer-
Lemeshow (H-L) statistic for logistic regression, which answers the question, “how best does my 
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model fit the data?” was used as the model goodness-of-fit statistic (Allison 2013). If the p-value 
produced from the statistic was low (< .05) then the model was rejected. If the p-value was high, 
then the model passed the test as a good fit (Allison 2013; Agresti, 2013). Any probability value  
of significance (p-value) generated in the regression model, which was less than the level of 
significance (0.05) was considered statistically significant. 
Threats to Validity 
It is important to note the potential threats that can affect the validity of the study. The 
most common threats are to the internal, external and statistical conclusion validity. Threats to 
internal validity compromise the researcher’s confidence to indicate if a relationship exists 
between the independent and dependent variables. Information presented below was developed 
based on the list of threats to internal validity by Michael (2014). History should not be a threat 
to this study as both the intervention and control groups were from the same clinic and had 
initiated on ART during a similar time period. If an unexpected event occurred during the study 
period, which may affect the outcome noted, it would have affected both the groups and thus 
should not have an effect on the differences noted between the two groups. Maturation was not a 
threat to this study as both the groups experienced the same progression of their illness at the 
same rate. Selection bias was a possible threat to the internal validity of this study as the 
participants self-selected to enroll in the intervention. Experimental mortality or the attrition in 
number of participants over the study period could have been a minor threat to this study, 
however, the full extent of this threat could only be ascertained once data was received for 
analyses. That said, the mHealth project manager has mentioned to the researcher that 
individuals asking to opt out of the intervention were few. The project collected information on 
the reason for opting out which was reviewed as part of this study. Testing was not part of this 
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intervention therefore it was not a valid threat. The dependent variables were measured using the 
project and clinic data for both the groups, thus instrumentation was not a threat for this study. 
Design contamination could have been a possible threat to this study, especially since all 
individuals were approached and the intervention was explained and offered to everyone. In 
addition, all individuals enrolled in the appointment reminder intervention also received weekly 
adherence messages. It was difficult to confidently state if the outcomes observed were a result 
of the appointment reminder or the adherence messages. It was not possible to control for the 
adherence intervention as the study used retrospective data. It would have been a better practice 
if the groups of individuals who received the two interventions (appointment reminder and 
adherence messages) were kept separate as originally planned. Full extent of this issue may 
become apparent at the time of data analysis. Compensatory rivalry and resentful demoralization 
did not affect this study as the intervention was offered to all the patients on ART (Michael, 
2014). 
According to Michael (2014), threats to external validity can compromise confidence in 
making the study results generalizable to other populations. Some important threats to external 
validity are: i) interaction of testing, ii) interaction effects of selection biases and the 
experimental treatment testing reactivity, iii) reactive effects of experimental arrangements, and 
iv) multiple-treatment interference.  
Interaction effect of testing occurs when a pre-test interacts with the intervention under 
study and alters the outcomes such that the results cannot be generalizable beyond the study 
population (Michael, 2014). This phenomenon was not a threat to this study as the participants 
were not tested during the course of the intervention. Interaction effects of selection biases and 
the experimental treatment takes place when some aspect of the group based on the selection of 
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the participants interacts with the intervention, which would not have happened if the 
participants were randomly selected (Michael, 2014). This was a potential threat to this study as 
the participants self-selected to receive the intervention. Reactive effects of experimental 
arrangement also known as the Hawthorne effect is a phenomenon experienced by some 
participants who may alter their behaviors because they are part of a study (Michael, 2014). This 
could have been a viable threat to this study. It is possible that the participants receiving the 
intervention altered their treatment adherence. Multiple treatment interference occurs when 
subjects are given multiple doses of the treatment or, as is the case in a repeated measures study 
design. This makes it difficult for the researcher to generalize the results to the actual effect of a 
single treatment (Michael, 2014). While this study population will be measured repeatedly for 
adherence to appointments and LTF, multiple treatment interference was not a viable threat to 
this study population based on the planned intervention, which sent a set number of reminders to 
the participants every month.  
Threat to construct or statistical conclusion validity (SCV) comes into play when 
inappropriate or inadequate statistical analysis are used for data analysis or measurement of 
variables, which produce results that would have been different if the correct data analysis tool 
were utilized (Garcia-Perez, 2012). A threat to SCV can lead the researcher to incorrect 
conclusions about the relationship between the indirect and direct variables. They can lead to two 
main types of errors: (a) the researcher concludes that there is no relationship when in reality 
there is a relationship or (b) the researcher concludes that there is a relationship when in reality 
there is no relationship. These are similar to the Type I and Type II errors that can be 
encountered in hypothesis testing. Some of the common threats to SCV according to a WEB 
center for social research methods article (2014) include: (a) slow reliability of measures, (b) 
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poor reliability of treatment implementation, (c) random heterogeneity of respondents, (d) low 
statistical power, and (e) violated assumptions of statistical tests. 
Low reliability of measures comes up if the measurement tool is not appropriate. That is, 
there is poor layout or design of the tool or questions that may not be appropriate for the study. 
Poor reliability of treatment implementation is particularly important in an evaluation setting. 
This occurs, when the program is not implemented as planned or there are inconsistencies in the 
actual implementation. This can make it difficult to ascertain relationships between the 
independent and dependent variables. Random heterogeneity of the respondents pertains to the 
different types of people who may be participating in the study, which would increase variance 
in the responses. Some of the variability may be useful for the study while others could 
potentially cause hindrance in observing any relationships. The above three items may mask 
actual relationship; however, the strongest threat to SCV is low statistical power. This affects the 
strength of any relationship or associations. Violated assumptions of statistical tests are 
important as a researcher can make incorrect assumptions when conducting data analysis; for 
example, assuming that the data is normally distributed when it is not (WEB center for social 
research center, 2014).  
Some of the recommendations based on the above mentioned threats to SCV include: 
using robust statistical power, ensuring appropriate reliability, implementation of the 
intervention, and good understanding about the data and use of appropriate statistical tests. The 
sample size for the intervention group was pre-determined for this study and individuals on ART 
at the clinic who had not received the intervention were randomly sampled for inclusion in the 
comparison group. The total sample size was large enough to provide a strong power for this 
study. The intervention did not use any tools to measure study variables, it used actual data from 
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the clinic and pharmacy. Therefore, the study was not at risk for inappropriate reliability. 
Appropriate implementation of the intervention could be an area of concern for this study. The 
WEB center for social research center (2014), has recommended that to achieve good 
implementation of intervention researcher should have standardized protocols and train the 
program staff to implement the intervention uniformly and appropriately. The mHealth team had 
trained and mentored the field workers and other program staff on appropriate participant 
recruitment, patient confidentiality, follow up, and data quality, so the effect of this threat were 
minimal to this study. In addition, the team had developed Standard Operating Procedures and 
recruitment flow charts for the fieldworkers to use in their day-to-day project tasks. To avoid 
violated assumption of statistical tests, the researcher shared the analysis plan with the 
dissertation committee before starting the analysis.  
Ethical Procedures 
As mentioned earlier, the project team had submitted an application to the Wits 
University IRB to implement the three mHealth interventions and evaluate them. As part of the 
Wits IRB application, the project had to obtain a letter of approval from the provincial DoH 
leadership to implement the project at the DoH sites in the inner city of Johannesburg. The Wits 
IRB application was approved in 2012, and the approval letter was included in the Walden 
University IRB application.  Letters of permission to access the project and clinic data were 
obtained for this study from WRHI and included in the IRB application and/or the final 
dissertation as required.  
Ethical concerns in relation to recruitment materials and processes, data collection, and 
intervention activities were not expected given the retrospective nature of this study, and since 
no new data was collected as part of this evaluation study. The appointment reminder project was 
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described as a low risk intervention by the WRHI mHealth team in the Wits University IRB 
application, which means that the participants had low risk of adverse events resulting from 
participating in the project. The mHealth team used specific measures to protect patient 
confidentiality in line with the Wits University IRB requirements. As mentioned earlier, the 
project used patient clinic IDs to link with the clinical information and for follow up activities, in 
an effort to protect participant confidentiality. Once the Walden IRB approval was received (IRB 
approval number 10-15-14-0108616), the WRHI mHealth team made the project data available 
to the researcher. In addition, specific demographic and clinical information on the patients in 
both the intervention and comparison group from the clinic’s EMR and pharmacy databases was 
requested by the researcher. Walden IRB required the researcher to not have access to the 
patient’s clinic ID numbers. The researcher was the only person to have access to the raw data 
for the study. The study database was password protected and stored on the researcher’s personal 
computer at home. The study database will be deleted from the computer five years after the 
completion of the dissertation or as required by the Walden University IRB.  
This study was conducted at the researcher’s previous place of employment. As the head 
of department for the Monitoring and Evaluation (M&E) team at WRHI from 2006 - 2013, the 
researcher supervised five portfolios in the department. However, all the portfolios were 
managed by program managers. While the researcher provided technical assistance to the 
mHealth portfolio and supervised the program managers, the mHealth program manager had 
recruited the mHealth team members and managed the day-to-day functioning of the portfolio. 
The researcher was not involved with the training of the intervention staff and did not have 
access to the project data prior to the evaluation, except for the routine program monitoring 
outputs reported by the team via quarterly reports. The researcher  left WRHI to relocate to the 
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US in March 2013 and has not had any management or technical connections to the M&E team 
since.  
WRHI leadership promotes and supports its staff to pursue higher educational degrees. 
Four M&E staff members are pursuing or completed their Masters degrees in the last five years. 
One of the program managers already has a PhD and three of the remaining four are currently 
pursuing their PhDs – two of the dissertation topics are mHealth related, therefore there is no risk 
of power differential regarding this dissertation. Furthermore, based on the independent mHealth 
dissertations underway, the two program managers and the researchers expect to provide a well-
rounded evidence base on the effectiveness of mHealth in strengthening HIV/AIDS care and 
treatment in South Africa.  
Summary 
This evaluation was based on a retrospective cohort study design using quantitative 
analysis. The effectiveness of appointment reminders sent via SMS, in reducing missed 
appointments among individuals enrolled in the intervention versus individuals not enrolled in 
the intervention was ascertained by this study. Loss to follow up rates at six and twelve months 
post ART initiation were also reviewed for the above two groups. The appointment reminder 
intervention is one of first mHealth projects to be implemented in South Africa and the results 
from the evaluation are expected to have an effect on the expansion of other mHealth and HIV 
projects in South Africa.  
While this chapter provided information on the study methodology and data analysis 
plan, the next chapter includes actual data from the study, analysis of the data, study observations 
and explains any deviations or alterations to the information in this chapter. 
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Chapter 4: Results 
Introduction 
The purpose of this study was to evaluate the effectiveness of a mHealth patient 
appointment reminder intervention to improve retention in care of patients initiating ART at a 
large public sector ART clinic located in a community health center in Johannesburg, South 
Africa. The two research questions queried differences in LTF rates at 6 and 12 – months 
between clients enrolled in the ART appointment reminder intervention and clients in the 
comparison group.  The hypotheses were that there were no statistically significant differences in 
the LTF rates at 6 and 12 months, between the intervention and the comparison groups. 
This chapter starts with information on the research questions, and the null and alternate 
hypotheses. This is followed by tables with descriptive statistics on the basic demographics and 
various study covariates of the two study groups. Chi-square and regression analyses between the 
covariates and the dependent variables form the next part of this chapter. A model chi-square 
analysis for the full study population is presented first, followed by cohort-level chi-square and 
regression analyses for each of the six cohorts in the study. The chapter ends with a summary of 
the findings and introduction to Chapter 5. 
 
Data Collection 
As mentioned in Chapter 3, the project data requested from the host organization was for 
the period September, 2012 to June, 2014. However, the organization was able to provide data 
for this period only for the intervention group. Data for the comparison groups was available 
through January 2014. In 2011, the national DoH made a decision to roll out a standardized 
HMIS called Tier.net at all the public sector HIV clinics in the country. The accompanying new 
policy mandated all sites to shut down any existing HMIS and switch to the new DoH one. Ward 
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21, the study site, was allowed a 2-year grace period to shift to the new system as the existing 
HMIS in use at the clinic was more advanced than Tier.net. In December 2013, the DoH asked 
the site to switch over to Tier.net immediately, thus the time period for the data for the 
comparison group was shortened to January, 2014. Nonetheless, the truncated period did not 
impact this study and it was possible to make LTF decisions at the 12-month mark for all the 
patients in the intervention and the comparison groups. The researcher also noted that individuals 
who were identified as LTF at 6 months continued to be LTF at 12 months.  
According to the preliminary information from the intervention implementation team, 
806 individuals were expected to be in the intervention group. As mentioned in chapter three, the 
comparison group cohorts were to be oversampled by approximately 20%. In actual, a total of 
832 individuals qualified to be included in the intervention group during the study enrollment 
period of September 1, 2012 to February 28, 2013. The actual size of the comparison group was 
918, for a total study population of 1750 individuals. Participants were randomly selected for the 
comparison group based on the gender and age breakdown of the six intervention group cohorts. 
Data cleaning was conducted before the analyses; any individuals who did not have an ART 
initiation date or were LTF before September 2012 were removed from the dataset.  
The study sample size was N = 1750 participants (832 in the intervention group and 918 
in the comparison group), of whom n = 1135 (64.9%) were female and n = 615 (35.1%) were 
male. The demographic and descriptive characteristics of the sample population are summarized 
in Table 1. The mean age of participants was 37.34 years (Md = 36.00, SD = 8.25), and 
participants ranged in age from 18 to 79 years. Of the n = 832 participants in the intervention 
group, n = 523 (62.9%) were female and n = 309 (37.1%) were male. The mean age of 
intervention group participants was 37.41 years (Md = 36.50, SD = 8.11), and intervention 
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participants ranged in age from 18 to 67 years. Of the n = 918 participants in the comparison 
group, n = 612 (66.7%) were female and n = 306 (33.3%) were male. The mean age of the 
comparison group participants was 37.28 years (Md = 36.00, SD = 8.38), and the participants in 
this group ranged in age from 19 to 79 years. Of the 1135 females in the study group, n = 61 
(5.4%) were pregnant. Of these, n = 27 were in the intervention group and n = 34 were in the 
comparison group. 
Table 1 
Study Participants by Group (N = 1750) 
 Intervention 
n = 832 
Comparison 
n = 918 
 Frequency Percentage Frequency Percentage 
Gender     









































Pregnant      
No 496 94.6 578 94.1 
Yes 27 5.4 34 5.9 
     
 Mean SD Mean SD 
Age 37.41 8.11 37.28 8.38 
 
A chi-square (χ²) test of independence showed that there was a slight but significant 
association between gender and the intervention and comparison group classification, χ² = 2.77, 
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p = .01. An independent samples t-test showed that the intervention and comparison groups of 
participants did not significantly differ on age, t (1748) = 0.34, p = .73. Table 2, shows 
breakdown for gender by the intervention and comparison group cohorts and table 3, provides 
the age breakdown information by each cohort in the two study groups.  
Table 2 
Study Participants Gender by Intervention and Comparison Group Cohorts (N = 1750) 




  Frequency Percentage Frequency Percentage 
Cohort 1 Female 55 62.5 72 67.3 
 Male 33 37.5 35 32.7 
Cohort 2 Female 60 58.8 89 65.4 
 Male 42 41.2 47 34.6 
Cohort 3 Female 43 55.8 58 69.0 
 Male 34 44.2 26 31.0 
Cohort 4 Female 120 65.2 128 65.3 
 Male 64 34.8 68 34.7 
Cohort 5 Female 123 64.7 132 64.7 
 Male 67 35.3 72 35.3 
Cohort 6 Female 122 63.9 133 69.6 









Study Participant Mean Age by Intervention and Comparison Cohorts (N = 1750) 
 Intervention  
(n = 832) 
Comparison 
(n = 918) 
 Mean Age 
(years) 



































Descriptive Statistics: Study Population 
Analyses were done to ascertain the first, baseline and most current CD4 counts of the 
individuals in the study groups. First CD4 counts were found for n = 1519 (87%) of the study 
population. Baseline CD4 counts were available for n = 1395 (80%) of the study population. It 
was noted that of the n = 355 (20%) of individuals with missing baseline CD counts, 
approximately n = 162 (50%) had transferred into this clinic after initiating ART at another 
clinic. If the individuals’ record was missing a baseline CD4 count, but had a first CD4 count, 
then the difference between the date of the first CD4 count and ART initiation date was 
ascertained. If the first CD4 count date was less than six months prior to the ART initiation date, 
then the first CD4 count value was used as the baseline CD4. The median first CD4 count for the 
entire study population was 148 cells/mm3 while the median baseline CD4 count for the entire 
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study population was 137 cells/mm3. Current CD4 counts were available for n = 1708 (98%) of 
the study population. The median current CD4 count for the entire study population was 384 
cells/mm3. Median baseline and current CD4 counts by intervention and comparison group 
cohorts are presented in table 4. In cases where a value was missing for variables first reported 
CD4 or baseline CD4 or current CD4, a mean value substitution was done. The median figures 
presented above for first, baseline and current CD4 count data were before the mean value 
substitutions were done.  
Table 4 
Baseline and Current CD4 Median by Intervention and Comparison Group Cohorts (N = 1750) 
 Intervention (n = 832) Comparison (n = 918) 








All cohorts 137 391 137 379 
Cohort 1 157 299 188 271 
Cohort 2 202 350 181 311 
Cohort 3 165 325 157 323 
Cohort 4 130 385 136 366 
Cohort 5 124 403 106 425 
Cohort 6 111 485 120 514 
Note: The median CD4 values in table 4 are based on data before mean value substitutions were done 
for missing CD4 data. For the rest of the analyses for this study, the mean value adjusted first, baseline 
and current CD4 values have been used. 
Current viral load was one of the study covariates. This information was available for 
95% (n = 1672) of the study population. Viral load is one of the markers used to detect ART 
success or the ability of the ART to keep the virus level under control. Viral load is measured in 
terms of virus copies per milliliter of blood. Viral load of  < 49 virus copies/ml of blood is 
considered undetectable (http://www.aidmap.com). A viral load of  > 49 virus copies /ml of 
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blood should be a red flag for health care providers to query possible ART adherence issues or 
possible ART failure. A viral load of  < 49 virus copies/ml of blood is referred to as undetectable 
while a viral load of > 49 virus copies/ml of blood is considered to be in the detectable range. Of 
the 1672 individual who had current viral load information available, n = 1455 (87%) had an 
undetectable viral load. The virus was detectable in n = 126 (15%) and n = 91 (10%) of the 
individuals in the intervention and comparison groups respectively.  
A large variation in the viral load range in individuals with detectable viral load values 
was found. Median substitutions were done in some cases as there were some major outliers, 
which were affecting the mean values. A median value was more representative of the values in 
the large sample, but even this led to values in the regressions that were not interpretable (b = 
0.000). Transforming the median current viral load into a z-score led to more useful information, 
which was used for all the regression analyses.  
For the purpose of this study, current ART regimen was defined as the ART regimen the 
patient was on between June 2012 (three months prior to the study period) and January 2014 (the 
study end period). The South African government released new guidelines for ART regimens in 
2013 (The South African Antiretroviral Treatment Guidelines, 2013). According to the new 
guidelines, the regimens were re-categorized as regimen 1 and 2 versus the previous guidelines 
(included in chapter 3), which had the categorization of regimen 1A, 1B and 2. The updated 
2013 guidelines were used during data analysis. ART regimen data was available for all 1760 
individuals in the study. Most of the individuals were on the first line regimen n = 1465, (83.7%) 
during the study period. The remaining 285 (n = 16.3%) individuals were on the second line 
regimen. Changes in regimen during the study period were not noted during analysis. Table 5, 
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includes ART regimen information disaggregated by the six cohorts in both the intervention and 
the comparison groups.  
Table 5 
First and Second ART Regimen by Intervention and Comparison Goup Cohorts (N = 1750) 
 Intervention Group (n = 832)  Comparison Group (n = 918) 































































Cohort 6 139 72.8 52 27.2  138 72.3 53 27.7 
 
Table 6, provides descriptive statistics for individuals who transferred into the clinic after 
initiating ART at another clinic and for individuals who initiated on ART at the study clinic but 
transferred out to another clinic. Individuals transferred in and transferred out may not be the 










Transfers In and Transfers Out by Intervention and Comparison Group Cohorts (N = 1750) 
 Intervention Group  
(n = 832) 
Comparison Group 
(n = 918) 
 Transferred in Transferred out Transferred in Transferred out 
 n % n % n % n % 
























































Descriptive statistics were ascertained for individuals who had ART side effects: 
lipodystrophy, lactic acidosis and/or peripheral or poly neuropathy listed in their records. These 
were the three most commonly noted side effects found during the 2009 patient file audit 
conducted at this clinic, thus these side effects were used in this study. Similarly, a few of the 
more commonly associated co-morbidities with HIV, namely tuberculosis, herpes zoster and 
kaposi sarcoma identified via a patient file audit conducted at this clinic in 2009 (unpublished 
report), were included in the analyses. Tables 7 and 8 include the descriptive statistics for the 
side effects and the co-morbidities found in the patients’ clinical records. Three individuals had 
more than one side effect or co-morbidity concurrently reported during the study period. 
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Table 7  
Lipodystrophy, Lactic Acidosis, and Peripheral/Poly Neuropathy Rates by Intervention and 
Comparison Group Cohorts (N = 1750) 
  Intervention 
Group         
(n = 832) 
   Comparison 
Group       
(n = 918) 
 
 LIPO LA PNP  LIPO LA PNP 
  n % n % n %  n % n % n % 
All 
cohorts 


































































Cohort 6 13 6.8 1 0.5 2 1.0   57 29.8 7 3.4 28 14.7 















Tuberculosis, Herpes Zoster, and Kaposi Sarcoma Rates by Intervention and Comparison Group 
Cohorts (N = 1750) 
  Intervention    Comparison  
 TB HZ KS  TB HZ KS 
 n % n % n %  n % n % n % 


































































Cohort 6 4 2.1 3 1.6 0 0.0  1 0.5   1 0.5 1 0.1 
Note. TB = Tuberculosis; HZ = Herpes Zoster; KS = Kaposi Sarcoma. 
 
Most of the individuals enrolled in the intervention were retained in the program at the 
time of this evaluation. Only n = 8 (1%) individuals in the intervention group opted out.  
Testing of Covariates and Logistic Regression Analyses 
A series of chi-square analyses were conducted between the variables age, gender, ART 
regimen type, transferred in, intervention (independent variable), side effects (i.e., lipodystrophy, 
lactic acidosis, and peripheral/poly neuropathy), concurrent illnesses (i.e., tuberculosis, herpes 
zoster, kaposi sarcoma), first CD4 count, baseline CD4 count, current CD4 count, z-score viral 
load, and the two dependent variables: LTF at 6 and 12 months, to determine if there were any 
significant associations between the covariates and the dependent variables. The variables: 
gender, pregnancy, ART regimen type, transferred in, intervention, lipodystrophy, lactic 
acidosis, peripheral/poly neuropathy, tuberculosis, herpes zoster, kaposi sarcoma, and opt out 
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were coded as nominal and dichotomous. Similarly, the two dependent variables, LTF at 6 and 
12 months were also coded as nominal and dichotomous. Associations between the nominal and 
dichotomous variables listed above, and the dependent variables were ascertained using chi-
square (χ²) and phi (φ) statistics. This was a slight deviation from the information included in 
chapter 3, which stated use of Spearman chi square. The variables: age, first CD4 count, baseline 
CD4 count, current CD4 count and z-score viral load were coded as nominal but were not 
dichotomous. Associations between these variables and the dichotomous dependent variables 
were determined using a chi-square (χ²) and Cramer’s V or Cramer’s phi statistic (φc). Covariates 
found to be associated with the dependent variables with p-values of < 0.25 were included as 
predictor variables in the logistic regression models in an effort to answer the two study research 
questions. The following ranges for the phi and Crammer’s V statistics were used to interpret the 
strength of associations/effect size between the independent/ covariate and the dependent 
variables (http://faculty.quinnipiac.edu/libarts/polsci/Statistics.html):   
If phi (φ) =  
+.70 or higher. Very strong positive relationship  
+.40 to +.69. Strong positive relationship  
+.30 to +.39. Moderate positive relationship  
+.20 to +.29. Weak positive relationship  
+.01 to +.19. No or negligible relationship  
-.01 to -.19. No or negligible relationship  
-.20 to -.29. Weak negative relationship  
-.30 to -.39. Moderate negative relationship  
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-.40 to -.69. Strong negative relationship  
-.70 or higher. Very strong negative relationship 
If Cramer’s V (φc) =  
.25 or higher. Very strong relationship  
.15 to .25. Strong relationship  
.11 to .15. Moderate relationship  
.06 to .10. Weak relationship  
.01 to .05. No or negligible relationship 
Results from the model chi square analyses for the full study sample are presented in 
Tables 9 and 10. Below are the relevant (p < .25) associations found. The independent variable, 
intervention, was negatively associated with LTF at 6 months,  χ² (1, N = 1750) = 68.40, φ = -
.20, p < .001 and at 12 months, χ² (1, N = 1750) = 29.43, φ = -.13, p < .001,suggesting that 
individuals in the comparison group had a higher chance of LTF versus individuals in the 
intervention group. However, the phi statistic indicated a weak association between the two 
variables. Gender was negatively associated with LTF at 6 months χ² (1, N = 1750) = 4.51, φ = -
.05, p < .05, and with LTF at 12 months χ² (1, N = 1750) = 2.40, φ = -.04, p < .25, indicating that 
men had a higher chance of LTF. However, the phi statistic for both the outcomes indicated 
negligible or no association between gender and the two LTF outcomes. Pregnancy was 
positively associated with LTF at 6 months χ² (1, N = 1750) = 12.24, φ = .08, p < .001 and LTF 
at 12 months χ² (1, N = 1750) = 8.63, φ = .07, p < .01, indicating that pregnant women had a 
higher chance of LTF. However, the phi statistic for both the outcomes indicated negligible or no  
association between pregnancy and the LTF outcomes. ART regimen type was negatively 
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associated with LTF at 6 months χ² (1, N = 1750) = 9.14, φ = -.07, p < .01 and LTF at 12 months 
χ² (1, N = 1750) = 2.33, φ = -.04, p < .25, indicating that individuals on ART regimen 1 had a 
higher chance of LTF versus individuals on ART regimen 2. However, the phi statistic for both 
the outcomes indicated negligible or no association between ART regimen and the LTF 
outcomes. Individuals who had transferred in had a negative association with LTF at 6 months χ² 
(1, N = 1750) = 3.44, φ = -.04, p < .25, indicating that individuals who had initiated on ART at 
another site and transferred to the study site had a lower chance of LTF at 6 months. However, 
the phi statistic indicated negligible or no association between the two variables. Peripheral/poly 
neuropathy had a negative association with LTF at 12 months χ² (1, N = 1750) = 1.44, φ = -.03, p 
< .25, indicating that individuals with peripheral/poly neuropathy had a lower chance of LTF at 
12 months. The phi statistic indicated negligible or no association between the two variables. 
Herpes Zoster had a negative association with LTF at 12 months χ² (1, N = 1750) = 1.66, φ = -
.03, p < .25, indicating that individuals with herpes zoster had a lower chance of LTF at 12 
months. The phi statistic indicated negligible or no association between the two variables. Opt 
out was positively associated with LTF at 12 months χ² (1, N = 1750) = 5.18, φ = .05, p < .05, 
indicating that individuals who had opted out of the intervention had a higher chance of LTF at 
12 months. However, the phi statistic indicated negligible or no association between the two 
variables.  
Age was positively associated with LTF at 6 months χ² (51, N = 1750) = 83.40, φc = .22, 
p < .01 and at 12 months χ² (51, N = 1750) = 65.03, φc = .19, p < .25, indicating that older 
individuals has a higher chance of LTF at both 6 and 12 months. The Cramer’s V statistic 
indicated a strong association between the two variables. Current CD4 count was positively 
associated with LTF at 6 months χ² (702, N = 1750) = 743.15, φc = .65, p < .25 and LTF at 12 
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months χ² (702, N = 1750) = 746.66, φc = .65, p < .25, indicating that individuals with higher 
current CD4 count had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic 
indicated a very strong positive association between the two variables. Current viral load was 
also positively associated with LTF at 6 months χ² (194, N = 1750) = 469.82, φc = .52, p < .001 
and LTF at 12 months χ² (194, N = 1750) = 333.88, φc = .44, p < .001, indicating that individuals 
with higher viral load had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic 
indicated a very strong positive association between the two variables. 
Table 9  
Associations Between Nominal and Dichotomous Variables and LTF at 6 and 12 months for the 
Entire Study Population (N = 1750) 
 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 68.40 -.20 .000 29.43 -.130 .000*** 
Gender 4.51 -.05 .03 2.40 -.04 .12^ 
Pregnancy 12.24 .08 .00 8.63 .04 .00** 
Transferred in 3.44 -.04 .06 .10 -.01 .75 
Current ART Regimen 9.14 -.07 .00 2.33 -.04 .13^ 
Lipodystrophy .28 -.01 .60 .38 -.01 .534 
Lactic Acidosis .48 .02 .49 .15 -.01 .70 
Peripheral/Poly 
Neuropathy 
.016 .00 .90 1.44 -.03 .23^ 
Tuberculosis .70 .02 .40 .05 -.00 .83 
Herpes Zoster .71 -.02 .40 1.66 -.03 .20^ 














Note. ^p < .25; *p < .05; **p < .01; ***p < .001 




Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 months for the 
Entire Study Population  (N = 1750) 
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 83.37 .22 .00* 65.03 .19 .09^ 
First reported CD4 330.05 .43 .77 386.79 .47 .59 
Baseline CD4 743.15 .65 .14^ 325.01 .43 .83 
Current CD4 469.82 .52 .000*** 746.56 .65 .12^ 
Current viral load (z-
score) 
387.71 .47 .58 333.88 .44 .000*** 
Note. ^p < .25; *p < .05; **p < .01; ***p < .001 
 
Chi square analyses were conducted for each of the six cohorts to examine which 
covariates were relevant predictors (p < .25), of LTF at 6 and/or 12 months in each cohort. The 
independent variable, intervention as well as any covariates that were found to be correlated (p < 
.25) to LTF at 6 and/or 12 months were included in the subsequent cohort level logistic 
regression models. In addition, baseline CD4 count was included in each of the cohort level 
regression models based on studies found in the literature, which found correlations between this 
covariate and LTF (Larson et al, 2010; Dalal et al, 2007). 
Results for Cohort 1 
Testing of covariates.  Results from the model chi square analyses for cohort 1 are 
presented in Tables 11 and 12. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months,  χ² (1, N = 
195) = 3.42, φ = -.13, p = .06 and at 12 months, χ² (1, N=195) = 2.50, φ = -.11, p = .11, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
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individuals in the intervention group. However, the phi statistic fell in the category of negligible 
or no association between the two variables. Transferred in was positively associated with LTF 
at 12 months, χ² (1, N=195) = 2.14, φ = .10, p = .14, indicating that individuals in cohort 1, who 
initiated on ART at another facility and transferred into the study site had a higher chance of 
being LTF at 12 months. The phi statistic indicated negligible or no association between the two 
variables.  
Baseline CD4 was positively associated with LTF at 6 months χ² (134, N = 195 ) = 
151.23, φc = .88, p = .15, indicating that individuals with higher baseline CD4 count had a higher 
chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong association between 
the two variables. Current viral load was also positively associated with LTF at 6 months χ² (27, 
N=195) = 32.50, φc = .87, p = .21, indicating that individuals with higher viral load had a higher 
chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong association between 
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Table 11  
Cohort 1: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months 
(N = 195) 
 
           Note. ^p <.25; *p < .05; **p < .01; ***p < .001 
 
Table 12 
Cohort 1: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
Months (N = 195) 
           LTF 6 Months LTF 12 Months 
      X2    φc p       X2 φc p 
Age 42.46 .47 .28 38.99    .45 .42 
First reported CD4 144.98 .86 .58 141.35    .85 .66 
Baseline CD4  151.23 .88 .15^ 126.26    .80 .67 
Current CD4  147.61 .87 .52 155.15    .89 .35 
Current viral load 
(z-score) 
32.50 .41 .21^ 30.21    .39 .30 
    LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 3.42 -.13 .06^ 2.50 .11 .11^ 
Gender .42 .05 .51   .22  -.03 .64 
Pregnancy .84 .06 .36    .06 .02 .81 
Transferred in .48 -.05 .49  2.14   -.10 .14^ 
Current ART 
Regimen 
.64 -.06 .42  1.28 -.08 .26 
Peripheral/Poly 
Neuropathy 
.16 .03 .69   .31 -.04 .58 
Tuberculosis .09 .02 .76      .37 .04 .54 
Herpes Zoster .73 -.06 .39      .04   -.01 .84 
Opt Out n/a n/a n/a      n/a      n/a n/a 
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Note. ^p < .25; *p< .05; **p < .01; ***p < .001. 
 
Logistic Regression.  The first logistic regression for cohort 1 was conducted in relation 
to the dependent variable of 6-month loss to follow-up. Variables included in the model were the 
independent variable intervention, covariates found to be relevant associated (p < .25) with LTF 
at 6 months in the cohort 1 model chi-square analyses. In addition, baseline CD4 covariate was 
included in each regression model.  
The results from the logistic regression are presented in Table 13. The model chi-square 
was significant, χ² (3, N=195) = 8.53, p = .04, indicating that the independent variables 
significantly predicted LTF at 6 months in cohort 1. The non-significance of the Hosmer and 
Lemeshow chi-square test indicated that the data fit the model, χ² (8) = 8.60, p = .38. The 
classification table output for model 1 (which included the various predictor variables) correctly 
classified 93.3% of the 6-month loss to follow-up outcome. In comparison, the classification 
table for model 0 (the model without the various predictor variables) indicated that the 
independent variable - intervention without the confounders correctly classified 92.8% of the 6 – 
month loss to follow up outcomes. There was a minimal difference in the classification tables 
between model 0 and 1. The Nagelkerke R2 indicated 10.6% variance in the model.  
 Two variables significantly predicted (p < .05), 6-month loss to follow-up. Intervention 
group classification was significant, Wald (1) = 3.95, p = .04. The negative correlation with the 
outcome and odds ratio (Exp B) of .22 indicated that the odds of LTF at 6 months among 
individuals in the intervention group were .22 times less compared to individuals in the 
comparison group. Additionally, current viral load (z-score) was a significant predictor for LTF 
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at 6 month in cohort 1, Wald (1) = 5.37, p = .02. The odds ratio indicated that increases in viral 
load increased the odds of LTF at 6 months by 1.24 times. 
 
Table 13 
Cohort 1: Intervention and Predictor Variables for 6 Month LTF (N = 195) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -2.25 .58 14.82 .000 .10   
Intervention -1.53 .77 3.95 .04* .22 .05 .98 
Baseline CD4 .000 .003 .02 .88 1.00 .99 1.01 
Current Viral 
Load 
.21 .09 5.37 .02* 1.24 1.03 1.48 
χ² 8.53       
Df 3       
Correct 
Classified 
93.3       
Note. ^p < .25; *p < .05; **p < .01; ***p < .001. 
 
The second logistic regression for cohort 1was conducted with regards to the dependent 
variable of 12-month loss to follow-up. As with the first logistic regression, variables included in 
the model were the independent variable – intervention and covariates found to be associated (p 
< .25) with LTF at 12 months in the cohort 1 model chi-square analyses. In addition, baseline 
CD4 covariate was included in each regression model. The results from the logistic regression 
are presented in Table 14. The model chi-square was not significant, χ² (3, N=195) = 4.27, p = 
.23, indicating that the independent and covariate variables did not significantly predict LTF at 
12 months in cohort 1.  






Cohort 1: Intervention and Predictor Variables for 12 Month LTF (N = 195) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -1.49 .44 11.54 .001 .22   
Intervention -.69 .45 2.32 .13 .50 .21 1.22 
Transferred in 1.17 .90 1.67 .20 .50 .21 1.22 
Baseline CD4 -.001 .002 .22 .64 .99 .99 1.00 
χ² 4.27       
Df 3       
Correct Classified 86.7%       
Note. ^p <.25; *p < .05; **p < .01; ***p < .001. 
 
Analysis for Cohort 2. 
Testing of Covariates. Results from the model chi square analyses for Cohort 2 are 
presented in Tables 15 and 16. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N = 
238) = 7.33, φ = -.17, p = .01 and at 12 months, χ² (1, N = 238) = 4.79, φ = -.14, p = .03, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF 
outcomes indicated negligible or no association between the two variables. Pregnancy was 
positively associated with LTF at 6 months χ² (1, N = 238) = 11.41, φ = .22, p = .001 and at 12 
months, χ² (1, N=238) = 9.22, φ = .20, p = .002, indicating that pregnant women had a higher 
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chance of LTF at 6 and 12 months. However, the phi statistic at both 6 and 12 months LTF 
outcomes indicated a weak association between the two variables. The covariate, herpes zoster 
had a significant negative association with LTF at 12 months, χ² (1, N = 238) = 1.39, φ = -.08, p 
= .24, indicating that individuals in cohort who had herpes zoster had a lower chance of LTF at 
12 months. However, the phi statistic indicated negligible or no association between the 
variables.  
Age was positively associated with LTF at 6 months χ² (37, N=238) = 42.50, φc = .42, p 
= .25, indicating that older individuals had a higher chance of LTF at 6 months. The Cramer’s V 
statistic indicated a strong association between the two variables. Baseline CD4 count was 
positively associated with LTF at 12 months, χ² (131, N=238) = 142.22, φc = .77, p = .24, 
indicating that individuals in cohort 2 with higher baseline CD4 count had a higher chance of 
LTF at 12 months. The Cramer’s V statistic indicated a very strong association between the two 
variables. Current viral load was also positively associated with LTF at 6 months χ² (32, N = 
238) = 43.89, φc = .43, p = .078 and at 12 months, χ² (32, N = 238) = 39.21, φc = .41, p = .18, 
indicating that individuals with higher viral load had a higher chance of LTF at 6 and 12 months. 
The Cramer’s V statistic indicated a strong association for between the two variables at both the 












Cohort 2. Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months 
(N = 238) 
   Note. ^p < .25; *p < .05; **p < .01; ***p < .001. 
 
Table 16 
Cohort 2: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
Months (N = 238) 
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 42.50 .42 .25^ 41.88 .42 .27 
First reported CD4 143.83 .78 .71 153.58 .80 .49 
Baseline CD4 125.07 .72 .63 142.22 .77 .24^ 
Current CD4 193.88 .90 .53 193.83 .90 .53 
Current viral load (z-
score) 
43.89 .43 .08^ 39.21 .41 .18^ 
Note. ^p <.25; *p<.05; **p < .01; ***p < .00. 
 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 7.32 -.17 .007** 4.79 -.14 .03* 
Gender .82 -.06 .36 .12 -.02 .73 
Pregnancy 11.41 .22 .001** 9.22 .20 .002** 
Transferred in .22 -.03 .64 1.04 -.07 .31 
Current ART Regimen .44 -.04 .51 .02 .01 .88 
Peripheral/Poly 
Neuropathy 
.06 -.02 .81 .59 -.05 .44 
Tuberculosis .06 .02 .80 .00 -.00 .97 
Herpes Zoster .88 -.06 .36 1.39 -.08 .24^ 




Logistic Regression.  Similar to Cohort 1 analyses, the first logistic regression was 
conducted with regards to the dependent variable of 6-month loss to follow-up for Cohort 2. 
Variables: intervention, pregnancy, age, baseline CD4 count, and current viral levels were 
included in the regression model. The results from the logistic regression are presented in Table 
17. The model chi-square was significant, χ² (5, N = 238) = 16.10, p =.01, indicating that the 
independent variables significantly predicted LTF at 6 months in Cohort 2. The non-significance 
of the Hosmer and Lemeshow chi-square test confirmed that the data fit the model, χ² (8) = 4.41, 
p = .82. The classification table output for model 1 (which included the various predictor 
variables) correctly classified 86.1% of the 6 month – loss to follow up outcome. The 
classification table for model 0 (the model without the various predictor variables) indicated that 
the independent variable - intervention without the confounders correctly also classified 86.1% 
of the 6 – month loss to follow up outcomes. The Nagelkerke R2 indicated 11.8% variance in the 
model.  
 Two variables were found to significantly (p < .05), predict 6-month loss to follow-up in 
Cohort 2. Intervention group classification was significant, Wald (1) = 5.08, p = .02. The 
negative correlation with the outcome and odds ratio (Exp B) of .36 indicated that the odds of 
LTF at 6 months among individuals in the intervention group was .36 times less likely compared 
to individuals in the comparison group. Pregnancy was a significant predictor, Wald (1) = 7.20, p 








Cohort 2: Intervention and Predictor Variables for 6 Month LTF (N = 238) 
 B S.E. Wald p Exp(B) 95% CI for EXP(B) 
      Lower    Upper 
Constant -1.46 1.06 1.89 .17 .23   
Intervention -1.03 .46 5.08 .02 .36 .14 .87 
Pregnancy 1.86 .69 7.20 .007 6.43 1.65 25.02 
Age        -.00        .02        .004       .95 .99 .95    1.05 
Baseline CD4 
count 
-.001 .002 .05 .82 .99 .99 1.00 
Current Viral 
Load 
.41 .32 1.68 .19 1.51 .81 2.83 
χ² 16.10**       
Df 5       
Correct 
Classified 
86.1%       
Note. *p < .05; **p < .01; ***p < .001. 
 
The second logistic regression was conducted with regards to the dependent variable of 
12- month loss to follow-up. The results from the logistic regression are presented in Table 17. 
The model chi-square was significant, χ²(5, N = 238) = 21.87, p = .001, indicating that the 
independent variable significantly predicted LTF at 12 months in Cohort 2. The non-significance 
of the Hosmer and Lemeshow chi-square test indicated that the data fit the model, χ²(8) = 4.395, 
p = .820. The classification table output for model 1 (which included the various predictor 
variables) correctly classified 79.8% of the 12-month loss to follow-up outcome. In comparison, 
the classification table for model 0 (the model without the various predictor variables) indicated 
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that the independent variable - intervention without the confounders correctly classified 78.6% of 
the 12 – month loss to follow up outcomes. There was a minimal difference in the classification 
tables between model 0 and 1. The Nagelkerke R2 indicated 13.6% variance in the model.  
 Only pregnancy status significantly predicted (p < .05) 12- month loss to follow-up 
among individuals in Cohort 2  Wald (1) = 7.02, p =.01. The odds of LTF at 12 months were 
6.02 times higher among pregnant women.  
Table 18 
Cohort 2: Intervention and Predictor Variables for 12 Month LTF (N = 238) 
 B S.E. Wald p Exp(B) 95% CI 
      Lower   Upper 
Constant -.74 .38 3.80 .05 .48   
Intervention -.60 .35 2.89 .09 .55 .28 1.10 
Pregnancy 1.79 .68 7.02 .01 6.02 1.60 22.71 
Herpes 
Zoster  
-22.37 15181.68 .00 .99 .00 .00 - 
Baseline 
CD4  
-.002 .002 1.11 .29 .99 .99 1.00 
Current 
Viral Load 
1.19 .62 3.70 .05 3.28 .98 10.99 
χ² 21.87**       
Df 5       
Correct 
Classified 
79.8%       
Note. ^p < .25, *p < .05; **p < .01; ***p < .001. 
 
Analysis for Cohort 3 
Testing of Covariates.  Results from the model chi square analyses for Cohort 3 are 
presented in Tables 19 and 20. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, 
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N=161) = 3.59, φ = -.15, p = .06 and at 12 months, χ² (1, N = 161) = 1.59, φ = -.10, p = .21, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF 
outcomes indicated negligible or no association between the two variables. Current ART 
regimen was negatively associated with LTF at 6 months χ² (1, N=161) = 2.48, φ = -.12, p = .11, 
indicating that individuals in Cohort 3 on ART regimen 1 had a higher chance of LTF at 6 
months versus individuals on ART regimen 2. However, the phi statistic indicated negligible or 
no association between the two variables. Individuals in Cohort 3, who had initiated on ART at 
another facility and transferred into this clinic had a positive association with LTF at 12 months 
χ² (1, N=161) = 2.55, φ = .13, p = .11. However, the phi statistic indicated negligible to no 
association between the variables.  
Age was positively associated with LTF at 12 months χ² (36, N = 161) = 43.25, φc = .52, 
p = .19, indicating that older individuals had a higher chance of LTF at 12 months. The Cramer’s 
V statistic indicated a strong association between the two variables. Current viral load was 
positively associated with LTF at 6 months χ² (23, N = 161) = 50.18, φc = .56, p = .001 and at 12 
months, χ² (23, N = 161) = 42.64, φc = .51, p = .008, indicating that individuals with higher viral 
load had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic indicated a strong 












Cohort 3: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months   
(N = 161) 
   Note. ^p < .25; *p < .05; **p < .01; ***p < .001. 
 
Table 20 
Cohort 3: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
Months (N = 161) 
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 29.85 .43 .75 43.25 .52 .19^ 
First reported CD4  107.73 .82 .83 120.73 .87 .54 
Baseline CD4  96.34 .77 .85 113.62 .84 .44 
Current CD4  137.49 .92 .50 138.99 .93 .46 
Current viral load (z-
score) 
50.18 .56 .001** 42.64 .51 .008** 
 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 3.60 -.15 .06^ 1.59 -.10 .21^ 
Gender .16 -.03 .69 .02 .01 .89 
Pregnancy .22 .04 .64 .00 .00 .95 
Transferred in .07 .02 .79 2.55 .13 .11^ 





-.03 .70 .27 -.04 .61 
Tuberculosis .52 .06 .47 .04 .01 .85 
Herpes Zoster .46 -.05 .50 .82 -.07 .37 
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Note. ^p <.25; *p<.05; **p < .01; ***p < .001. 
 
Logistic Regression.  The first logistic regression was conducted with regards to the 
dependent variable of 6-month loss to follow-up for Cohort 3. Variables: intervention, Current 
ART regimen, and current viral load were found to be correlated (p < .25) to LTF at 6 months in 
Cohort 3 so these were included in the regression model along with the covariate, baseline CD4 
count. The results from the logistic regression are presented in Table 21. The model chi-square 
was significant, χ² (4, N = 161) = 18.42, p = .001, indicating that the independent and/or 
covariate variables significantly predicted LTF at 6 months in Cohort 3. The non-significance of 
the Hosmer and Lemeshow chi-square test indicated that the model adequately fit the data, χ² (8) 
= 7.45, p = .49. The classification table output for model 1 (which included the various predictor 
variables) correctly classified 88.2% of the 6 - month loss to follow-up outcome. In comparison, 
the classification table for model 0 (the model without the various predictor variables) indicated 
that the independent variable - intervention without the confounders correctly classified 87.0% of 
the 6 – month loss to follow up outcomes. There was a minimal difference in the classification 
tables between model 0 and 1. The Nagelkerke R2 indicated 20.1% variance in the model. None 
of the variables in the regression model significantly predicted LTF at 6 months in Cohort 3. 
Table 21 
Cohort 3: Intervention and Predictor Variables for 6 Month LTF (N = 161) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant 41.79 6564.45 .00 .99 1.417E+18   
Intervention -.96 .56 2.95 .09 .38 .13 1.14 
ART regimen -42.37 6564.45 .00 .99 .00 .00 - 
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Baseline CD4 -.01 .00 3.01 .083 .99 .99 1.00 
Current Viral 
Load 
1.57 .89 3.14 .08 4.83 .85 27.52 
χ² 18.42**       
Df 4       
Correct 
Classified 
88.2       
Note. *p < .05; **p < .01; ***p < .001. 
 
The second logistic regression was conducted with regards to the dependent variable – 
LTF at 12 months. Variables: intervention, transferred in, age and viral load were found to be 
correlated (p < .25) to LTF at 12 months in Cohort 3 so these were included in the regression 
model along with baseline CD4 count. The results from the logistic regression are presented in 
Table 22. The model chi-square was not significant, χ² (5) = 7.67, p = .17, indicating that the 
model was not significant and the independent and covariate variables did not significantly 















Cohort 3: Intervention and Predictor Variables for 12 Months LTF (N = 161) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -.01 .99 .00 .99 .99   
Intervention -.63 .42 2.27 .13 .53 .23 1.21 
Age -.02 .02 .51 .47 .98 .94 1.03 
Transferred in 1.16 .66 3.13 .08 3.02 .88 11.63 
Baseline CD4 -.00 .00 2.11 .15 .99 .99 1.00 
Current Viral Load .06 .12 .29 .59 1.06 .85 1.34 
χ² 7.67       
Df 5       
Correct Classified 77.6%       
Note. ^ p <.25; *p < .05; **p < .01; ***p < .001. 
 
Analysis for Cohort 4 
Testing of Covariates.  Results from the model chi square analyses for Cohort 4 are 
presented in Tables 23 and 24. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N = 
380) = 11.31, φ = -.17, p = .001 and at 12 months, χ² (1, N = 380) = 1.80, φ = -.07, p = .18, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF 
outcomes indicated negligible or no association between the two variables. Gender was 
negatively associated with LTF at 6 months χ² (1, N = 380) = 2.82, φ = -.09, p = .09 and at 12 
months χ² (1, N =380) = 1.96 φ = -.07, p = .16, indicating that in Cohort 4, women had a lower 
	  	  	  
 
122 
chance of LTF at 6 and 12 months versus men. However, the phi statistic indicated a negligible 
or no association between the variables for both the outcomes.  
Age was positively associated with LTF at 6 months χ² (39, N=380) = 50.55, φc = .36, p 
= .10, indicating that older individuals had a higher chance of LTF at 6 months. The Cramer’s V 
statistic indicated a very strong association between the two variables. First CD4 count was 
positively associated with LTF at 6 months χ² (204, N = 380) = 223.60, φc = .77, p = .16, 
indicating that individuals with higher first CD4 count had a higher chance of LTF at 6 months. 
The Cramer’s V statistic indicated a very strong association between the variables. Baseline CD4 
count was positively associated with LTF at 6 months χ² (188, N = 380) = 206.67, φc = .74, p = 
.17, indicating that individuals with higher baseline CD4 count had a higher chance of LTF at 6 
months. The Cramer’s V statistic indicated a very strong association between the variables. 
Current CD4 count was positively associated with LTF at 6 months, χ² (288, N = 380) = 334.16, 
φc = .94, p = .03, indicating that individuals in Cohort 2 with higher baseline CD4 count had a 
higher chance of LTF at 12 months. The Cramer’s V statistic indicated a very strong association 
between the two variables. Current viral load was also positively associated with LTF at 6 
months χ²(51, N=238) = 156.98 φc = .64, p < .001 and at 12 months, χ² (51, N = 238) = 77.35, φc 
= .45, p = .01, indicating that individuals with higher viral load had a higher chance of LTF at 6 
and 12 months. The Cramer’s V statistic indicated a very strong association between the two 










Cohort 4: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months 
(N = 380) 
   Note. ^p <.25; *p < .05; **p < .01; ***p < .001. 
 
Table 24 
Cohort 4: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
months (N = 380) 
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 50.55 .36 .10^ 32.55 .29 .76 
First reported CD4 mean 223.60 .77 .16^ 191.21 .71 .73 
Baseline CD4 mean 206.67 .74 .17^ 180.26 .69 .64 
Current CD4 mean 334.16 .94 .03* 288.26 .87 .48 
Current viral load (z-
score) 
156.30 .64 .000*** 77.35 .45 .01* 
     Note. ^p <.25; *p<.05; **p < .01; ***p < .001. 
 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 11.31 -.17 .001** 1.80 -.07 .18^ 
Gender 2.83 -.09 .09^ 1.96 -.07 .161 
Pregnancy .33 .03 .56 .05 .011 .82 
Transferred in .26 -.03 .61 1.18 .06 .28 
Current ART Regimen .06 -.01 .80 .08 .01 .78 
Peripheral/Poly 
Neuropathy 
.31 -.03 .58 1.065 -.05 .30 
Tuberculosis .25 -.03 .62 .85 -.05 .36 
Herpes Zoster .12 -.02 .72 .42 -.03 .52 




Logistic Regression. The first logistic regression for Cohort 4 was conducted with 
regards to the dependent variable of 6- month LTF. Variables: intervention, age, gender, opt out, 
first CD4 count, baseline CD4 count, current CD4 count and current viral load were found to be 
correlated (p < .25) to LTF at 6 months in Cohort 4 so these were included in the regression 
model. The results from the logistic regression are presented in Table 25. The model chi-square 
was significant, χ² (7, N = 380) = 34.43, p < .001, indicating that the independent and/or 
covariate variables significantly predicted LTF at 6 months in Cohort 4. The non-significance of 
the Hosmer and Lemeshow chi-square test indicated that the model adequately fit the data, χ² (8) 
= 7.49, p = .48. The classification table output for model 1 (which included the various predictor 
variables) correctly classified 93.9% of the 6-month loss to follow-up outcome. In comparison, 
the classification table for model 0 (the model without the various predictor variables) indicated 
that the independent variable - intervention without the confounders correctly classified 94.2% of 
the 6 – month loss to follow up outcomes. There was a minimal difference in the classification 
tables between model 0 and 1. The Nagelkerke R2 indicated 24.2% variance in the model.  
 Three variables significantly predicted (p < .05), 6-month loss to follow-up in Cohort 4. 
Intervention group classification was significant, Wald (1) = 8.854, p = .003. The negative 
correlation with the outcome and the odds ratio (Exp B) of .15 indicated that the odds of LTF at 6 
months among individuals in the intervention group was .15 times less likely compared to the 
individuals in the comparison group. Age was negatively correlated to 6 month LTF, Wald (1) = 
3.94, p = .04, The odds ratio (Exp B) of .94 indicated that the odds of LTF at 6 months was 
marginally lower among older individuals in Cohort 4. Current CD4 was negatively correlated 
with LTF at 6 months, Wald (1) = 8.89, p = .003. The odds ratio (Exp B) of .99 indicated that the 
odds of LTF at 6 months marginally decreased with increases in current CD4 counts.  




Cohort 4: Intervention and Predictor Variables for 6 Month LTF (N = 380) 
 B SE B Wald p Exp(B) 95% CI 
      Low High 
Constant 1.38 1.31 1.11 .29 3.98   
Intervention -1.92 .65 8.85 .003** .15 .04 .52 
Gender -1.13 .61 3.39 .07 .32 .09 1.08 
Age -.06 .03 3.94 .04* .94 .88 .99 
First CD 4 -.01 .01 .42 .51 .99 .98 1.01 
Baseline CD4 
Current CD4 






















χ²                                  34.43*** 
Df                                     7 
Correct Classified           93.9                                 
Note. *p < .05; **p < .01; ***p < .001. 
 
The second logistic regression for Cohort 4 was conducted with regards to the dependent 
variable of 12- month loss to follow up. Variables: intervention and current viral load were found 
to be correlated (p < .25) to LTF at 12 months in Cohort 4 so these were included in the 
regression model along with baseline CD4 count. Results from the logistic regression are 
presented in Table 26. The model chi-square was significant, χ² (3, N=380) = 9.24, p = .03, 
indicating that the independent variables significantly predicted LTF at 12 months in Cohort 4. 
The non-significance of the Hosmer and Lemeshow chi-square test confirmed that the data fit the 
model, χ² (8) = 5.89, p = .66, meaning that the model appropriately predicted the outcome. The 
classification table output for model 1 (which included the various predictor variables) correctly 
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classified 82.6% of the 12-month loss to follow-up outcome. In comparison, the classification 
table for model 0 (the model without the various predictor variables) also indicated that the 
independent variable - intervention without the confounders correctly classified 82.6% of the 12 
– month loss to follow up outcomes. There was no difference in the classification tables between 
model 0 and 1. The Nagelkerke R2 identified 4.0% variance in the model. 
One variable significantly predicted (p < .05), 12-month loss to follow-up. Baseline CD4 
count was positively correlated to the LTF outcome, Wald (1) = 4.51, p = .03. However, the 95% 
confidence interval for baseline CD4 included 1.00, thus the odds ratio was not significant.  
Table 26 
Cohort 4: Intervention and Predictor Variables for 12 Month LTF (N = 380) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -1.89 .30 39.15 .000 .151   
Intervention -.36 .28 1.66 .20 .70 .40 1.21 
Baseline CD4 .00 .00 4.51 .03 1.00 1.00 1.01 
Current Viral 
Load 
.46 .24 3.71 .05 1.58 .99 2.51 
χ² 9.24*       
Df 3       
Correct 
Classified 
82.6       








Analysis for Cohort 5. 
Testing of Covariates.  Results from the model chi square analyses for Cohort 5 are 
presented in Tables 27 and 28. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N = 
393) = 21.19, φ = -.23, p = .000 and at 12 months, χ² (1, N = 393) = 6.77, φ = -.13, p = .01, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
individuals in the intervention group. However, the phi statistic at 6 month indicated a weak 
association while the phi statistic at 12 months LTF indicated a negligible or no association 
between the variables. Current ART regimen had a negative association with LTF at 6 months χ² 
(1, N = 393) = 7.04, φ = -.134, p = .01, and with LTF at 12 months χ² (1, N = 393) = 3.53, φ = -
.09, p = .06 indicating individuals on ART regimen 1 had a higher chance of LTF compared to 
individuals on ART regimen 2. The phi statistic indicated a negligible or no association between 
the variables for both the outcomes. Opt out was positively associated with LTF at 12 months χ² 
(1, N = 393) = 1.72, φ = .07, p = .19 indicating that individuals who had opted out of the 
intervention had a higher chance of LTF at 12 months compared to individuals who had stayed 
enrolled in the intervention. However, the phi statistic indicated a negligible or no association 
between the two variables.  
Current CD4 count was associated with LTF at 6 months χ² (305, N =3 93) = 335.06, φc 
= .92, p = .11, indicating that individuals with a higher current CD4 count had a higher chance of 
LTF at 6 months. The Cramer’s V statistic indicated a very strong association between the two 
variables. Current viral load was associated with LTF at 6 months χ² (53, N=393) = 43.89, φc = 
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.63, p = .000 and at 12 months, χ² (53, N=393) = 115.20, φc = .54, p = .000, indicating that 
individuals with higher viral load had a higher chance of LTF at 6 and 12 months. The Cramer’s 
V statistic indicated a very strong association for between the two variables at both the 6 and 12 
months outcomes.  
Table 27 
Cohort 5: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 months 
(N = 393) 






 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 21.19 .23 .000*** 6.77 -.13 .01* 
Gender .26 -.03 .61 .43 -.03 .51 
Pregnancy .12 -.02 .73 .74 .04 .39 
Transferred in .11 -.02 .74 1.25 .06 .26 
Current ART Regimen 7.04 -.13 .01* 3.53 -.09 .06^ 
Peripheral/Poly 
Neuropathy 
.34 -.03 .56 .70 -.04 .40 
Tuberculosis .36 .03 .55 .02 -.01 .90 
Herpes Zoster .27 -.03 .60 .58 -.04 .45 
Opt Out .18 -.02 .67 1.72 .07 .19^ 




Cohort 5: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
months (N = 393) 
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 26.20 .28 .96 37.90 .31 .61 
First reported CD4 mean 194.56 .70 .81 206.87 .73 .60 
Baseline CD4 mean 175.19 .67 .77 191.07 .70 .46 
Current CD4 mean 335.06 .92 .11^ 308.80 .89 .43 
Current viral load (z-
score) 
154.80 .63 .000*** 115.20 .54 .000*** 
Note. ^p <.25; *p<.05; **p < .01; ***p < .001. 
 
Logistic Regression. The first logistic regression for Cohort 5 was conducted with 
regards to the dependent variable of 6-month loss to follow-up. Variables: intervention, current 
ART regimen, baseline CD4, current CD4, and current viral load were found to be correlated (p 
< .25) to LTF at 6 months in Cohort 5, so these were included in the regression model. Results 
from the logistic regression are presented in Table 29. The model chi-square was significant, χ² 
(5) = 39.79, p < .001 indicating that the independent variables significantly predicted LTF at 6 
months in Cohort 5. The non-significance of the Hosmer and Lemeshow chi-square test 
confirmed that the data did fit the model, χ² (8) = 12.45, p = .13 and the model could predict the 
outcomes well. The classification table output for model 1 (which included the various predictor 
variables) correctly classified 91.9% of the 6-month loss to follow-up outcome. In comparison, 
the classification table for model 0 (the model without the various predictor variables) also 
indicated that the independent variable - intervention without the confounders correctly classified 
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91.9% of the 6 – month loss to follow up outcomes. The Nagelkerke R2 suggested 22.3% 
variance in the model.  
 Three variables significantly predicted 6-month loss to follow-up in Cohort 5. 
Intervention was correlated with LTF at 6 months, Wald (1) = 13.76, p < .001. The negative 
correlation with the outcome and odds ratio (Exp B) of .10 indicated that the odds of LTF at 6 
months among individuals in the intervention group were .10 times less likely compared to the 
individuals in the comparison group. Current ART regimen was also correlated with LTF at 6 
months, Wald (1) = 3.90, p = .04. The negative correlation with the outcome and the odds ratio 
(Exp B) of .13 indicated that the odds of LTF at 6 months among individuals on ART regimen 2 
was .13 times less likely compared to individuals on ART regimen 1. Current CD4 was 
negatively correlated with LTF at 6 months, Wald (1) = 4.56, p = .03. The odds ratio (Exp B) of 
.99 indicated that the odds of LTF at 6 months marginally decreased with increases in current 
CD4 counts. However, the upper bound of 95% confidence interval for baseline CD4 included 















Cohort 5: Intervention and Predictor Variables for 6 Month LTF (N = 393) 
 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant 1.44 1.17 1.52 .22 4.23   
Intervention -2.30 .62 13.76 .000*** .100 .03 .34 
ART Regimen -2.05 1.04 3.90 .04* .129 .017 .985 
Baseline CD4 .00 .00 .00 .99 1.00 .99 1.01 
Current CD4 -.00 .00 4.56 .03* .99 .99 1.00 
Current Viral 
Load 
.06 .21 .07 .79 1.06 .70 1.59 
χ² 39.79***       
Df 5       
Correct 
Classified 
91.9       
Note. ^p<.25;*p < .05; **p < .01; ***p < .001. 
 
The second logistic regression for Cohort 5 was conducted with regards to the dependent 
variable of 12-month loss to follow. Variables, intervention, current ART regimen, opt out and 
current viral load were found to be correlated (p < .25) to LTF at 6 months in Cohort 5 so these 
were included in the regression model along with baseline CD4 count.. The results from the 
logistic regression are presented in Table 30. The model chi-square was significant, χ² (5, 
N=393) = 21.89, p = .001, indicating that for Cohort 5, the independent variables  significantly 
predicted the outcome of LTF at 12 months. The non-significance of the Hosmer and Lemeshow 
chi-square test confirmed that the data fit the model, χ² (8) = 5.56, p = .70, so the model could 
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predict the outcome appropriately. The classification table output for model 1 (which included 
the various predictor variables) correctly classified 85% of the 12-month loss to follow-up 
outcome. In comparison, the classification table for model 0 (the model without the various 
predictor variables) indicated that the independent variable - intervention without the 
confounders correctly classified 84% of the 12 – month loss to follow up outcomes. There was  
minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2 
showed a 9.3% variance in the model.  
Two variables significantly predicted 12-month loss to follow-up among individuals in 
Cohort 5. Intervention group classification was significant, Wald (1) = 5.51, p = .019. The 
negative correlation with the outcome and odds ratio (Exp B) of .50 indicated that the odds of 
LTF at 12 months among individuals in the intervention group were .50 times less likely 
compared to the individuals in the comparison group. Current viral load was a significant 
predictor for LTF at 12 month, Wald (1) = 5.49, p = .02. The odds ratio indicated that increases 















Cohort 5: Intervention and Predictor Variables for 12 Month LTF (N = 393) 
 B  SE B Wald P Exp(B) 95% CI 
      Low High 
Contrast -.40 .55 .53 .47 .67   
Intervention -.70 .30 5.51 .02 .50 .28 .89 
Current ART 
Regimen 
-.82 .43 3.68 .06 .44 .20 1.02 
Opt Out 2.39 1.60 2.23 .13 10.90 .48 249.81 
Base CD4 count .00 .00 .00 .95 1.00 .99 1.00 
Current viral load .97 .41 5.49 .02 2.63 1.17 5.92 
χ² 21.89**       
Df 5       
Correct Classified 85%       
Note. *p < .05; **p < .01; ***p < .001. 
 
Analysis for Cohort 6. 
Testing of Covariates.  Results from the model chi square analyses for Cohort 6 are 
presented in Tables 31 and 32. Below are the relevant (p < .25) associations found. The 
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N = 
382) = 26.75, φ = -.26, p = .000 and at 12 months, χ² (1, N = 382) = 15.50, φ = -.20, p = .000, 
suggesting that individuals in the comparison group had a higher chance of LTF versus 
individuals in the intervention group. The phi statistic at both 6 and 12 months LTF outcomes 
indicated a weak association between the two variables. Gender was negatively correlated with 
LTF at 6 months, χ² (1, N = 382) = 5.55, φ = -.12, p = .02, indicating that females in Cohort 6 
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had a lower chance of LTF at 6 months versus males. Pregnancy was positively associated with 
LTF at 6 months χ² (1, N = 382) = 10.81, φ = .17, p = .001 and at 12 months, χ² (1, N = 382) = 
5.75, φ = .12, p = .02, indicating that pregnant women had a higher chance of LTF at 6 and 12 
months. However, the phi statistic for both 6 and 12 months LTF outcomes indicated a negligible 
or no association between the two variables. Transferred in has a negative association with LTF 
at 6 months, χ² (1, N = 382) = 1.42, φ = -.06, p = .23, indicating that individuals who had 
initiated on ART at another clinic and transferred into the study clinic had a lower chance of LTF 
at 6 months. However, the phi statistic indicated a negligible or no association. Peripheral/ poly 
neuropathy had a positive association with LTF at 6 months, χ² (1, N = 382) = 2.45, φ = .08, p = 
.12, indicating that individuals in cohort 6 who had peripheral/poly neuropathy had a higher 
chance of LTF at 6 months versus individuals who did not have peripheral/poly neuropathy. 
However, the phi statistic indicated negligible or no association between the variables. Herpes 
Zoster had a positive association with LTF at 6 months, χ² (1, N = 382) = 2.25, φ = .08, p = .13, 
indicating that individuals in Cohort 6 who had herpes zoster had a higher chance of LTF at 6 
months versus individuals who did not have herpes zoster. However, the phi statistic indicated 
negligible or no association between the variables. Opt out was positively associated with LTF at 
12 months, χ² (1, N = 382) = 5.38, φ = .12, p = .02, indicating that individuals in Cohort 6 who 
had opted out of the intervention had a higher chance of LTF at 12 months versus individuals 
who did not opt out of the intervention. However, the phi statistic indicated negligible or no 
association between the variables.  
Current CD4 count was positively associated with LTF at 6 months, χ² (300, N=382) = 
324.77, φc = .92, p = .16, indicating that individuals in Cohort 6 with higher current CD4 count 
had a higher chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong 
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association between the two variables. Current viral load was also positively associated with LTF 
at 6 months χ² (60, N=382) = 152.57, φc = .63, p = .000 and at 12 months, χ² (60, N=382) = 
106.03, φc = .53, p = .000 indicating that individuals with higher viral load had a higher chance 
of LTF at 6 and 12 months. The Cramer’s V statistic indicated a strong association for between 
the two variables at both the 6 and 12 months outcomes.  
Table 31 
Cohort 6: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 months 
(N = 382)   






 LTF 6 Months LTF 12 Months 
 X2 φ p X2 φ p 
Intervention 26.75 -.26 .000*** 15.50 -.20 .000*** 
Gender 5.55 -.12 .02* .86 -.05 .35 
Pregnancy 10.81 .17 .001** 5.75 .12 .02* 
Transferred in 1.42 -.06 .23^ 4.74 -.11 .03* 
Current ART Regimen .16 -.02 .69 .02 -.01 .88 
Peripheral/Poly 
Neuropathy 
2.45 .08 .12^ .02 .01 .88 
Tuberculosis .35 -.03 .55 .94 .05 .33 
Herpes Zoster 2.25 .077 .13^ .26 .03 .61 
Opt Out .07 -.01 .79 5.38 .12 .02* 




Cohort 6: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 
months (N = 382)	  
 LTF 6 Months LTF 12 Months 
 X2 φc p X2 φc p 
Age 24.73 .25 .98 31.72 .29 .85 
First reported CD4  171.93 .67 .61 159.45 .65 .84 
Baseline CD4  163.78 .66 .49 153.76 .63 .71 
Current CD4  324.76 .92 .16^ 301.43 .89 .47 
Current viral load (z-
score) 
152.57 .63 .000*** 106.03 .53 .000*** 
Note. ^p <.25; *p<.05; **p < .01; ***p < .001 
 
Logistic Regression.  The first logistic regression for Cohort 6 was conducted with 
regards to the dependent variable of 6 month LTF. Variables: intervention, gender, pregnancy, 
transferred in, peripheral/poly neuropathy, herpes zoster, current CD4 count and current viral 
load were found to be associated (p < .25) with LTF at 6 months in Cohort 6 so these were 
included in the regression model along with baseline CD4. The results from the logistic 
regression are presented in Table 33. The model chi-square was significant, χ² (9) = 58.40, p < 
.001, indicating that the independent variables significantly predicted LTF at 6 months in Cohort 
6. The non-significance of the Hosmer and Lemeshow chi-square test confirmed that the model 
adequately fit the data, χ² (8) = 3.19, p = .92. The classification table output for model 1 (which 
included the various predictor variables) correctly classified 94.2% of the 12-month loss to 
follow-up outcome. In comparison, the classification table for model 0 (the model without the 
various predictor variables) indicated that the independent variable - intervention without the 
confounders correctly classified 93.5% of the 12 – month loss to follow up outcomes. There was 
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a minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2 
indicated 37.0% variance in the model.  
 Two variables significantly predicted 6 month LTF among Cohort 6. Gender was a 
significant predictor, Wald (1) = 4.42, p = .04. There was a negative correlation indicating that 
females were .223 times less likely to be LTF at 6 months compared to males. Pregnancy was a 
significant predictor, Wald (1) = 6.76, p = .01. Pregnant women were 24.44 times more likely to 
be LTF at 6 months follow-up.  
Table 33 
Cohort 6: Intervention and Predictor Variables for 6 Month LTF (N = 382)	  
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -1.07 .73 2.16 .14 .34   
Intervention -32.61 3256.49 .00 .99 .00 .00 - 
Gender -1.50 .71 4.42 .04* .22 .05 .90 
Pregnancy 3.20 1.23 6.75 .01* 24.44 2.19 272.25 
Transferred in .40 .52 .59 .44 1.50 .54 4.18 
Peripheral/Poly 
Neuropathy 
.26 .65 .16 .69 1.29 .36 4.65 
Herpes Zoster 17.70 2321.63 .00 .99 48730578.22 .00  
Baseline CD4 
count 
.00 .00 .06 .81 1.00 .99 1.01 
Current CD4 
Count 
-.00 .00 2.69 .10 .99 .99 1.00 
Current Viral 
Load 
.15 .12 1.65 .20 1.16 .92 1.47 
χ² 58.40***       
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Df 9       
Correct 
Classified 
94.2       
Note. ^p.25; *p < .05; **p < .01; ***p < .001 
 
The second logistic regression for Cohort 6 was conducted with regards to the dependent 
variable of 12-month loss to follow-up. Variables: intervention, pregnancy, transferred in, opt 
out, and current viral load were found to be correlated (p < .25) to LTF at 12 months in Cohort 6 
so these were included in the regression model along with baseline CD4 count.  
The results from the logistic regression are presented in Table 34. The model chi-square 
was significant, χ² (6, 382) = 25.73, p < .001. The non-significance of the Hosmer and 
Lemeshow chi-square test confirmed that the data fit the model, χ² (8) = 6.78, p = .56. That is, 
the model predicted the outcome appropriately. The classification table output for model 1 
(which included the various predictor variables) correctly classified 84.8% of the 12-month loss 
to follow-up outcome. In comparison, the classification table for model 0 (the model without the 
various predictor variables) indicated that the independent variable - intervention without the 
confounders correctly classified 84.3% of the 12 – month loss to follow up outcomes. There was 
a minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2 
indicated 11.2% variance in the model.  
One variable significantly predicted 12-month loss to follow-up among individuals in 
Cohort 6. Intervention was a significant predictor, Wald (1) = 12.24, p < .001. The negative 
correlation to the outcome and odds ratio (Exp B) of .31 indicated that individuals in the 
intervention group were .31 times less likely to be LTF at 12 months compared to the individuals 
in the comparison group.  




Cohort 6: Intervention and Predictor Variables for 12 Month LTF (N = 382) 
 B  SE B Wald p Exp(B) 95% CI 
      Low High 
Constant -1.18 .28 17.58 .00 .31   
Intervention -1.17 .33 12.24 .00 .31 .16 .60 
Pregnancy 1.29 .79 2.68 .10 3.62 .78 16.89 
Transferred 
in 
-.30 .33 .79 .37 .74 .38 1.43 
Opt out 22.28 40192.97 .00 1.0 4.74E+6 .00 . 




.12 .10 1.31 .25 1.12 .92 1.38 
χ² 25.73***       
Df 6       
Correct 
Classified 
84.8%       
Note. ^p<.25; *p < .05; **p < .01; ***p < .001 
 
Treatment and/or Intervention Fidelity  
 As mentioned in Chapter 3, the intervention was implemented as planned with the 
exception that all individuals enrolled in the appointment reminder intervention also received 
weekly adherence messages. This may be a major threat to the internal validity of the study as it 
is difficult to ascertain if the outcomes observed were a result of the appointment reminder or the 
weekly adherence messages that the individuals received in the intervention group. Additionally 
the full impact of combining the two interventions could not be ascertained by this study. There 
were no adverse events reported by the team. 




In response to the two research questions, yes, there was a difference in 6 and/or 12-
month LTF rates among patient enrolled in the appointment reminder intervention versus the 
comparison group in five out of six study cohorts. Regression analyses by each cohort indicated 
that individuals in Cohorts 1, 2, 4 & 5 had a lower likelihood of LTF at 6 months compared to 
individuals in the comparison group. Similarly, individuals in Cohorts 5 and 6 had a lower 
likelihood of LTF at 12 months compared to the individuals in the comparison group.  
Other variables that had a positive or a negative correlation with LTF were pregnancy, 
age, gender, current ART regimen, current CD4 count, and current viral load. The independent 
and covariate variables significantly predicted LTF at 6 months for all the cohorts except for 
Cohort 3. In contrast, the independent and covariate variables significantly predicted 12 month 
LTF for Cohorts 2, 4, 5 & 6 only.  
The next chapter includes a discussion of and conclusions based on the study findings. 
Limitations of the study, future recommendations for continued research, and the social change 
implications are also included in Chapter 5. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to evaluate the effectiveness of a mHealth patient 
appointment reminder intervention to improve retention in treatment of patients initiating ART at 
a large public sector ART clinic in the inner city of Johannesburg, South Africa. This clinic is 
one of the largest ART clinics located at a secondary-level community health facility in Sub-
Saharan Africa, and it has a relatively heterogeneous population accessing HIV care and 
treatment. The appointment reminder intervention was one of three mHealth interventions 
developed, piloted, and scaled up at this and the surrounding primary health care clinics in the 
inner city of Johannesburg, in an effort to reduce the loss to follow up rates among patients on 
ART. The appointment reminder intervention was implemented at this clinic in September 2012. 
Individuals on ART at the clinic were approached and the intervention was offered to them. 
Individuals self-selected to participate in the project. This study was a program evaluation of the 
intervention based on a quantitative retrospective cohort design. Retrospective project and 
clinical data was used for this study for the period September 1, 2012 to January 31, 2014.  
This study was conducted in an effort to find evidence if mHealth can be an effective way 
to reduce post-ART LTF. As mentioned in Chapter 2, currently there are only a few studies in 
the scientific literature, which look at the effectiveness of interventions to reduce LTF among 
patients on ART. Furthermore, since mHealth is an up and coming field, there is a gap in the 
literature on studies on the effectiveness of mHealth interventions in reducing LTF, especially in 
the context of Sub-Saharan Africa.  
The two research questions for this study sought to ascertain whether there were 
differences in 6 and 12 - month LTF outcomes between the intervention and the comparison 
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groups. The analyses were based on the study design, which included assignment of individuals 
in the intervention and comparison groups to one of six cohorts, based on their time on ART 
when the intervention was implemented.   
The study population was demographically representative of the clinic population. The 
mean age and gender disaggregation of the study population were found to be similar to the 
clinic population information reported in the HCHC file audit report from 2009 (unpublished 
report). The intervention and comparison groups were found to be similar in terms of gender and 
age. The study sample size was sufficient to provide responses to the study questions. Individuals 
in the intervention group were found to have less likelihood of LTF at 6 months in four of the six 
cohorts, and in two of the six cohorts for LTF at 12 months. Thus, the two null hypotheses were 
rejected for a subset of the study cohorts. In addition, current CD4 counts, pregnancy status and 
current viral load predicted LTF outcome among three cohorts. Age, gender, baseline CD4 count 
and ART regimen predicted either 6- or 12-month LTF outcome for one non-mutually exclusive 
cohort each.  
Opt-out from the intervention was low - only eight - three of whom provided reasons: 
transfer to maternity clinic, recognition that the existing support was enough that reminders were 
not needed, concern about disclosure of HIV status.  
Interpretation of the Findings 
The study results indicated a significant correlation (p < .05), between enrollment in the 
intervention group and decreased likelihood of LTF at 6 and/or 12 months, compared to 
individuals in the comparison group in a subset of the six study cohorts. Other significant 
findings among a few of the study cohorts were the links between 6 and/or 12 month LTF and 
each of the covariates: pregnancy, current CD4 count and current viral load. Pregnant women 
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had a higher likelihood of LTF in four instances among three cohorts. Increases in current CD4 
count were correlated with lower LTF outcome, and increases in viral load count were correlated 
with higher likelihood of LTF among individuals in three of the study cohorts for both of these 
covariates. Age, gender, current ART regimen and baseline CD4 count were correlated with 6 or 
12 - month LTF outcomes in one cohort each, whereby, older individuals had a higher likelihood 
of LTF, women had a lower likelihood of LTF, and individuals on ART regimen 2 had a lower 
likelihood of LTF compared to individuals on ART regimen 1. Baseline CD4 count was found to 
be significantly correlated however the odds ratio was not significant.  
 The median baseline CD4 count of 137 cells/mm3 indicated that the patients were being 
initiated on ART at the facility much later than the NDoH 2012 guidance to initiate individuals 
with CD4 <350 cells/mm3 on ART within a short duration of HIV diagnosis, and to immediately 
initiate all children under 5 years, HIV pregnant women and any patients identified with 
tuberculosis, regardless of CD4 count. (South African National Strategic plan on HIV, STIs, and 
TB 2012-2016; South African HIV/AIDS treatment and PMTCT guidelines, 2011 and 2013). It 
was beyond the scope of this study to conduct in depth analyses on this issue and differentiate if 
the delay in ART initiation pertained to individuals who had been initiated on ART a while ago 
(Cohorts 3-6), or if it was also the case for individuals who had been recently initiated on ART 
(Cohorts 1-2). The median figure of 384 cells/mm3 for the current CD4 count indicated that 
regardless of the baseline CD4 count, most of the individuals had an increase in their CD4 count 
after initiating ART. A large portion of individuals, who had recent viral load information in 
their records, had an undetectable viral load. Among individuals who had a detectable viral load, 
increases in viral load values were correlated with increases in the LTF outcomes in two cohorts. 
A majority of the individuals in the study were on ART regimen 1. Approximately, 20% of the 
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individuals had been switched to regimen 2, and the number of individuals on regimen 2 was 
higher for Cohorts 3-6 indicating an increase in ART regimen change with increase in time on 
ART. Approximately 11 % of the study sample experienced a side effect of lipodystrophy, lactic 
acidosis or peripheral/poly neuropathy during the study period. Similarly, 5% of the study 
population had a documented concurrent illness of tuberculosis, herpes zoster or kaposi sarcoma 
during the study period.  
The appointment reminder intervention was significantly linked to lower likelihood of 6 
and/or 12 months LTF among patients who had initiated on ART anywhere from a few days to a 
few years prior to enrolling in the intervention. In addition, there were a few covariates that also 
significantly impacted LTF outcomes among multiple study cohorts. The correlation between 
pregnancy and LTF was a key finding, and this correlation has been previously reported in the 
literature (Bateman, 2013; Clouse, 2013; Wang et al, 2011). The current South African guideline 
for Prevention of Mother to Child Transmission of HIV (PMTCT) includes providing HIV 
positive pregnant women who are not already on ART when they become pregnant, with 
antiretrovirals for the duration of the pregnancy up to one-year post pregnancy, to cover the one-
year of breast feeding period. Some women may need to continue on ART for the rest of their 
lives if their CD4 count is <350 cell/mm3 (Bateman, 2013). This study confirms the high risk of 
LTF outcome among pregnant women and highlights a need to adjust services provided to 
pregnant women.  
The correlation between increases in viral loads and increased LTF is another key study 
finding. Annual viral load monitoring and informing the individuals of their viral load status via 
text messaging is a potential intervention that can be recommended to the NDoH to undertake.  
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This study confirms and adds evidence to the existing literature about the effectiveness of 
using mHealth-based interventions to improve HIV/AIDS care and treatment programs. As 
mentioned in Chapter 2, Bahadur & Murray, 2010 had conducted a review of publications to find 
the outcomes of SMS in health care settings. The authors concluded that a few studies that 
indicated that SMS had improved health service delivery through appointment reminders, 
however, most of the research was conducted in developed countries and most of them either 
reported on pilots or feasibility studies. A need was identified for studies that are conducted in 
low resource countries and/or which report on scaled up projects versus pilots. Another gap 
identified from the literature search was that there is a lack of studies, which examine the 
association or effectiveness of SMS on improving ART clinic appointment adherence among 
patients on ART in South Africa. This study meets the gaps mentioned above as it was 
conducted in a low resource setting, at a public sector ART site, and it was an evaluation of a 
project that had been implemented as a scale up following the success of an earlier pilot project. 
This study extends the knowledge base around use and effectiveness of mHealth based 
interventions in the field of HIV/AIDS.  
Findings in the Context of the Theoretical Framework 
As mentioned in Chapter 2, the theoretical framework that formed the basis of this study 
was the “cues to action” construct of the health belief model. The key question stated in Chapter 
2, in terms of the theoretical framework was “How effective were the cues to action in leading to 
the desired behavior or intervention outcome?”  The cues to action for this study were the 
appointment reminders sent to the individuals enrolled in the intervention. Some of the 
assumptions that were made before the study was conducted were that individuals who agreed to 
partake in the appointment reminder intervention perceived: the benefit of initiating ART and the 
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benefit that the intervention offered to them. The study data showed that the cues were effective 
in leading to reduction in LTF rates among the individuals enrolled in the intervention who 
received the cues, versus the individuals in the comparison group who only received the standard 
of care at the clinic. The low opt out rate from the intervention may indicate the perceived 
benefits and effectiveness of the cues too.  
Limitations of the Study 
The limitations to validity and reliability that arose from the execution of the study were 
in line with the expected limitations mentioned in chapter 1. A major limitation to this study was 
the change in the way the intervention was implemented versus the project plan. Instead of 
offering only the appointment reminder intervention to individuals newly (< 30 days) initiating 
ART, all individuals on ART (regardless of time on ART) were offered the appointment 
reminder intervention along with weekly treatment adherence reminder messages for one year. 
While this modification was based on the lessons learned, it potentially had an impact on the 
study outcomes. It was beyond the scope of this study to ascertain if the differences noted 
between the intervention and control groups were due to the appointment reminder or the 
adherence reminder intervention. An evaluation of the adherence reminder program may assist to 
distinguish the differences between the two interventions.  
Another limitation of the study was the non-random selection of individuals to enroll in 
the intervention. The participants self-selected to receive the intervention, thus the risk of 
selection bias was valid. The comparison group was selected using a partly purposeful, partly 
random stratified approach in an effort to lower the effect of the selection bias among the 
individuals enrolled in the intervention group. The low difference found between the intervention 
and comparison group should have assisted in reducing the impact of the selection bias. 
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Another limitation of this study was that a quantitative method of inquiry was used for 
the evaluation. A mixed method would have been a more appropriate methodology as a 
qualitative component could have assisted in explaining some of the participant behavior, 
decisions or nuances leading to the outcomes noted. These items are not easy to ascertain from a 
quantitative methodology only. Furthermore, given the quantitative nature of this study, it was 
not possible to ascertain how the cues to action affected the perceptions of and led to behavior 
change among the individuals enrolled in the intervention. This is a limitation of the study and 
could be better answered via a qualitative inquiry.  
Data quality was found to be less than ideal. Errors identified in the data included 
discrepancies in the ART initiation dates between the intervention database and the HMIS 
information available from the clinic. When the dates did not match, the information from the 
HMIS was used as that is the archived data used by the clinic. Similarly, if discrepancies were 
found in the “last visit date” information, which was the variable used to ascertain the LTF 
outcome, the information from the HMIS dataset was used versus the intervention database. 
Other limitations as mentioned in Chapter 1, are still valid as they were beyond the 
researcher’s control. Given the sheer size of the HIV epidemic in South Africa, HIV is the focus 
of the government, donors and other international agencies agendas. For example, the minister of 
health started country wide HIV counseling and testing campaigns in 2010. These campaigns are 
in their fourth year now and continue to be scaled up as still only 31% of the HIV positive 
individuals in South Africa are on ART (HSRC report, 2012). The South African public is 
constantly exposed to messages regarding HIV prevention, testing and treatment from the 
government, donors, non-government organizations, community based organizations and others. 
In addition, it is likely that given the high prevalence of HIV, a large proportion of the 
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population in South Africa has been affected by HIV directly or indirectly. Therefore, it is 
possible that the other experiences and exposures may act as cues to action for the study 
participants, and possibly drive the outcomes towards the null hypothesis.  
A limitation that was identified in Chapter 1, but which did not have an effect on the 
study outcome was that the South African public has a tendency to change their cell phone 
numbers frequently so the intervention participants may not have received the messages as 
planned. In actuality, the project was able to successfully dispatch the appointment reminders to 
almost all the individuals enrolled in the intervention. The project implementers had instituted 
two interventions to reduce this issue. The first intervention pertained to instant verification, that 
is, when individuals enrolled in the intervention, the field workers immediately sent a 
verification message to make sure the number provided was correct. The second intervention 
involved asking the participants if their phone numbers had changed since the last clinic or 
pharmacy visit. The above two interventions may have been successful in making sure that the 
project always had the most up to date phone numbers for the individuals enrolled in the 
intervention.  
  Recommendations 
Recommendations for Further Study 
A recommendation based on the outcome of the study is that a qualitative inquiry should 
be conducted on the population enrolled in the intervention to find out: the reasons for 
individuals enrolling and continuing with the intervention, the reasons for the behavior change 
noted, which components of the intervention were most useful and which areas need 
improvement, and if the frequency and content of the text messages were sufficient or could be 
improved. Qualitative study will also assist in obtaining lessons learned, and ascertaining areas 
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of improvement or intervention strengths that could be incorporated in the project before scale up 
to other ART facilities.  
While the results from this study can be generalized to other clinics in South Africa, there 
is a need for this type of intervention and follow up inquiry in a rural health care setting as a 
large proportion of individuals on ART in South Africa and other resource limited countries 
reside in rural areas. As mentioned in chapter 2, individuals in urban and rural settings may have 
different set of barriers, which may hinder retention in ART. 
It is important to ascertain what impact the adherence reminder intervention which was 
implemented along with the appointment reminders had on the LTF outcomes. It would also be 
useful to follow up the patients beyond the 12 month period, ideally for 24 and 36 months to see 
if there are changes in LTF rates between the intervention and comparison groups over an 
extended period.  
Recommendations for Action  
The positive correlation between pregnancy and LTF is a key finding and requires 
adjustments in ART service delivery to this group of individuals.  The outcome highlights the 
need to closely monitor pregnant women on ART both during and after their pregnancies to 
make sure that they continue to adhere to ART.  Specific messaging either via text messages or 
in person counseling, which highlight the importance of treatment retention to pregnant women 
could be useful. Another option is to incorporate the messages in other Maternal and Child 
Health (MCH) related projects. One such instance is the MCH related mHealth project that was 
implemented at the MCH clinic located at the study site in 2012. In this project, women enrolled 
in the intervention receive weekly messages about their pregnancy, fetal growth, appropriate 
nutrition and other items, till the baby is a year old. Women who want messages regarding HIV 
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and pregnancy can opt in to receive these messages. At the end of 2014, the South African 
government asked for and received funding from USAID & CDC to scale up this MCH related 
mHealth project to all public sector sites in the country. Based on the evidence obtained from 
this evaluation, it would be useful for the NDoH to include importance of continuation of ART 
post pregnancy and appointment retention messages in this MCH project.  
The positive correlation between increase in viral loads and LTF is another area 
indicating a need for modification in the public sector ART service delivery in South Africa.  As 
mentioned above, annual viral load monitoring of patients on ART is recommended so that 
patients and the caregivers can monitor the patient’s viral load.  In addition to this, systems need 
to be put in place that raise a red flag to the clinician and other relevant clinic staff when the viral 
loads go from undetectable to detectable range.  This is important in terms of monitoring 
development of ART drug resistance in the patient, identifying possible ART adherence issues, 
and providing additional counseling to patient to adhere to their ART appointment as they are at 
higher risk of LTF.   
Given the high acceptability and feasibility of mHealth related interventions in South 
Africa, along with the evaluation outcomes, the appointment reminder intervention can be scaled 
up to other sites. In addition, other fields such as MCH, immunizations, and tuberculosis 
treatment could benefit from mHealth projects similar to the appointment reminder intervention 
as these health service areas require frequent visits to the clinic whether they are for pre-natal 
visits for MCH or immunizations which have to be given to children at specific ages or for TB 
which usually requires an intensive treatment regimen for six months or longer. Similar to ART, 
TB treatment is an area that requires the patients to be strictly adherent to the treatment regimen 
for it to be fully effective and to avoid development of drug resistance.  
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The appointment reminder interventions was funded by the US Government as a public 
private partnership grant in conjunction with the Vodacom Foundation – the not for profit 
division of Vodacom, one of the largest cell phone companies in Africa and Europe. Vodacom 
had provided subsidized rates for SMS messages for this intervention however, if the South 
African Government is going to take this and related mHealth interventions to scale in the 
country, then a cost effectiveness study needs to be conducted. 
The next steps after the conclusion of this dissertation includes sharing of the information 
with the stakeholders including the host institution, individuals enrolled in the intervention, clinic 
leadership, funders of the mHealth projects and the South African NDoH. The results will be 
disseminated via a formal correspondence to the host institution to share with the NDoH and 
presented at public health conferences. The dissertation information will be used to develop an 
article for a peer-reviewed journal. 
Implications 
Positive Social Change 
As stated in earlier chapters, the social change impact of this study is substantial at 
various levels. At the individual level, the intervention is an effective external cue to action that 
reminds and assists the individuals to adhere to their ART appointments. Some individuals found 
the appointment reminders motivating. Evidence of this was found from some anecdotal 
comments from the study staff, who stated that patients felt that “someone (clinic) cared about 
them”. Another instance was an example from the MCH mHealth project when a pregnant 
woman shared the weekly SMS message she received regarding her baby’s growth and other 
information for that week, with other women in the waiting room. This led to a surge in women 
wanting to enroll in the mHealth MCH project.    
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This intervention and the results from this study are important at the family level too as 
studies in the scientific literature, listed in chapter 2, have shown that adherence on ART and 
retention in care reduced the risk of HIV related complications and other illnesses. If the 
individual is healthy then they can provide for and support their family much better. At the 
organizational level, the results from this intervention and study can have a positive impact on 
the quality of the services provided by the clinic, and the funding of the services by the DoH. If 
individuals are adhering to their appointment date, the clinic can have improved scheduling 
leading to reduction in patient waiting times, and the clinic leadership can better plan for their 
ARV stocks. Since there is a lower chance of individuals developing treatment resistance when 
they are adherent on ART, the clinic can save on the costs of running some of the expensive viral 
resistance blood tests.  
Loss to follow up is a major issue that the NDoH is struggling with in South Africa and 
the results of this study provide an evidence base for an innovative solution to reduce LTF. 
Appointment reminders can be included as standard of care and offered to all individuals 
initiating ART in the public sector. This study along with the feasibility, acceptability and pilot 
studies results provide compelling evidence that mHealth is an effective mode of reducing LTF 
and improving retention in care of individuals on ART. At the scientific community level, the 
results of this study provide evidence on the effectiveness of mHealth to reduce LTF in a low 
resource setting and in the field of HIV/AIDS. The results from this study will be useful to 
support some of the mandates of international policy organizations such as the Joint United 
Nations Programme on HIV/AIDS (UNAIDS) or for funding programs such as the President’s 
Emergency Plan for AIDS Relief (PEPFAR). In the 2014 gap report, UNAIDS set an ambitious 
goal of 90/90/90 to end the HIV epidemic by 2020. That is, by 2020: 90% of all people living 
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with HIV will know their HIV status, 90% of all people diagnosed with HIV infection will 
receive ART, and 90% of all people receiving ART will have viral suppression. (UNAIDS Gap 
report, 2014). PEPFAR is currently in its third five-year cycle and the leadership has made 
90/90/90 the main objective of PEPFAR 3. This intervention supports the third 90 in the 
90/90/90 that is maintenance of viral suppression once individuals have initiated on ART 
(OGAC presentation, 2014). 
Conclusion 
This study responded to the gaps identified in the scientific literature and provided 
evidence on the effectiveness of using mHealth interventions to improve post ART retention in 
care and treatment in a resource limited setting. Reduction of LTF rates has a positive social 
impact from the individual to the international donor level. In the history of man, no other 
technology has been accepted and adapted at the level that cell phone use and technology has 
achieved. Cell phone coverage is available to population in the richest to the lowest resourced 
countries, and cell phones are in use in the largest cities to the remotest parts of the world. The 
cell phone coverage continues to increase at a phenomenal rate. Consequently, the acceptability 
and feasibility of using cell phones in the field of medicine and public health is also continuing 
to strengthen. This study indicates that mHealth interventions have the capability to reach and 
lead to behavior change at the individual level, support HIV related public health service goals of 
individual countries, and provide solutions to meet the global targets set my policy making and 
funding entities.  
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